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palavras-chave 
 
Eletrofiação, suportes celulares, engenharia de tecidos, hérnia abdominal, 
poli(3-hidroxibutirato-co-3-hidroxivalerato), quitosana, poli(tereftalato de 
etileno). 
resumo 
 
 
Esta tese centra-se no desenvolvimento de materiais biodegradáveis e não-
degradáveis produzidos por eletrofiação com aplicação na área biomédica. O 
poli(3-hidroxibutirato-co-3-hidroxivalerato) (PHBV), um poliéster biodegradável, 
foi selecionado como base dos materiais biodegradáveis, enquanto o 
poli(tereftalato de etileno) (PET), um polímero sintético, estável e 
biocompatível, foi selecionado para a produção das matrizes não degradáveis. 
Adicionou-se quitosana aos sistemas com o objetivo de melhorar o processo 
de eletrofiação e as propriedades morfológicas, físico-químicas e biológicas 
dos materiais resultantes. 
A composição química, bem como as características morfológicas e físico-
químicas dos materiais em estudo, foram manipuladas de modo a otimizar a 
sua performance como suportes celulares para engenharia de tecidos. Foram 
realizados estudos in vitro com cultura de fibroblastos L929 para avaliar o 
comportamento das células, i.e. viabilidade, adesão, proliferação e morte, 
quando cultivadas nas matrizes produzidas por eletrofiação. Adicionalmente 
foram realizados ensaios in vivo para investigar o potencial dos materiais em 
estudo na regeneração cutânea e como tela abdominal. 
Os principais resultados encontrados incluem: o desenvolvimento de novas 
matrizes híbridas (PHBV/quitosana) adequadas ao crescimento de fibroblastos 
e ao tratamento de lesões de pele; o desenvolvimento de um sistema de 
eletrofiação com duas seringas para a incorporação de compostos bioativos; 
diversas estratégias para manipulação das características morfológicas dos 
materiais de PHBV/quitosana e PET/quitosana produzidos por eletrofiação; 
uma melhoria do conhecimento das interações fibroblastos-suporte polimérico; 
a verificação de uma resposta inflamatória desencadeada pelos materiais não-
degradáveis quando utilizados no tratamento de defeitos da parede abdominal, 
o que sugere a necessidade de novos estudos para avaliar a segurança do uso 
de biomateriais produzidos por eletrofiação. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
keywords 
 
Electrospinning, scaffold, tissue engeniering, abdominal hernia, poly(3-
hydroxybutyrate-co-3-hydroxyvalerate), chitosan, polyethylene terephthalate.  
abstract 
 
This thesis focuses on the development of biodegradable and non-degradable 
electrospun materials with application in the biomedical field. Poly(3-
hydroxybutyrate-co-3-hydroxyvalerate) (PHBV), a natural biodegradable 
polyester, was selected as the basis of the biodegradable materials while 
polyethylene terephthalate (PET), a biocompatible stable synthetic polyester, 
was selected for the production of the non-degradable ones. Chitosan was 
added to both systems in order to enhance electrospinnability as well as 
morphological, physico-chemical, and biological features of the biomaterials. 
The chemical composition, morphological and some physico-chemical 
characteristics of these materials were manipulated toward an optimized 
biological performance as scaffolds for tissue engineering. In vitro cell culture 
studies were performed with L929 fibroblasts in order to study the cell behavior, 
i.e. viability, adhesion, proliferation and death, when cultured on the 
electrospun materials. Furthermore, in vivo assays were conducted in order to 
investigate the potential of the materials under study for skin and abdominal 
wall repair. 
The main achievements of this thesis include: the development of new 
PHBV/chitosan hybrid mats suitable for fibroblasts growth and with a good 
performance when used as a scaffold for skin repair; the development of a dual 
syringe electrospinning system for incorporation of bioactive compounds; 
several strategies to manipulate the morphological characteristics of 
electrospun materials of both PHBV/chitosan and PET/chitosan blends; an 
improvement of the knowledge of cell-scaffolds interactions; the detection of an 
important inflammatory response elicited by the non-degradable electrospun 
materials when used as prosthetic meshes for abdominal defect repair, 
suggesting the need of further studies on the safety of nanosized electrospun 
biomaterials. 
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Preface 
One of the biggest challenges of biomaterials development is to integrate knowledge from 
different scientific fields such as chemistry, pharmacology, materials science, biology, and 
medicine. From the raw material to the final design, there is a long journey to be travelled 
before obtaining a biomaterial with characteristics that matches specific requirements for a 
certain application. This development process includes several steps since the first 
experiments on the lab bench until the last clinical trials. This PhD research comprises the 
first exploratory phases of the development of electrospun materials with application in the 
tissue engineering field. We have focused on two main nanofibrous systems: a 
biodegradable one based on a bacterial polyester, poly(3-hydroxybutyrate-co-3-
hydroxyvalerate) (PHBV), and a non-degradable based on a synthetic polyester, 
polyethylene terephthalate (PET). In both systems chitosan was added as a tool to 
manipulate morphological, physico-chemical, and biological features of the biomaterials. 
The electrospinning fabrication process and the properties of the nanofibrous materials 
such as morphology, biodegradability, and surface properties were studied. Fibroblasts 
were selected to analyze the behavior of cells when cultured on the scaffolds, since they 
are the most abundant cells of connective tissue and they play a determinant role not only 
in the wound healing of skin, but in several other body processes. Viability, adhesion, 
spreading, proliferation, ECM secretion, and dead of cells cultured on the scaffolds were 
studied in vitro, and in vivo models were applied as preliminary tests to evaluate the 
performance of those materials in specific applications.  
The main objectives of this thesis are: 
I. To develop PHBV/chitosan (PHBV/C) electrospun hybrid mats suitable for skin 
engineering applications; 
II. To incorporate bioactive extracts from Aloe barbadensis and Ilex paraguariensis in 
the PHBV/C blends and to study their effects on cell behavior and wound healing 
process; 
III. To manipulate the chemical composition and architecture of non-biodegradable 
PET/chitosan (PET/C) scaffolds and to study their effects on L929 cell behavior; 
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IV. To study the performance of an electrospun mat of PET as a non-absorbable wound 
dressing membrane; 
V. To evaluate the potential of PET and PET/C non-degradable electrospun mats as 
abdominal meshes for incisional hernia repair. 
 
This thesis is organized in seven chapters. The first Chapter presents a bibliographic 
review of the main issues treated in this thesis including the electrospinning process and 
some key topics in the biomaterials and tissue engineering fields. In the subsequent 2 
chapters, the development of biodegradable materials with application in skin engineering 
is reported. Indeed, in Chapter 2  we describe the development of a new hybrid 
nanofibrous material of PHBV and chitosan with potential of application in the wound 
healing process. Several issues were studied, including the optimization of the 
electrospinning process, the characterization of hybrid mats, and the evaluation of their 
potential as scaffolds for skin engineering using both in vitro and in vivo methodologies. 
The PHBV/C blend that exhibited the best performance for skin engineering purposes was 
selected as the basis of the dual-fiber mats developed in Chapter 3 . In this chapter, our 
main purpose was to develop a dual syringe electrospinning system with one aqueous 
polymer solution that allows the incorporation of herbal extracts. Phytochemical extracts 
from Aloe barbadensis and from Ilex paraguariensis with biological activities in the 
wound healing process were chosen. 
In Chapter 4 the application of an electrospun mat of PET as a removable wound 
dressing material is discussed and Chapter 5  is dedicated to the development of non-
degradable fibrous scaffolds made of PET and chitosan. In a similar approach to that of 
Chapter 2, we studied the nanofibers production by electrospinning, the characteristics of 
the electrospun mats, and we evaluated the potential of these materials in tissue 
engineering with in vitro cell culture studies. Chapter 6  reports the application of PET 
and PET/C hybrid mats as meshes for abdominal defects repair.  
Finally, Chapter 7  is devoted to the main conclusions as well as some suggestions for 
future work.  
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1.1. Biomaterials 
A biomaterial is defined as any substance (other than a drug) or combination of substances, 
synthetic or natural in origin, which can be used for an extended period of time, as a whole 
or as a part of a system which treats, augments, or replaces any tissue, organ, or function of 
the body (Boretos and Eden 1984).  
Polymers are the most widely used materials in the biomedical field. Because of their easy 
manufacturability and good processability, as well as the wide range of mechanical, 
chemical, and physical properties available, polymers are often the material of choice in 
medical applications. Numerous polymeric biomaterials are currently available in the 
market, including orthopedic prosthesis, abdominal meshes, vascular grafts, scaffolds for 
tissue engineering, breast implants, contact lens, sutures, and wound dressings.  
Synthetic polymers are by far the most used in biomaterials due to their mechanical 
properties, thermo stability and easy processability. Nevertheless, there has been an 
increasing interest in natural polymers, mainly because of their biocompatibility and 
biofunctionality. Blending synthetic and natural polymers has been an alternative approach 
to obtain materials with increased mechanical and biological performances, compared with 
those of single components. 
Many techniques have been used to fabricate a broad variety of polymeric biomaterials. 
Among them, electrospinning has become an outstanding technology for the fabrication of 
micro and nanofibrous materials. The following subsection provides a brief review of the 
electrospinning process and the production of nanofibrous biomaterials with application in 
medicine. 
1.2. Electrospinning 
Electrospinning technique uses an electric field to produce micro and nanofibers from a 
polymeric solution. Although it was first patented in 1934 by Formhals (Formhals 1934), 
electrospinning has only become popular in the 90s. In fact, the growing interest in 
nanotechnology and the search for new materials have reintroduced this technique. Since 
then, most of the research effort has focused on exploring what polymers can be 
.$%/+0',12*& ( 3#0'2, &4"+, & ('0 &,5 3* &"*6&"#6'43*"$ &7"$ $ & 0%1"30 &
&
&G&
electrospun and on optimizing the nanofiber production towards specific applications. 
Numerous polymers have been successfully electrospun into nanofibers including synthetic 
polymers such as polyvinyl alcohol (PVA), poly(ethylene oxide) (PEO) and polylactic acid 
(PLA), and biopolymers, e.g. collagen, silk, and chitosan (Koski et al. 2004; Jin et al. 
2002; Kenawy et al. 2002; Chen et al. 2008).   
The standard configuration of the electrospinning system consists of a high voltage power 
supply, a syringe pump with a syringe and a metallic needle, and a grounded collector. 
During the electrospinning process, a high voltage current is applied to create electrically 
charged jets of a polymeric solution. As these jets travel from the needle tip to the 
collector, the polymer molecules are stretched and the solvent evaporates generating fibers. 
Usually, these fibers are collected as nonwoven fibrous mats on a static or rotating 
collector. The electrospun mats are characterized by a high porosity, small pore sizes with 
an interconnected structure, and a large surface area per unit volume. These characteristics 
have made the electrospun mats attractive in a variety of applications, including filtration 
(Shin et al. 2005; Gopal et al. 2006), protective clothing (Schreuder-Gibson et al. 2002), 
and biomedical applications (e.g., tissue engineering scaffolds, vascular grafts, and drug 
delivery systems) (Barnes et al. 2007; Khil et al. 2005; Chen et al. 2006; Ma et al. 2005; 
Powell and Boyce 2008; Sikareepaisan et al. 2008).  
Versatility is one of the most important advantages of electrospinning technique. Different 
morphologies can be achieved by varying configuration and parameters of the 
electrospinning process. Creative electrospinning setups have been developed in order to 
obtain mats with distinctive characteristics such as aligned (Li et al. 2003), porous (Hsu 
and Shivkumar 2004), hollow (Li and Xia 2004), and core-shell nanofibers (Sun et al. 
2003). Furthermore, many systematic studies have brought advances in the knowledge of 
the governing parameters of the electrospinning process. In spite of it, optimizing the 
electrospinning system is still a laborious task due to the high number of parameters that 
affect the process and the interdependence among them. Even more, the electrospinning 
setup and the parameters optimization are tightly related to the polymer and solvent 
system. Nevertheless, some general principles about the parameters that affect the 
electrospinning process will be discussed in the following section.  
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1.2.1. Governing parameters of the electrospinning process 
The chemical composition of the electrospinning solution is the key component of the 
physico-chemical, mechanical, and biological properties of the electrospun mat. The 
intrinsic proprieties of the selected polymers reflect on the final characteristics of the 
electrospun mat, while the nanofibrous arrangement brings unique features to the material. 
Varying concentration and molecular weight (MW) of the polymer are the most effective 
way to control the morphology of the electrospun mats, especially the diameter of the 
fibers. Rising concentration and MW increases the fiber diameter as a result of the increase 
in solution viscosity. The diameter of PET nanofibers, for example, augmented from 201 
nm to 729 nm by changing the solution concentration from 10 wt.% to 30 wt.% 
(Veleirinho et al. 2008). Koski et al. (2004) have reported augmented PVA fiber diameters 
from 250 nm to 2 µm, by increasing the polymer concentration and MW . 
In case of polymer blends, changing the polymer ratio can be a strategy to modify not only 
the morphology but also mechanic and physicochemical characteristics of the electrospun 
mats. For example, by increasing the chitosan concentration in hybrid systems of PVA and 
chitosan, the electrospinnability and uniformity of fibers have been improved (Lin et al. 
2006). Modifications on mechanical properties have also been achieved by changing 
polymer ratio in blends of pullulan and PVA (Karim and Islam 2011). In PVA and 
quaternized chitosan blends, the increase of chitosan derivative ratio resulted in smaller 
fiber diameters and higher antibacterial effect (Alipour et al. 2009). Another example is the 
improved hydrophilicity, cell viability, and proliferation of vascular smooth muscle cells in 
poly (l-lactide)/polyvinyl pyrrolidone (PVP) systems with the increasing ratio of PVP (Xu 
et al. 2009). 
The effect of solvent is complex since several properties affect the electrospinning process. 
In general, solvents with low surface tension, high volatility, and high dielectric constant 
improve the electrospinnability and decrease the diameter of the electrospun fibers 
(Veleirinho et al. 2008; Chuangchote et al. 2009). 
Lastly, the operational parameters and the collection conditions also influence the final 
traits of the electrospun mats. The applied voltage is the most critical parameter as there is 
a minimum voltage required for the fiber formation according to the polymer/solvent 
system. Above such value, the increase of applied voltage results, generally, in smaller 
fiber diameters, as a result of the increased stretching.  There are several reports showing a 
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strong dependence of the fiber collection conditions such as collector distance, humidity, 
and temperature on the final characteristics of the mats. Amiraliyan et al. (2009) have 
shown that the shape of silk-based nanofibers changed from a circular morphology with 
smooth surface to flattened with ribbon-like shape with the increase of temperature from 
25ºC to 75 ºC. Additionally, Casper et al. (2004) have demonstrated the formation of pores 
on the surface of polystyrene fibers for environmental humidity above 30%.  
1.3. Tissue Engineering  
Over the past decades tissue engineering has emerged as a field of growing importance 
with promising solutions for tissue and organ regeneration, and as one of the most 
important areas for application of electrospun micro- and nanofibrous mats. A general 
overview of the aims of tissue engineering and the use of electrospun scaffolds in this field 
is presented subsequently. 
Tissue engineering is an interdisciplinary field that combines the knowledge of multiple 
disciplines, i.e. biology, chemistry, materials engineering, and clinical research, towards 
the development of substitutes that restore or improve the function of a biological tissue. 
One outstanding strategy has been the use of artificial scaffolds to provide a propitious 
environment for the regeneration of a certain tissue or organ.  
Several attempts have been made to create either biodegradable or non-degradable 
materials that mimic the complex structure of the natural (cell-derived) extracellular matrix 
(ECM). Biodegradable scaffolds are thought to support cells for a temporary period, until 
they produce native ECM components.  Numerous biodegradable scaffolds have been 
developed for different uses e.g. skin (Blackwood et al. 2008; Lee et al. 2007; Huss et al. 
2010), bone (Kim et al. 2006; Yoshimoto et al. 2003), and cartilage (Lubiatowski et al. 
2006) repair. However, in some situations, where a complete regeneration cannot be 
achieved or when tissue withstands high tensile loads, a long-term non-degradable scaffold 
is required. Vascular grafts (Ma et al. 2005; Blanchemain et al. 2005), abdominal wall 
repair meshes (Klosterhalfen et al. 1998),  ligament and tendon grafts (Seitz et al. 1998; 
Iannace et al. 1995), and bone tissue engineering (Jansen et al. 2005) are some examples 
where non-degradable biomaterials are applied. 
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Among the several polymers that have been used to produce electrospun mats, PET, 
PHBV, and chitosan possess several attributes that make them particularly interesting in 
tissue engineering. These were the polymers used in this thesis and, therefore, further 
details covering this subject will be reviewed following in this chapter. 
1.3.1. Application of polymers in tissue engineering  
1.3.1.1.  PET 
PET is a linear aromatic polyester with remarkable biological features, including 
biocompatibility and biostability (Moukwa 1997) . PET has long been used in vascular 
grafts, orthopedic prosthesis, and abdominal meshes, for example. More recently, PET 
materials have been developed for tissue engineering of bone, cartilage, tendon, and blood 
vessels (Moreno et al. 2011; Neves et al. 2005; Lu et al. 2005). PET has been successfully 
electrospun into nanofibers with potential application as scaffolds for blood vessel or bone 
engineering (Ma et al. 2005; Veleirinho et al. 2008; Lu et al. 2005). Despites the potential 
of PET nanofibrous mats, few studies are available regarding their application in the 
biomedical field. Particularly less frequent are the reports describing the biomedical 
potential of usage of these non-degradable nanofibrous mats based on in vivo models. Such 
an approach is essential taking into consideration the protocols for developing products for 
human health.  
1.3.1.2.  PHBV 
Polyhydroxyalkanoates are an emerging class of biodegradable polyesters that have been 
widely studied as an alternative to petroleum based plastics, due to their similarities in 
mechanical, physical and thermoplastics properties (Avella et al. 2000). Moreover, these 
polymers have shown to be biocompatible and non-toxic turning them also attractive for 
biomedical applications (Sombatmankhong et al. 2007). Among the 
polyhydroxyalkanoates, poly(3-hydroxybutyrate) (PHB) and its copolymer PHBV have 
been the most explored in both scientific and industrial fields. Compared to PHB, PHBV is 
less crystalline, more flexible, and more biodegradable (Avella et al. 2000; Chen et al. 
2002; Chan et al. 2004). These characteristics make PHBV especially attractive in the 
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biomedical field. There are several reports about electrospinning of PHBV, pure or 
blended with other polymers, including gelatin, collagen, and keratin (Meng et al. 2008; 
Meng et al. 2007; Yuan et al. 2009; Suwantong et al. 2007b). Interestingly, the electrospun 
nanofibers of PHBV have demonstrate ability to support in vitro growth of fibroblast 
(Suwantong et al. 2007b). More recently, in vivo animal models have revealed promising 
results regarding the application of PHBV mats in skin engineering (Han et al. 2007; 
Kuppan et al. 2011). However, the cellular responses involved in the skin regeneration 
process are not enough explored, hampering a more rational strategy for developing skin 
repair products with technological and economical appeal. 
1.3.1.3.  Chitosan 
Chitosan is a cationic polysaccharide essentially composed by a linear chain of N-acetyl-
glucosamine and glucosamine residues linked by !-(1-4) bonds, with a predominance of 
the non-acetylated residues. Chitosan has been one of the most studied biopolymers in the 
biomedical field due to its notable proprieties i.e. biocompatibility, wound healing effect, 
anti-inflammatory, and antimicrobial activity (Ueno et al. 2001; VandeVord et al. 2002; 
Zheng and Zhu 2003; Ueno et al. 1999). Chitosan fibers were successfully produced by 
electrospinning using concentrated acetic acid (Geng et al. 2005) and trifluoracetic acid 
(TFA) (Ohkawa et al. 2004). However, the poor mechanical properties of these fibers have 
restricted biomedical applications and therefore a number of blends with other polymers 
have been proposed, e.g. chitosan blends with PET (Lopes-da-Silva et al. 2009), 
polylactide (Peesan et al. 2006), PVA (Li and Hsieh 2006; Lin et al. 2006), and PEO 
(Duan et al. 2004; Spasova et al. 2004; Subramanian et al. 2005). 
When used in polymer blends, chitosan not only improves biological properties of hybrid 
electrospun mats, but also their morphology, hydrophilicity, and biodegradability (Lin et 
al. 2006; Lopes-da-Silva et al. 2009; Peesan et al. 2006). 
1.3.2. Scaffolds: a provisory environment for cells 
The comprehension of the basic phenomena of cell-substratum interaction is claimed as 
essential for the development of tissue engineering scaffolds. In the subsequent 
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subsections, a brief review of key aspects of cell adhesion in natural and artificial 
environments will be presented. 
1.3.2.1.  Focal adhesion 
In their natural environment, anchorage dependent cells adhere to the ECM. The ECM is a 
network of macromolecules, including proteins and polysaccharides. There are several 
forms of ECM found in connective tissues such as bone, tendon, and skin.  In the skin, for 
example, EMC is a thin, tough, flexible sheet of macromolecules usually denominated 
basal lamina. The basal lamina supports the epidermis and is essential for the barrier and 
mechanical attributes of the skin. 
The ECM not only provides support for cells but also participates in numerous cellular 
events, including attachment, proliferation, communication, differentiation, and 
morphogenesis (Lukashev and Werb 1998; Brown 2000; Bowers et al. 2010; Boudreau 
and Bissell 1998). Cell adhesion proteins from the plasma membrane, i.e. integrins, attach 
the cell to the external environment and function as a communication gate with a powerful 
influence on cell behavior. Integrins are heterodimeric glycoproteins composed of two 
subunits (" and !). The extracellular domain of integrin binds to specific amino acid 
sequences from ECM proteins. The most important one is the arginine-glycine-aspartic 
acid (RGD) peptide. The intracellular domain is linked to the !-actin from the cytoskeleton 
via a complex of proteins that includes talin, vinculin, "-actin, and paxillin. When integrin 
binds to a ligand, several intracellular events occur initiating different signaling pathways. 
This is an outside-in regulation, as outside signals modulate intracellular events. 
Additionally, cells also regulate its interaction with ECM by activating integrin receptors 
or by changing the conformation of the cytoskeleton (inside-out signaling). In this context, 
the substratum is an active participant of the cell adhesion process, commanding several 
cellular events. In anchorage dependent cells, adhesion to a substratum is even more 
important for cell survival. It is well established that focal adhesion has an anti-apoptotic 
effect on anchorage dependent cells. In a remarkable study, Chen et al. (1997) have shown 
that cells underwent programmed cell death when spreading was limited to islands of 20 
!m of diameter. However, if the spaces among multiple islands were lower than 10 !m, 
cells were able to spread across the spaces and establish focal adhesion points on the 
neighbor adhesion islands, switching off apoptosis.  
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1.3.2.2.  Adhesion in artificial substrata 
As in natural environment, adhesion of cells to artificial scaffolds is also crucial for the 
viability and subsequent activities of cells. Scaffolds must provide conditions for cell 
adhesion and spreading. In the absence of RGD motifs, adhesion initially occurs through 
proteins adsorbed on the surface of the biomaterial from blood, plasma or serum.  
Several strategies have been adopted to improve the adhesion of cells to biomaterials. 
Coating artificial substrata with ECM components, e.g. fibronectin and collagen, has been 
a common approach (Vo et al. 2001; Min et al. 2004). Although in vitro this procedure is 
usually successful, the use of proteins bears some disadvantages. Firstly, proteins have to 
be extracted and purified from organisms and the use of proteins has been many times 
associated with inflammatory or immune responses. Moreover, interactions with the 
biomaterial surface can alter the protein conformation, obstructing the cell binding motifs, 
and hampering the adhesion process. To overcome these limitations, immobilization of 
RGD motifs on the surface of biomaterials has been another adopted strategy, with several 
studies reporting an improvement in cell adhesion by immobilization of RGD sequences 
on electrospun mats (Gentsch et al. 2011; Wang et al. 2012; Kim and Park 2006). 
However, mimicking the natural pattern of RGD distribution at the molecular level is a 
challenging task. Moreover, the RGD motif is not an isolated binding site. The surrounding 
amino acids, the conformation of the protein, and the distance among RGD residues also 
influence the adhesion and spreading of the cell. Even more, the distribution and 
arrangement of ECM on natural proteins depends on the cell type. Providing an attachment 
that allows and stimulates ECM synthesis and deposition in the scaffold may be a 
preferable strategy. An improved biocompatibility and adhesion could be achieved since 
cells would produce ECM according to their own needs. Additionally, ECM deposition, as 
well as cell proliferation, could occur in parallel to the biodegradation of the scaffold, 
replacing the provisory substratum with the regenerated tissue. 
Architecture ultimately determines the cell-scaffold interactions and the functionality of 
the regenerated tissue. Porosity, distribution and pore size of biomaterials affect cell 
behavior, i.e. morphology, attachment, differentiation, and function (Ng et al. 2009; 
Kasten et al. 2008; Papenburg et al. 2009). Fiber diameters and orientation are also thought 
to have an important effect on the potential of fibrous scaffolds as substratum for cells 
(Yang et al. 2005; Moroni et al. 2006). For instance, for poly(D, L-lactic-co-glycolic acid) 
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electrospun scaffolds, Bashur et al. (2006) showed that the fibroblast area increased with 
the augment of fiber diameter from 0,14 !m to 3.6 !m, but proliferation was not sensible 
to fiber diameter. On the other hand, Badami et al. (2006) revealed an increase of 
osteoblastic cells density on PLA fibrous scaffolds, with the enlargement of fiber diameter 
from 0.14 !m to 2.1 !m. In a recent paper, Lowery et al. (2010) showed a faster rate of 
proliferation of human dermal fibroblasts in policaprolactone (PCL)/PEO nanofibers for 
pore diameters greater than 6 !m. Also, when the pore diameter changed from 12 !m to 23 
!m cells tended to adhere to single fibers instead of multiple ones. Thus, as a general 
remark, the ideal design of a scaffold is always dependent on its composition and 
application and the manipulation of its architecture constitutes an important tool to control 
scaffold-cell interactions and, ultimately, to obtain the best design for a certain application. 
The regeneration of skin has been an important target for tissue engineering. In this context 
the morphology of the electrospun nanofibrous scaffolds is particularly relevant for skin 
repair. In the following sections the application of electrospun mats for the treatment of 
skin will be discussed. 
1.3.3. Skin engineering 
The skin is the largest organ of the human body and constitutes the major physical barrier 
to external pathogens, as well as mechanical, chemical, thermal or radiation insults. The 
skin also controls the body temperature and prevents the loss of body fluid. Several 
metabolic pathways such as the vitamin D synthesis take part in the skin. It is also the main 
sensory organ, richly supplied by nerve terminals and receptors for touch, temperature, and 
other stimuli.  
The skin is composed of two main layers, the epidermis and the dermis. The epidermis 
comprises several layers of keratinocytes fusing together and establishing an effective 
barrier against the outside environment. Three less abundant cells, i.e. melanocytes, 
Langerhans cells, and Merkel cells, are also found in the epidermis. The dermis consists of 
vascularized connective tissue with abundant ECM, especially collagen. It is normally 
subdivided in two sub layers, the papillary and the reticular layers. The first one is more 
cellular and has thin and less organized collagen arrangement. The reticular dermis is 
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mostly composed by bundles of tick collagen fibers aggregated. The dermis contains 
several appendages including hair follicles, sweat, and sebaceous glands.  
1.3.3.1.  Wound healing 
In case of injury, when the skin barrier is destroyed, the body immediately initiates a 
complex wound healing process. The duration of this process depends on the extension of 
the damage; nevertheless, wound healing is typically divided in four phases: hemostasis, 
inflammation, proliferation, and maturation. These phases are not strictly separated events; 
on the contrary, they overlap each other.  
The wound healing process begins with hemostasis. The main purpose of hemostasis is to 
control bleeding. This is achieved by a rapid vasoconstriction, followed by platelets 
aggregation in order to provide a provisionary plug. The coagulation cascade is then 
initiated to form the fibrin clot. The coagulation cascade is a series of enzymatic reactions 
in which prothrombin is activated into thrombin and thrombin converts fibrinogen to 
fibrin. Fibrin is then cross-linked, resulting in a polymeric mesh with platelets embedded 
that constitutes the fibrin clot. 
The fibrin clot protects the wound against external contaminants and serves as a 
provisional matrix during the repair process. The fibrin clot has also an important function 
in signaling further events of the healing process since it provides numerous cytokines and 
growth factors. The most important ones are platelet derived growth factor (PDGF) and 
transforming growth factor beta (TGF-!). PDGF attracts neutrophils, macrophages, 
fibroblasts, and smooth muscle cells to the wound site and also stimulates the proliferation 
of fibroblasts and smooth muscle cells. In its turn, TGF-! has an important function in 
attracting and activating macrophages. 
The degranulation of platelets triggers the recruitment of inflammatory cells to clean the 
wound. This is the beginning of the inflammatory phase, which can be macroscopically 
identified by redness, heat swelling, and pain. Vasodilation and increased permeability of 
blood vessels occur to facilitate plasma proteins and leucocytes penetration in the wound 
area. Polymorphonuclear (PMN) cells, mainly neutrophils, are the first cells to arrive at the 
wound site, usually four hours after injury. The main role of these cells is to eliminate 
bacteria, debris, and foreign bodies. Despite the rapid action of neutrophils, the activity of 
these cells is strictly associated to damages in the surrounding tissues. Mononuclear (MN) 
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cells, especially monocytes, arrive in the wound site approximately 48 hours after injury. 
Monocytes are activated into macrophages, a key cell on the wound repair process. 
Macrophages continue to clean the wound by phagocytosis and by secreting cytokines and 
growth factors, including PDGF, fibroblast growth factor (FGF), tumor necrosis alpha, and 
interleukin I. 
During the proliferative phase, fibroblasts are activated, proliferate and start to produce 
and secrete collagen, which replaces the provisional ECM. The granulation tissue is 
characterized by a high density of new blood vessels as a result of the intense 
angiogenesis. Angiogenesis is essential for the nutrition of the developing tissue and is 
stimulated by several growth factors including vascular endothelial growth factor (VEGF), 
FGF and TGF-! that are secreted by fibroblasts, macrophages, epidermal, and endothelial 
cells. Simultaneously, re-epithelialization is stimulated by epidermal growth factor (EGF) 
and transforming growth factor alpha that are produced by macrophages, platelets, and 
keratinocytes. Re-epithelialization occurs as a result of keratinocytes proliferation and 
migration from the wound edges and skin appendages towards the center of the wound. 
Wound contraction is another important phenomenon in the wound closure process. 
During contraction the surrounding skin is pulled toward the wound in order to decrease 
the wound site without the need of new tissue formation. Although contraction is important 
for a rapidly closure, a decrease in function of the tissue is usually a consequence of this 
phenomenon. 
Remodeling of tissue initiates during the proliferative phase and persists for weeks, months 
or years. During remodeling the cellularity of the granulation tissue gradually decreases as 
a result of cell apoptosis. Additionally, a series of rearrangements of ECM take place, i.e. 
changes in the ratio of various collagen types, fibril arrangement, and cross-linking of 
collagen in order to maximize the tissue strength.  
The consequence of wound repair is a scar, which is brittle, less elastic than normal skin, 
and does not contain skin appendages. 
1.3.3.2.  Impairment of wound healing 
Several conditions can lead to prolonged healing times or even to a failure of wound 
healing process. Upon such conditions, wounds are classified as chronic wounds. The 
factors that contribute to the non-healing condition of these wounds include foreign bodies, 
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infection, pressure, advanced age, diabetes, or other chronic diseases. The most common 
chronic wounds are venous ulcers, pressure ulcers, and diabetic foot ulcers.  
The major goal of skin engineering is to develop strategies to help the body to complete 
the regeneration when a given clinical condition hampers the normal healing process. A 
common approach has been the use of biodegradable scaffolds to sustain and guide cellular 
growth through the regeneration process. The scaffold role is to provide an artificial 
environment for cell adhesion, migration, and spread thus allowing the cell proliferation 
and ECM synthesis.  
1.3.3.3.  Electrospun mats as scaffolds for skin engineering 
Several characteristics of the electrospun mats are attractive for skin engineering. These 
includes: 
• Architecture and dimensional similarity with the ECM structure; 
• Ability to promote attachment, migration, and proliferation of cells, such as 
fibroblasts and keratinocytes; 
• The microporous structure that confers protection against bacteria and other 
contaminants and allows gas exchanges while maintaining a moist environment;  
• The high surface area to volume ratio, which enhances the ability to absorb 
exudate; 
• The possibility to make fibers of functional polymers or add bioactive compounds 
in the polymeric mesh. Even more, a system with controlled release of bioactive 
compounds can be developed. 
 
Several electrospun mats have been proposed as wound dressing materials including 
polyurethane (Khil et al. 2003), collagen/chitosan (Chen et al. 2008; Ma et al. 2003), 
chitosan/ polyethylene glycol (Tchemtchoua et al. 2011), PVA/silver (Hong 2007), and 
water-soluble carboxyethyl chitosan/PVA  (Zhou et al. 2008) mats. Additionally, 
electrospun mats for controlled release of drugs (Katti et al. 2004) or even herbal extract 
(Sikareepaisan et al. 2008) have also been developed. Incorporation of growth factors such 
as FGF (Yang et al. 2012) and EGF (Choi et al. 2008) or angiogenesis factors (Kuppan et 
al. 2011) has successfully improved the wound healing process, even in diabetic animals. 
More refined approaches, such as co-culture of hair follicular epithelial and dermal cells on 
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PHBV based mats have also demonstrated great potential in the wound healing treatment 
(Han et al. 2007).  
Despite the enormous research progress over the past decades, the development of 
electrospun scaffolds for skin engineering is still in the laboratory phase. The current 
scenario of increasing age-related problems and chronic diseases urge for new cost-
effective solutions to treat extensive or chronic wounds.  
1.4. Concluding remarks 
Electrospinning has attracted the interest of researchers from different fields as a simple 
and versatile technique to produce nanofibers with a wide range of application in medicine. 
Many studies have improved the knowledge of the electrospinning process and different 
approaches have confirmed the potential of the electrospun materials in the biomedical 
field. Despites all the promising results, much remains to be studied, particularly the 
design of strategies to manipulate the morphological characteristics of the electrospun 
mats. Also, the development of hybrid systems of natural or synthetic polymers with 
superior features is still a wide-open subject. Other interesting but poorly explored 
approach is the combination of polymers with plant extracts through electrospinning. The 
key challenge in this issue is to point out solutions for replacing the organic solvents 
usually required, thus allowing the incorporation of bioactive compounds without losing 
activity. Moreover, in vitro studies regarding the development of non-degradable scaffolds 
are particularly scares. Besides, a deeper characterization of the inflammatory tissue 
response to these new nanodimensional materials is also recognized as fundamental for 
future technological applications. The use of electrospun mats as prosthetic abdominal wall 
substitutes, for example, is a promising alternative that has never been reported. Lastly, 
studies regarding cell nanofibers interactions, i.e. cell adhesion, spreading, and 
proliferation, as well as apoptotic or necrotic death of cells when cultivated on these 
scaffolds are indispensable for achieving a successful design.  

  
 
 
 
 
 
 
 
 
 
2.   Electrospun PHBV/chitosan 
blends as scaffolds for skin 
engineering 
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2.1. Introduction 
Among all the applications of the electrospinning technique, the fabrication of scaffolds for 
tissue engineering is probably the one that attracts the most attention. The morphological 
and structural similarities between the electrospun structures and the natural ECM make 
these materials potential substrata for cell growth. Several electrospun scaffolds have been 
proposed for skin regeneration based on different polymers and their blends (Rho et al. 
2006; Chong et al. 2007; Kumbar et al. 2008). In this chapter our main purpose was to 
develop new hybrid nonwoven scaffolds of PHBV and chitosan to act as cytocompatible 
temporary templates for cell growth. 
As previously mentioned (§1.3.1), PHBV and chitosan are biopolymers with remarkable 
properties in the biomedical field, including biocompatibility and biodegradability (Avella 
et al. 2000; Chen and Wu 2005). PHBV is a bacterial polyester with good mechanical 
properties and nonwoven electrospun PHBV fibrous mats have already been produced and 
revealed (in vitro) a better performance for chondrocytes and fibroblasts attachment, 
growth, and proliferation when compared to their 2D film counterparts (Suwantong et al. 
2007b; Lee et al. 2004). Despite these advantages for biomedical purposes, PHBV 
applications as scaffold materials for cell colonization are restricted due to its intrinsic 
hydrophobicity. 
A well-known strategy to improve the mechanical and surface properties of the PHBV, and 
its cellular response, is the blending with other polymers (Sombatmankhong et al. 2007; Li 
et al. 2009). Here we followed a similar approach by blending the polyester with chitosan, 
a hydrophilic and biocompatible biopolymer. As already mentioned, chitosan has been 
extensively explored for biomedical applications due to its notable properties i.e. 
biocompatibility, wound healing effect, anti-inflammatory, and antimicrobial activities 
(Liu et al. 2011). Recently, chitosan electrospun nanofibers have been demonstrated as 
advantageous wound-healing biomaterials, improving cell adhesion and proliferation in 
vitro and inducing a fast regeneration of both the epidermis and dermis tissues in vivo 
(Tchemtchoua et al. 2011). 
PHBV grafted with chitosan and oligochitosans has shown improved protein adsorption 
and fibroblast attachment in vitro (Hu et al. 2003a, 2003b). Here, our objective was to 
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develop hybrid nanofibrous mats that combine PHBV and chitosan and to control the 
scaffolds architecture and degradation rate through the manipulation of polymer ratio, 
solvent composition, and chitosan MW. 
In addition to epithelial (keratinocytes) and endothelial cells in the skin injury region, other 
essential cell types are involved in the wound healing process. Amongst them, fibroblasts 
are a critical cellular element in the proliferative phase (Pitzer and Patel 2011), being 
involved in the production of ECM constituents as well as growth factors, which are 
crucial in the subsequent phases of wound healing. Due to the relevance of the fibroblasts 
for skin healing processes, we have performed in vitro studies using L929 fibroblastic cell 
line to study cell-scaffold interaction, based on adhesion, viability, proliferatiobn, and 
death. Afterwards, the PHBV/chitosan (PHBV/C) electrospun scaffolds were tested in vivo 
using a rat skin full-thickness wound model. 
2.2. Experimental 
2.2.1. Materials 
PHBV (12 wt.% poly (3-hydroxyvalerate) content) and chitosan (medium MW, 85% 
deacetylated) were purchased from Sigma-Aldrich Chemical Company. All chemicals 
were of analytical grade and obtained from Sigma-Aldrich Chemical Company. All 
biological supplies were purchased from Invitrogen (Invitrogen Grand Island, NY, USA) 
unless otherwise noted.  
2.2.2. Oxidative depolymerisation of chitosan  
Chitosan samples with varying MW were obtained by oxidative depolymerisation 
(Tommeraas 2001). Briefly, a solution of 7.5 x 10-3 M NaNO2 was added to a 1% chitosan 
solution in 0.1 M acetic acid and allowed to react under N2 gas at room temperature. After 
moderate stirring for 45 minutes and 180 minutes, 0.1 M NaOH was added to the reaction 
mixture up to pH=8. After centrifugation, the precipitate was washed with water/ethanol 
mixtures of increasing ethanol concentration until neutrality, followed by acetone. Samples 
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were dried in an oven at 35°C for 12 hours. The two different reaction times were selected 
to originate chitosan samples with different and desired MW, based on previous reported 
results (Lopes-da-Silva et al. 2009). 
 
The MW was calculated using the MarkHouwink–Sakurada equation proposed by Kasaai 
et al. (2000). The relative viscosities in 0.25 M acetic acid/0.25 M sodium acetate were 
measured using a Cannon-Fenske capillary viscometer at 25.0 ± 0.1 °C. The intrinsic 
viscosity was determined by extrapolating to in"nite dilution, using the combined 
Huggin’s and Kraemer’s equations (Santos et al. 2006).  
2.2.3. Preparation of electrospinning solutions 
In order to prepare the electrospun mats, 20 mL of polymer solutions (total polymer 
content = 10% w/v) of several PHBV/C ratios (5:0, 4:1, 3:2, 2:3, 1:4, and 0:5 w/w) in 
blends of TFA/ 1,1,1,3,3,3-hexafluoro-2-isopropanol (HFIP) (3:7 and 1:1 v/v) were 
prepared. For that, chitosan was dissolved in the selected solvent mixture for 24 hours, 
followed by PHBV addition and dissolution for another 24 hours. Three chitosan samples 
with distinct MW (§ 2.2.2.) were tested. 
2.2.4. Optimization of the electrospinning process 
Electrospinning was performed using a typical experimental set up, that consisted on a 
syringe with a metallic needle, a syringe pump (Harvard apparatus PHD 2000), a high-
voltage power supply (Spellman CZE 1000R), and a grounded rotating collecting drum 
(Figure 2.1). The operational parameters of the electrospinning process (applied voltage, 
solution flow rate, needle to collector distance, and collector rotation speed) were 
optimized in order to obtain nanofibrous mats free of beads or clusters. Fibers were 
collected as nonwoven mats, on the rotating drum in air and at room conditions (20 ± 2ºC, 
45–50% relative humidity).   
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Figure 2.1. Illustrative representation of the electrospinning system. 
2.2.5. Characterization of electrospun mats 
2.2.5.1.  Morphology 
Morphology and diameter of the nanofibers were analyzed by scanning electron 
microscopy (SEM, Hitachi S4100) at an accelerating voltage of 25 kV. The average fiber 
diameters were calculated from 100 measurements, using the SEM images and appropriate 
software (Image J 1.37c, Wayne Rasband, National Institute of Health, USA).  
2.2.5.2.  In vitro degradation 
For in vitro degradation tests, mats were cut into squares (1x1 cm2) and dried at 45 °C for 
24 hours and then in a desiccator in vacuum at room temperature for 1 hour. Each 
specimen was accurately weighed and introduced in 100 mL phosphate buffer solution 
(PBS, pH 7.4) and incubated for a requisite time at 37ºC, under moderate stirring. Samples 
were removed from the solution at different intervals (1, 3, 12, 24, 48, 168, 336, 504, and 
672h), washed with distilled water, dried and weighed. The % mass lost was calculated 
based on initial and final mass of the specimen. Morphological changes were examined by 
SEM. 
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2.2.5.3.  Attenuated total reflection-Fourier transform infrared 
spectroscopy (ATR-FTIR) 
The nanofibrous mats were characterized by ATR-FTIR, using a Golden-gate single 
reflection ATR in a Bruker IFS-spectrometer at a resolution of 8 cm-1 and 256 co-added 
scans. 
2.2.5.4.  Biological in vitro studies 
Mouse fibroblast cells (L929) were cultured in Dulbecco’s Modified Eagle’s Medium 
supplemented with 10% fetal bovine serum, 10 mM HEPES, 2mM L-glutamine, 100 
units/mL penicillin, and 100 g/mL streptomycin. The medium was replaced every 48 hours 
and all the cultures were maintained at 37 °C in a wet atmosphere containing 5% CO2. 
When the cells reached 70% confluence, they were treated with 0.25% trypsin containing 
1mM EDTA and counted by a hemacytometer prior to use. Scaffold pieces with an average 
thickness of 0.5 ± 0.2 mm were selected to perform the in vitro cell culture studies. 
Previously to biological assays, all scaffolds were sterilized under UV light for 1 hour 
(both faces) and immersed in ethanol 70% (v/v) for 30 minutes. All the experiments were 
performed in triplicate, unless otherwise stated. 
2.2.5.4.1. Indirect cytotoxicity assay 
The indirect cytotoxicity evaluation of scaffolds was adapted from ISO 10995-5. Scaffold 
pieces (4 mm diameter) were placed in a 96-well tissue culture plate (TCP, Techno Plastic 
Products) and incubated at 37 °C in fresh culture medium for 24 hours to prepare the 
extraction media (100 !L/well). L929 cells were seeded in empty wells (2 x 103 cells/well). 
After an attachment period of 24 hours, the culture medium was removed, replaced with 
the extraction medium of each specimen, and the cells were further incubated. Fresh 
medium was used as control. After 24 hours, the extraction medium was removed and the 
viability of cells was determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
tetrazolium bromide (MTT) assay. 100 !L of MTT solution (0.5 mg/mL) in fresh medium 
was added to each well and incubated for 2.5 hours at 37 ºC. After discarding the culture 
medium, 200 !L of dimethyl sulfoxide was added to dissolve the intracellular crystalline 
formazan product. The absorbance at 540 nm was read by spectrophotometry using a 
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microplate reader (TP-Reader, Thermoplate). The results were expressed as a percentage 
of the absorbance of control (n=24).  
2.2.5.4.2. Cell viability 
Cell viability was evaluated by the 3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay. L929 cells were 
seeded on sterile scaffold pieces (24-well plates, 1 x 105 cells/well) and incubated at 37 °C 
in a wet atmosphere containing 5% CO2 for 2, 7, and 14 days. MTS solution (Promega) 
was added and cells were incubated for 2 hours in the dark, at 37ºC. Absorbance at 490 nm 
was measured using a plate reader (TP-Reader, Thermoplate).   
2.2.5.4.3. Cell adhesion, spreading, and proliferation  
SEM and confocal laser scanning microscopy (CLSM) were used to study cell adhesion, 
morphology, spreading, and proliferation on the scaffolds. For that, L929 cells were seeded 
on sterile scaffold pieces (24-well plates, 1 x 105 cells/well) and incubated at 37 °C in a 
wet atmosphere containing 5% CO2 for 12 hours, 2 days and 7 days. For SEM analysis 
cells were fixed with 2.5% glutaraldehyde solution in PBS, dehydrated in increasing 
concentrations of ethanol (80, 90, and 100% (v/v)) and dried in air for 12 hours. Samples 
were mounted in aluminum stubs and sputter-coated with gold prior to observation in a 
scanning electron microscope (JEOL JSM-6390LV) with an accelerating voltage of 10 kV. 
For CLSM analysis, cells were fixed with 3.7% paraformaldehyde in PBS. Actin "laments 
were stained with Alexafluor 546 conjugated to phalloidin (A22283, Invitrogen). Vinculin 
was labeled with mouse monoclonal antibody  (90227, Millipore) followed by Alexafluor 
488 goat anti-mouse IgG conjugated as secondary antibody (A11029, Invitrogen). 
Extracellular fibronectin was immunolabeled with mouse monoclonal antibody anti-
fibronectin (SC-271098, Santa Cruz Biotech) followed by Alexafluor 488 goat anti-mouse 
IgG conjugated (A11029, Invitrogen). DNA was stained with 1 mg/mL of 4’,6-diamidino-
2-phenylindole (DAPI). Scaffolds were mounted on slides in ProLong Gold antifade 
reagent and covered with a coverslip. The cells were analyzed using a confocal laser-
scanning inverted microscope (Leica DMI6000 B Microscope). L929 cell outlines were 
traced from CLSM pictures and the cytoskeleton areas were measured using the ImageJ 
software (n>50).  
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Cell proliferation was also evaluated with 5-ethynyl-2’-deoxyuridine (EdU) incorporation 
assay. L929 cells were seeded (1 x 105 cells/well) on sterile scaffold pieces (24-well plates; 
treated group) or in TCP (control group), and incubated at 37 °C in a wet atmosphere 
containing 5% CO2 for an attachment period of 12 hours. EdU was added to the culture 
medium (10 µM) and incubated for 4 hours. Further, fixation, permeabilization, and EdU 
staining, were carried out according to the kit's protocol (Click-iT EdU Alexa Fluor 488 
Imaging Kit, C10337, Invitrogen,). Cell nuclei were stained with DAPI. Cells were 
analyzed by fluorescence microscopy (Olympus BX41 Fluorescence Microscope) and the 
percentage of proliferative cells was calculated from 10 random captured fields (total 
magnification 100x) from three independent experiments.  
2.2.5.4.4. Annexin V and propidium iodide (PI) staining  
L929 cells were seeded on sterile scaffold pieces (24-well plates, 1 x 105 cells/well) or 
control, i.e. TCP, and incubated for 48 hours. The culture supernatant (which contained 
some floating cells) was collected and the adherent cells harvested by a brief 
trypsinization. The two fractions were combined, centrifuged, and resuspended in fresh 
medium. Cells were labeled with annexin V- fluorescein isothiocyanate (FITC) 
(Immunostep SL) and PI and analyzed in a flow cytometer FACSCanto II (Becton 
Dickinson). 10000 events were collected for each sample. Data were processed using 
FlowJo 7.6.5 software (Tree Star, Ashland, OR, US) and the percentages of cells gated 
were calculated from at least three separate experiments.  
2.2.5.5.  Wound healing assay 
The wound healing experiment was approved by Animal Ethics Committee of Federal 
University of Santa Catarina (UFSC, PP0531). Male Wistar rats 2 months age and 
weighting 250-300 g were obtained from the Central Biotery of UFSC.  
Animals were anesthetized with an intramuscular injection of ketamine (90 mg/kg) and 
xylazine (15 mg/kg). After shaving, 4 incisional full-thickness wounds were made in the 
dorsum of each animal using a sterile surgical scalpel blade (Figure 2.2). Sterile 
PHBV/C scaffold pieces (1.0 x 1.0 cm) were implanted on the top of the wound. 
Tegaderm# (3M, St. Paul, MN, US) was used as control. Treatments were alternately 
distributed on each quadrant. After anesthesia recovery, animals were placed in individual 
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cages and observed during the total period of experiment. 
 
&
Figure 2.2. Schematic illustration of wound healing assay in rats. 
 
On days 3, 7, 14, and 21 post-surgery, animals were sacrificed in a carbon dioxide 
chamber, the wounds were measured with a caliper, and the wound tissues were collected 
for histological examination. Tissues were fixed in buffered formaldehyde solution (10%, 
pH 7.2), embedded in paraffin, sectioned at 4 µm thickness, and stained with hematoxylin 
and eosin (HE). Samples were analyzed under an optical microscope. For leukocyte count 
and tissue classification, 5 microscopical fields were captured at 400x magnification 
(Figure 2.2). PMN and MN leukocyte densities were calculated and the tissues were 
classified as inflammatory infiltrate (mostly composed by inflammatory cells and fibrin 
clot elements), granulation tissue (high density of fibroblasts and new blood vessels), 
immature regenerated tissue (with newly synthetized unarranged collagen fibers) or 
remodeled tissue (presence of skin appendages, mature blood vessels, and arrangement of 
collagen fibers resembling normal skin tissue).  
2.2.6. Statistics 
Statistical analysis was carried out using Instat 3.0 (GraphPad Software, San Diego, CA, 
US). Results were expressed as the mean ± standard deviation and compared through one-
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way analysis of variance (ANOVA) and Tukey-Kramer multiple comparisons test. P < 
0.05 was considered statistically significant. 
2.3. Results and discussion 
In this chapter we report the preparation of new electrospun hybrid nanofibers of PHBV 
and chitosan with potential application in the biomedical field. The effects of polymer 
ratio, chitosan MW, and solvent composition on the morphology of the nanofibers were 
investigated. Cell culture studies with L929 fibroblasts and an in vivo wound healing assay 
with Wistar rats were performed in order to evaluate the performance of the electrospun 
mats as scaffolds for skin engineering. 
2.3.1. Characteristics of the chitosan samples  
In order to obtain chitosan samples with distinct MW, oxidative depolymerization of a 
commercial sample (1500 kDa, 85% deacetylated) was performed. The MW of chitosan 
was reduced to 48 kDa after 90 minutes and to 15 kDa after 180 minutes. Those samples 
with distinct MW (1500, 48, and 15 kDa) were used to prepare the PHBV/C blends for the 
hybrid mats fabrication.  
2.3.2. Electrospinning process optimization 
The success of electrospinning, i.e. fiber formation from a polymeric solution, depends on 
the optimization of several electrospinning parameters, including solution and operational 
ones. This optimization is often a laborious task, due to the high number of variables and 
their inter-dependence. In this study, the effect of operational parameters, including the 
applied voltage, the solution flow rate, the needle to collector distance, and the collector 
rotation on the final fiber characteristics was studied in order to improve the fiber 
production. The selected values for each operational parameter are presented below: 
(1) Applied voltage: The applied voltage was fixed at 22 kV. Above this voltage, the 
electrospinning system became instable due to the occurrence of sparks on the 
needle and electric current cuts.  
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(2) Solution flow rate: The flow rate depends on the maximum amount of polymer that 
the system is able to stretch. When the feeding rate increases, more solution will be 
ejected from the needle tip at the same time. When the electric field force is not 
able to stretch the jet, the superfluous solution is deposited as beads or droplets 
(Zuo et al. 2005). The maximum flow rate reached for this system without beads or 
droplets formation was 8 µl/min.  
(3) Syringe-collector distance: During travelling of the jet from the needle to the 
collector, solvent has to evaporate, so that fibers could be formed. The minimum 
distance for adequate solvent evaporation was 14 cm, as bellow this value the 
solvent reached the collector creating fusion and beads in fibers.  
(4) Rotation of the cylinder: Regarding to the collector rotation, a nonwoven fibrous 
mat, with an essentially random fiber arrangement was produced at 900 RPM. 
2.3.3. Solvent effects 
As previously mentioned, solvent evaporates during the travelling of the electrospinning 
jet to the collector. Although it is not present in the final mat, solvent plays a determinant 
role on the formation and characteristics of electrospun nanofibers.  
TFA/HFIP blends were selected as solvent for co-dissolving PHBV and chitosan. Co-
solubilization was achieved from TFA/HFIP 3:7 to 1:1 (v/v). The effects of TFA/HFIP 
ratio on the fiber morphology were analyzed. 
The most considerable effect of solvent composition was in the main fiber diameter. In 
general, main fibers with higher diameters were obtained for TFA/HFIP 3:7 (v/v). For 
PHBV/C 5:0 (w/w), for example, the average diameter was 115 ± 35 nm for TFA/HFIP 1:1 
(v/v) and 227 ± 72 nm for TFA/HFIP 3/7 (v/v). The same effect was observed for the other 
PHBV/C ratios (as will be discussed in more detail § 2.3.4.2). The increase in the main 
fiber diameter observed with the increase of HFIP content is explained by the lower 
dielectric constant and the higher surface tension of this solvent. Solutions obtained from 
solvents with lower dielectric constants are expected to have a lower conductivity, 
resulting in a lower jet stretching during its #ight to the collector. A higher surface tension 
also acts against the charged jet stretching, resulting in larger "bers (Tan et al. 2005; Uyar 
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and Besenbacher 2008). Some properties of TFA and HFIP are summarized in Table 2.1.  
 
 
Table 2.1. Solvent properties. 
Solvent properties TFA HFIP 
Molar mass (g/mol) 114.02 168.05 
Boiling point (ºC) 72.4 58.2 
Density 25ºC (g/mL) 1.48 1.6047 
Dielectric constant (20ºC) 42.1 16.7 
Surface tension 25ºC (N/m) 0.0134 0.0161 
Viscosity 25º C (X10-3 Pa s) 0.81 1.64 
 
As it will be described below, solvent composition also affected the relative frequency and 
the mean diameter of secondary fibers. The mean diameter of secondary fibers increased as 
the HFIP content decreased. HFIP is a better solvent for PHBV than TFA. So, as HFIP 
decreases and the PHBV solubility decreases, more PHBV molecules branch off into 
secondary fibers and, consequently, the diameter of these fibers is increased. More details 
on this subject will be discussed below. 
2.3.4. Effects of PHBV/C ratio and chitosan MW on fiber formation and 
morphology 
The morphology of an electrospun mat is ruled, in the first instance, by solution 
composition. Defining polymer and solvent is the most effective way to control mat 
characteristics. In hybrid mats, the polymer ratio has an important effect on the final 
characteristics of the mats. Here, PHBV/C ratio was varied from pure PHBV until pure 
chitosan, using as solvents TFA/HFIP 1:1 or 7:3 (v/v), and the effects on fiber 
characteristics were examined. 
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2.3.4.1.  Formation of nanofibers 
Well-defined continuous fibrous structures could be obtained by changing the 
PHBV/chitosan ratio from 5:0 to 2:3 (w/w), for chitosan 1500 kDa and 15 kDa, while for 
chitosan 48 kDa, fibers were also formed for a PHBV/C ratio of 1:4 (w/w) (Table 2.2). 
 
Table 2.2. Electrospinnability of PHBV/C (10 wt.%) in TFA/HFIP (22 kV of applied 
voltage, flow rate of 8 µL/min). 
TFA/HFIP 
(v/v) 
Chitosan Mw 
(kDa) 
PHBV/C ratio (w/w) 
5:0 4:1 3:2 2:3 1:4 0:5 
3:
7 
1500 
! 
! ! ! " " 
48 ! ! ! ! # 
15 ! ! ! # # 
1:
1 
1500 
! 
! ! ! " " 
48 ! ! ! ! # 
15 ! ! ! # # 
! Complete dissolution; formation of fibers; 
# Complete dissolution; fibers were not formed; 
"Polymers were not soluble. 
 
Regarding to the highest MW chitosan, the maximum solubility was 6 wt.% for both 
solvents tested. The low solubility of this sample limited the production of fibers with 
higher chitosan contents. For lower MW chitosan samples (15 and 48 kDa), solutions were 
prepared until a chitosan content of 10 wt.%. Nevertheless, the maximum chitosan content 
that resulted in formation of fiber was 8 wt.% (PHBV/C 48 kDa 1:4 w/w). Above this 
concentration, electrospray took place, as chain entanglements were insufficient to form 
continuous structures, i.e. nanofibers, resulting in the spraying of droplets that were 
deposited on the collector. According to Tan et al. (2005), polymer MW plays an 
important role in determining the minimum polymer concentration to produce fibers via 
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electrospinning. As the MW decreases, polymer concentration needs to be improved in 
order to raise polymer entanglements.  
2.3.4.2.  Morphological characterization of the mats 
In general, all mats showed a typical nonwoven nanofibrous structure, with a layer-by-
layer deposition of nanofibers, and a high porosity. Nanofibers were predominantly 
cylindrical, uniform, and free of beads. Figure 2.3 and 2.4 illustrate the morphology of 
hybrid fibers as a function of PHBV/C ratio, for two different solvents. 
&
Figure 2.3. SEM images showing the morphology of fibers electrospun from PHBV/C 48 kDa 
solutions in TFA/HFIP 3:7 (v/v), at different polymer ratios: (a) 4:1 (b) 3:2 (c) 2:3 (d) 1:4 (w/w). 
 
For certain electrospun mats, SEM images revealed the occurrence of ramifications of the  
backbone fiber, giving rise to secondary fibers, predominantly interrupted, with smaller 
diameters (Figure 2.3b and 2.3c). The frequency of occurrence of the secondary fibers 
varied with the PHBV/C ratio and chitosan MW and, as previously mentioned, with the 
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solvent characteristics. To better understand the fiber branching process, the relative 
frequency of secondary fibers was calculated for each mat (Figure 2.5). 
 
(c) 
(b) (a) 
(d) 
&
Figure 2.4. SEM images showing the morphology of fibers electrospun from PHBV/C 48 kDa 
solutions in TFA/HFIP 1:1 (v/v), at different polymer ratios: (a) 4:1 (b) 3:2 (c) 2:3 (d) 1:4 (w/w). 
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Figure 2.5. Relative frequency of secondary fibers in electrospun PHBV/C mats: (a) TFA/HFIP 
3:7 (v/v) (b) TFA/HFIP 1:1 (v/v). 
 
Secondary fibers mostly occurred for intermediate PHBV/C ratios (PHBV/C 3:2 and 2:3 
(w/w)) and as chitosan MW increased. The fiber branching process may be related to 
polymer segregation, as a result of solution instability, during the jet stretching. Polymer 
blends are, in general, thermodynamically instable and this instability increases with the 
increase of polymer concentration and MW. During the electrospinning process, as the jet 
travels from the needle to the collector, solvent evaporates and the polymeric concentration 
becomes higher, increasing the instability of the system. This instability can reach a limit 
where separation of phases occurs and two kinds of fibers are formed. Phase separation as 
a result of solvent evaporation during the electrospinning process has been described and 
includes formation of core-sheath structures (Lopes-da-Silva et al. 2009; Wei et al. 2005), 
hollow (Zhang et al. 2009), and porous nanofibers (Han et al. 2005). However, no report 
was found describing a similar behavior of phase separation, i.e. branching of fibers. 
To study the effect of PHBV/C ratio and chitosan MW on fiber diameters, the average 
diameter of main and secondary fibers were calculated. Figure 2.6  displays the average 
diameter of the main fibers as a function of PHBV/C ratio and chitosan MW. 
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Figure 2.6. Average main fiber diameters of PHBV/C mats: (a) TFA/HFIP 3:7 (v/v) (b) TFA/HFIP 
1:1 (v/v). 
 
The average diameters of PHBV/C main fibers were in the range of 115-900 nm, 
increasing with the increase of chitosan content, irrespective of the chitosan MW or 
solvent composition. Increasing the amount of chitosan also tended to increase the 
dispersion of fiber diameters, to change the fiber shapes from tubular-like to more flat 
ribbon-like morphologies and to increase the connection between fibers. 
One could expect that the presence of chitosan would increase the conductivity of the 
solutions and consequently could lead to higher elongation forces and thinner fibers. 
However, solution viscosity also increased significantly as the chitosan content increased. 
For the same electrostatic force, a higher solution viscosity will result in a higher 
viscoelastic force to be overcome, and thus the polymer fibers will be less stretched, 
originating thicker fibers. 
Chitosan MW had a complex effect on the main fiber diameters. Fibers with chitosan 1500 
kDa had larger diameters than the lower MW samples. Chitosan 48 kDa, however, 
originated fibers with lower diameters than the 15 kDa sample. As the MW decreases, the 
solution viscosity reduces, and, consequently, diameter of fibers would decrease. However, 
as PHBV molecules branch off during the jet path, forming secondary fibers, the main 
fiber diameter decreases. Therefore, despite the higher viscosity of the 48 kDa chitosan 
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solution compared to the lowest MW sample, the more extensive formation of secondary 
fibers contributes to the neat reduction in the main fiber diameter.  
Unlike main fibers, the secondary fiber diameter decreased with the increase of chitosan 
content. The average secondary fiber diameters of the electrospun mats are represented in 
Figure 2.7 .  
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Figure 2.7. Average secondary fiber diameters of PHBV/C mats: (a) TFA/HFIP 3:7 (v/v) (b) 
TFA/HFIP 1:1 (v/v). 
 
As previously assumed, secondary fibers are formed due to polymer separation during the 
electrospinning process. Moreover, it is well established that fiber diameter increases with 
the increase of polymer concentration (Veleirinho et al. 2008). Considering that the 
diameter of secondary fibers reduced as PHBV content decreased one can infer that these 
fibers were mostly made of PHBV. 
Chitosan dissolution, on the contrary, was facilitated by the increase of TFA content. This 
explains why secondary fibers were formed for PHBV/C 4:1 (w/w) when higher 
concentration of TFA was used (Figure 2.7b). For higher chitosan contents (PHBV/C 3:2 
and 2:3 (w/w)), however, the relative frequency of secondary fibers decreased with the 
decrease of HFIP in the solvent. 
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Rupture of fibers was a specific characteristic of the pristine PHBV mat (Figure 2.8 a). 
This morphological detail was also frequently observed on secondary fibers of the 
PHBV/C mats as illustrated in Figure 2.8 b, and is thought to result from the stiffness of 
PHBV polymer in comparison to chitosan. This result is in accordance with the established 
hypothesis that secondary fibers were essentially composed by PHBV.  
 
&
Figure 2.8. SEM micrographs showing broken fibers: (a) PHBV/C 5:0 (w/w) in TFA/HFIP 1:1 (b) 
PHBV/C1500 kDa 2:3 (w/w) in TFA/HFIP 1:1 (v/v). 
2.3.5. FTIR analysis 
Figure 2.9  displays FTIR spectra of PHBV and PHBV/C blends. The FTIR spectra of the 
nanofibrous membranes electrospun from different PHBV/C ratios showed characteristic 
peaks of both polymers, confirming the presence of both in the fibers. The typical bands at 
3342 and 3280 cm-1 (O-H and N-H stretching) were observed in the spectrum of chitosan. 
As expected, with the increase of PHBV the relative strength of these peaks decreased. 
Also, the $O–H band shifts to higher wavenumber with the PHBV content increasing 
probably due to the occurrence of intermolecular hydrogen bonds between chitosan (O-H) 
and PHBV (C=O). The bands appearing in the region around 2870-2970 cm-1 correspond 
to the C-H aliphatic stretches. 
In the region of the carbonyl stretching and fingerprint region the FTIR spectrum of PHBV 
electrospun fibers showed a characteristic absorption band at 1718 cm-1 which is attributed 
to the C=O stretching of the ester groups of PHBV. Other characteristics bands are 
observed at 1098 cm-1 (symmetric C-O stretching) and at 1128 cm-1 (asymmetric C-O 
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stretching). The FTIR spectrum of the as-received chitosan showed the characteristic 
amide bands, i.e., at 1644 cm-1 for C=O stretching of amide I and at 1560 cm-1 for the N–H 
deformation in the CONH plane of amide II. The amide band has shifted about 30 cm-1 for 
the hybrid PHBV/C fibers compared to the behavior of the powder as-received chitosan, 
supporting the possible occurrence of intermolecular hydrogen bonds between both 
polymers in the hybrid fibers. As expected, with the increase of PHBV, the relative 
strength of the characteristic amide bands decreased, and the relative strength of peak at 
1718 cm-1 increased. 
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Figure 2.9. FTIR spectra obtained for electrospun fibers of PHBV/C 5:0 (w/w), 
 PHBV/C 48 kDa 4:1 (w/w), PHBV/C 48 kDa 2:3 (w/w) (TFA/HFIP 1:1 (v/v)), and for as-received 
chitosan. 
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2.3.6. In vitro degradation of the scaffolds 
The in vitro degradation tests under physiological conditions revealed the very low 
degradation rate of the PHBV fibrillar mats, with about 95% mass retention after 28 days, 
and the increasing biodegradability of the hybrid mats as the chitosan content increased 
(Figure 2.10). Changes in morphology and integrity of the electrospun fibers during the 
biodegradation tests have been analyzed by SEM (Figure 2.11). At higher chitosan 
content water penetration proceeds faster and the lost of fiber integrity occurs very quickly 
too. In the presence of a lower amount of the more hydrophilic polymer, the water 
penetration is expected to be slower and at least initially the mass loss is probably confined 
to the surface layers of the material. After 1 hour treatment fiber integrity is still preserved 
but extensive morphological changes have already occurred. Chitosan addition turns out to 
be an effective way to control the degradation rate of the electrospun PHBV scaffolds. 
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In general, main fibers with higher diameters were obtained for TFA/HFIP 30:70 (v/v) (Figure 2A), 
i.e., for higher HFIP content, what is explained by the lower dielectric constant and the higher 
surface tension of this solvent. 
Chitosan molecular weight had a complex effect on the main fiber diameters. Fibers with chitosan 
1500 kDa had larger diameters than the lower molecular weight samples. Chitosan 48 kDa, 
however, originated fibers with lower diameters than the 15 kDa sample. As the molecular weight 
decreases, the solution viscosity reduces, and, consequently, diameter of fibers would decrease. 
However, as PHBV molecules branch off during the jet path, forming secondary fibers, the main 
fiber diameter decreases. Therefore, despite the higher viscosity of the 48 kDa chitosan solution 
compared to the lower molecular weight sample, the more extensive formation of secondary fibers 
contributes to the neat reduction in the main fiber diameter. 
The in vitro degradation tests under physiological conditions revealed the very low degradation rate 
of the PHBV fibrillar mats, with about 95% mass retention after 28 days, and the increasing 
biodegradability of the hybrid mats as the chitosan content increased (Fig re 3). Changes in 
morphology and integrity of the electrospun fibers during the biodegradation tests have been 
analysed by SEM (cf. electronic supplementary). Chitosan addition turns out to be an effective way 
to control the degradation rat  of he elec rospun PHBV scaffolds. !
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Figure 2.10. In vitro degradation of mats containing different PHBV/C ratios and chitosan MW 
(TFA/HFIP 1:1 v/v used as solvent). 
.$%/+0',12*& ( 3#0'2, &4"+, & ('0 &,5 3* &"*6&"#6'43*"$ &7"$ $ & 0%1"30 &
&
&MA&
 
&
Figure 2.11. SEM images of electrospun fibers degraded in PBS (pH 7.4) at 37 ºC for (a-c) 0, (d-f) 
1 hour, and (g- i) 28 days. Left column for a PHBV/C 5:0 (w/w), middle column PHBV/C48 kDa 4:1 
(w/w), and right column for PHBV/C48 kDa 2:3 (w/w). TFA/HFIP 1:1 v/v used as solvent. 
&
2.3.7. Biological studies 
Amongst all blends, PHBV/C48kDa samples exhibited, in general, a better 
electrospinnability, i.e. fiber formation from a wider PHBV/C ratio range, superior jet 
stability, and, consequently, improved macroscopic homogeneity of the mat. Indeed, 
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PHBV/C48 kDa 4:1 (w/w) and PHBV/C48 kDa 2:3 (w/w) (from now on designated as 
PHBV/C 4:1 (w/w) and PHBV/C 2:3 (w/w), respectively) electrospun from solutions in 
TFA/HFIP 1:1 (v/v), were selected to perform the biological assays to evaluate their 
potential as scaffolds for skin engineering. The difference in polymer composition between 
these samples resulted in both morphological and degradation changes. Figure 2.12  
summarizes morphological characteristics and degradation information for these scaffolds.  
 
 &
Figure 2.12. SEM images showing the morphology of fibers electrospun from PHBV/C 48 kDa 
solutions in TFA/HFIP 1:1 (v/v), at two different polymer ratios: (a) 4:1 and (b) 2:3 (w/w). Also 
shown are the fiber average diameters, pore area, and degradation rates (as % mass loss) obtained 
after 14 days in a phosphate buffer solution (pH 7.4) at 37 °C. 
 
2.3.7.1.  Cell culture studies 
Figure 2.13  displays results from the indirect cytotoxicity assay. The indirect cytoxicity 
assay is used to evaluate the release of cytotoxic compounds from the scaffold to the 
extraction medium. These compounds can include soluble components from scaffolds i.e. 
chitosan or residues from the fabrication process, such as TFA or HFIP. The MTT assay to 
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measure the viability of cells revealed that none of the scaffold extraction media was toxic 
to L929 fibroblasts. 
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Figure 2.13. Absorbance 540 nm (% of control) obtained in the indirect cytotoxicity assay of L929 
cells cultured on PHBV/C 2:3 (w/w) and PHBV/C 4:1 (w/w) scaffolds. No significant differences 
were detected. 
 
The viability of fibroblasts cultivated on the PHBV/C scaffolds for 2, 7, and 14 days was 
evaluated by MTS assay. This assay quantifies the soluble formazan resulting from the 
reduction of the MTS tetrazolium compound in the mitochondria of living cells. The 
quantity of formazan product is measured spectrophotometrically (absorbance at 490 nm) 
and is directly proportional to the number of living cells in culture. The MTS assay 
revealed a similar cell viability profile for both scaffolds, with an increase in the number of 
living cells promoted by the scaffold-interaction during the first seven days of the 
experiment (Figure 2.14). After the 1st week the PHBV/C 4:1 (w/w) experimental group 
reached a stationary phase while the cells seeded on PHBV/C 2:3 (w/w) showed a slight 
decrease in the viability, probably related to the higher degradation rate observed for this 
scaffold, with an inherent higher loss of sites for cell attachment. 
Figure 2.15  displays SEM images of L929 cultured on PHBV/C 2:3 and PHBV/C 4:1 
(w/w) for 12 hours and 2 days, while Figure 2.16  shows the corresponding CLSM 
images after 12 hours, 2 days, and 7 days seeding. Both microscopic techniques showed 
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that L929 fibroblasts adhered to the blended fibers after 12 hours seeding, followed by a 
clear morphological change to well spread cells on the scaffolds, and an intense 
proliferation activity. Indeed, after 7 days of culture cells were confluent on the surface of 
both PHBV/C scaffolds under study (Figure 2.16). 
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Figure 2.14. Viability of L929 cells cultured on PHBV/C 2:3 and 4:1 (w/w) scaffolds for 2, 7, and 
14 days measured via MTS assay. No significant differences were detected. 
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Figure 2.15. SEM images of L929 cells cultured on PHBV/C 2:3 (w/w) (a and b) and 4:1 (w/w) (c 
and d) scaffolds for 12 hours (a and c) and 2 days (b and d). Bar = 5 µm. 
 
Figure 2.16. CLSM images of L929 fibroblasts cultured on PHBV/C 2:3 (w/w) (a-c) and PHBV/C 
4:1 (w/w) (d-f), for 12 hours (a and d), 2 days (b and e), and 7 days (c and f). F-actin (red) and 
nucleus (blue) stained with Alexafluor 546 conjugated to phalloidin and DAPI, respectively. Scale 
bar = 10 µm (a, b, d, and e) and = 50 µm (c and f). 
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Immunolabeling of fibronectin was performed in order to verify the presence of fibronectin 
from ECM on the surface of the scaffolds. As previously mentioned, in natural 
environment, adhesion of cells to the ECM occurs via focal adhesion, an integrin mediated 
process that involves binding of integrin from the plasma membrane to a specific peptide 
sequences such as the RGD of ECM proteins. These integrin mediated adhesions, i.e. focal 
adhesions, activate multiple signaling pathways, and have a tremendous impact on the 
survival and proliferation of anchorage dependent cells. On artificial substrata, where the 
RGD sequence is not present, adhesion can be initially mediated by proteins adsorbed on 
the surface of the material (e.g., originating from serum). Subsequently, the attached cells 
would be able to produce and secrete their own ECM, creating a coating layer on the 
scaffolds surface, which facilitates further cellular activities. Both PHBV/C 2:3 and 
PHBV/C 4:1 (w/w) scaffolds showed a plenty fibronectin distribution on their surfaces 
after 2 days of culture (Figure 2.17). 
 
&
Figure 2.17. Immunolabeling of extracellular fibronectin (green) deposited on the surface of 
PHBV/C 2:3 (w/w) (a) and PHBV/C 4:1 (w/w) (b) scaffold after 48 days of incubation with L929 
cells. Bar = 50 µm. 
 
Figure 2.18  displays the cells’ cytoskeleton area, measured with basis on the CLSM 
pictures, as function of culture time. Changes in fibroblasts morphology were observed 12 
hours after seeding, but the increase in cell’s area only occurred after the second day of 
culture. Cells cultured on PHBV/C 4:1 (w/w) scaffold reached higher levels of spreading, 
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i.e. their cytoskeleton areas were significantly greater than the related to cells cultured on 
PHBV/C 2:3 (w/w) (day 7).  
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Figure 2.18. Cytoskeleton area of L929 cells cultured on PHBV/C scaffolds as a function of 
culture time. Different letters indicate significant differences (p < 0.05). 
 
Vinculin is an intracellular protein involved in the focal adhesion process and commonly 
used as a focal adhesion marker. This protein belongs to the adhesion complex and is 
expressed when a focal adhesion takes place. Due to features described above, the 
immunolabeling of vinculin was performed to study the adhesion of cells on the hybrid 
scaffolds. Figure 2.19  shows the focal adhesion sites evidenced by vinculin 
immunostaining, obtained for the L929 cells adhered to the surface of PHBV/C scaffolds. 
Higher levels of vinculin expression were found in cells cultured on PHBV/C 4:1 (w/w) 
scaffold, indicating the occurrence of important levels of cellular adhesion in this scaffold. 
An increase of vinculin expression as a function of the incubation time was also observed. 
Adhesion is a crucial attribute for the survival of anchorage dependent cells and affects 
several subsequent cellular activities, including spreading, proliferation, and ECM 
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production (McGrath 2007). Furthermore, in the absence or even with limited sites for 
adhesion, potentially adherent cells can induce apoptosis (Chen et al. 1997). In this 
context, consistent adhesion levels may improve cell survival and, consequently, are a 
fundamental condition for provisional skin scaffolds, since they constitute a basis for cell 
adhesion in the lack of natural ECM. The adhered cells are thus able to assume their role in 
the tissue regeneration process, affording proliferation, migration, ECM synthesis and 
tissue organization. 
 
&
Figure 2.19. CLSM images of L929 fibroblasts cultured on (a) PHBV/C 2:3 (w/w) and (b) and (c) 
PHBV/C 4:1 (w/w), for 2 days (a and b) and 7 days (c). Vinculin (green) and nucleus (blue) stained 
with anti-vinculin monoclonal antibody followed by Alexafluor 488 goat anti-mouse and DAPI, 
respectively. Scale bar =10 µm. 
&
Although cell proliferation can be monitored by microscopic analysis of cell growth, the 
EdU uptake assay has been used as a specific method to study proliferation. EdU is a 
nucleoside analogue that binds to DNA during cell division. The percentage of 
proliferative cells was measured after attachment, i.e. 12 hours after seeding, for PHBV/C 
scaffolds and the control. Figure 2.20 displays the percentage of proliferating cells 
cultured on the electrospun scaffolds. PHBV/C 4:1 (w/w) displays a higher tendency to 
stimulate cell proliferation (53±9 %) as compared to PHBV/C 2:3 (w/w) (32±9 %), 
supporting the better performance of the PHBV/C 4:1 (w/w) scaffold as a substratum for 
cell attachment, i.e. to promote higher levels of adhesion and spreading.  
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Figure 2.20. Percentage of proliferating cells measured by the EdU assay. Different letters indicate 
significant differences (p < 0.05). 
 
The annexin V/ PI dual staining was used to investigate eventual occurrence of cell death 
by apoptosis or necrosis in the cultures. Annexin V probe binds to phosphatidylserine 
exposed on the plasma membrane of apoptotic cells while PI is used to identify membrane 
damage of necrotic cells. To perform this study, both adhered and detached cells, i.e. death 
cells in the culture medium, were collected. Figure 2.21 shows that low levels of cell 
death, either by apoptosis or necrosis were found (97.7 ± 0.6 of viability) for cells cultured 
on the PHBV/C 4:1 (w/w) scaffold. Furthermore, this scaffold decreased almost six times 
the necrotic cell death in comparison to control. On the other hand, PHBV/C 2:3 (w/w) 
exhibited a considerable level of necrotic death (17.7 ± 4.5 %). Necrotic death is related to 
the loss of membrane integrity and in this case may result from the higher content of the 
chitosan. It is speculated that the polycationic nature of chitosan in the pH conditions of 
the culture medium (7.2) may interact electronically with the fibroblasts' plasma 
membrane, causing a loss of membrane integrity and/or functionality in any extension. In 
fact, although chitosan has long been considered a safe material, there are several reports 
showing toxicity of chitosan, particularly in a nano-dimensional scale (Qi et al. 2007; Loh 
et al. 2010; Hu et al. 2011). 
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Figure 2.21. Annexin V-FITC/PI flow cytometry analysis of cell death after 48 hours of incubation 
on (a) control, (b) PHBV/C 2:3 (w/w), and (c) PHBV/C 4:1 (w/w). Viable cells (Annexin V-FITC 
negative/PI negative) are in the lower left quadrants; apoptotic cells (Annexin V-FITC positive/PI 
negative) are in the lower right quadrants; late apoptotic cells (Annexin V-FITC positive/PI 
positive) are in the upper right quadrants; and necrotic cells (Annexin V-FITC negative/PI positive) 
are in the upper left quadrants. The cytograms are representative of three independent experiments. 
Mean ± standard deviation of cell stages (d). 
2.3.7.2.  Wound healing assay 
The ability of scaffolds to promote tissue regeneration in vivo was evaluated on skin full-
thickness wounds implemented on the back of Wistar rats. The scaffold instantly adhered 
to the wound, absorbing the biofluids and showing itself as an hydrate membrane. The 
healing process was studied macroscopically and histologically for 21 days. 
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Wound areas, expressed as percentage of the initial wound area, and plotted in Figure 
2.22  as a function of the treatment time with each scaffold. At the 3rd day after injury, no 
significant differences were found among treatments in respect to wound closure. 
However, on the 7th day post-surgery PHBV/C 4:1 (w/w) group showed significant smaller 
wound areas (26 ± 11 %), compared to control (59 ± 17 %). At the 14th day, 44% of 
wounds treated with PHBV/C 4:1 (w/w) were totally healed, compared to 25% of PHBV/C 
2:3 (w/w) treatment and 13% of control, supporting the important role of the PHBV/C 4:1 
(w/w) hybrid scaffold to promote skin healing.  
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Figure 2.22. Wound area for PHBV/C 2:3 (w/w), PHBV/C 4:1 (w/w), and control groups during 
the wound-healing assay. Different letters indicate significant differences (P<0.05). 
 
Histological classification of wound tissues was performed by microscopy, enabling to 
identify the distribution of wound phases for each treatment (Figure 2.23). The density 
of PMN and MN cells were also calculated and are shown in Figure 2.24 as a function 
of treatment time with each scaffold. 
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Figure 2.23. Histological classification of wound tissues 3, 7, 14, and 21 days after injury for 
control and PHBV/C scaffolds: IF (inflammatory infiltrate), GT (granulation tissue), IM (immature 
regenerated tissue), and RT (remodeled tissue). 
 
As expected for the inflammatory phase, the 3rd day after injury was characterized by high 
densities of PMN leukocytes for all treatments. PHBV/C 4:1 (w/w) exhibited the higher 
density of PMN cells in comparison to PHBV/C 2:3 (w/w) and control. The lower levels of 
PMN on PHBV/C 2:3 (w/w) are probably attributed to the higher concentration of chitosan 
in this scaffold and its antimicrobial activity (Cai et al. 2010; Liu et al. 2001), whereas the 
lower levels of PMN cells found in the control group are probably related to the physical 
protection against external contaminants. Nevertheless, 7 days after injury, a substantial 
decrease of PMN cells was found on PHBV/C scaffolds but not on the control, where an 
increase of PMN cells was observed. At this stage, wound tissues from PHBV/C 4:1 (w/w) 
group were predominantly formed by granulation tissue while on the control group, 
considerable areas of inflammatory infiltrate were still found. 
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Figure 2.24. PMN and MN leukocyte densities during the wound healing process in rats. 
 
Two weeks after injury, PMN leukocytes were rarely found and the proliferative phase was 
almost complete in all treatments. In accordance with the wound closure results, the 
process of re-epithelialization was advanced in PHBV/C 4:1 (w/w). It is especially 
noteworthy that no traces of PHBV/C scaffolds residues were found on tissues at day 14, 
demonstrating a biodegradation rate suitable for skin repair. At the 21st day, wounds were 
completely re-epithelized in all groups, however tissues from PHBV/C 4:1 (w/w) group 
exhibited a higher level of tissue organization, with hair bulbs and glands distributed in the 
newly formed tissue, mature blood vessels, and arrangement of collagen fibers resembling 
normal skin tissue (Figure 2.25). 
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Figure 2.25. Histological sections showing the HE staining 21 days after surgical injury. Control 
(a), PHBV/C 2:3 (w/w) (b), and PHBV/C 4:1 (w/w) (c). Bar = 50 µm. 
 
MN cells are usually recruited when a more specialized defense is required to neutralize 
the aggressor, or as a response to a foreign material. For all treatments, relatively low 
densities of MN cells were found. Decreasing densities of these cells were observed with 
time, an additional evidence of the biocompatibility features and biodegradability property 
of PHBV/C biomaterial. 
2.4. Conclusion 
Hybrid nanofibrous mats of PHBV and chitosan were successfully produced by 
electrospinning using TFA and HFIP blends as the solvent. Solvent characteristics, 
polymer ratio and chitosan MW affected the electrospinnability of the solutions and the 
morphology of the mats. The 48 kDa chitosan was found to have the best 
electrospinnability, once nanofibers were obtained for all PHBV/C ratios, except for pure 
chitosan. For the other chitosan samples (15 and 1500 kDa), the maximum chitosan 
concentration suitable for fiber formation was 6 wt.%.  
During electrospinning, the thermodynamical instability of the polymer blends led to 
separation of phases and, consequently, a phenomenon of fiber ramification occurred. This 
phenomenon was characterized by ramifications of the main fibrous structure, giving rise 
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to short interrupted secondary fibers, with smaller diameters. These secondary fibers 
occurred more often in PHBV/C 3:2 and 2:3 (w/w) and with the increase of chitosan MW.  
In general, the average of main fiber diameters increased as chitosan content and MW 
increased and decreased with the decrease of HFIP concentration in solution. On the other 
hand, the average diameter of secondary fibers decreased as chitosan content and MW 
increased and increased with the decrease of HFIP concentration in the solution. 
In vitro and in vivo pre-clinical studies demonstrated the great potential of PHBV/C 
electrospun mats as scaffolds for promoting skin regeneration. The two PHBV/C ratios 
selected to perform the biological studies, 4:1 and 2:3 (w/w), were biocompatible and 
suitable for supporting cell growth. In vitro, PHBV/C [4:1] has shown a superior ability for 
improving fibroblasts adhesion and growth, compared to PHBV/C [2:3]. The 
characteristics of PHBV/C [4:1] scaffold, i.e. morphology, PHBV/C ratio, and 
biodegradation rate, confer an additional advantage to better fit the in vivo wound healing 
process. Taking together the properties of PHBV/C scaffolds might be instrumental in 
providing alternative tools for the dermal wounds therapeutics.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3. Dual-fiber mats as new support 
support matrices and vehicles for 
for bioactive compounds
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3.1. Introduction 
3.1.1. Nanofiber mats as vehicles for bioactive compounds  
Besides all the mentioned advantages of the electrospinning process, another interesting 
ability of this technique is the incorporation of bioactive compounds in the mats through 
their direct dissolution in the polymeric solution. While solvent evaporates and polymer 
molecules are stretched to form the nanofibers, the non-polymeric bioactive molecules, i.e. 
synthetic drugs or natural compounds, are expected to be entrapped into the nanofibrous 
mesh.  
Numerous studies are available about the incorporation of different drugs in nanofibrous 
electrospun mats, including antibiotics (Kenawy et al. 2002), analgesics (Taepaiboon et al. 
2007), anti-inflammatory (Shen et al. 2011), and anti-cancer compounds (Chen et al. 
2010). An interesting approach is the development of systems for controlled release of 
drugs, such as that developed by Kenawy et al. (2002) where a constant release of 
tetracycline from the electrospun poly(ethylene-co-vinylacetate) and PLA blend system 
was achieved for a period of 5 days.  
Despites the enormous advantages and importance of phytotherapeutics, few reports are 
found in the literature regarding the incorporation of natural compounds in electrospun 
mats. The complex composition of plant extracts and problems related with solubility, 
characterization, and standardization, often limit the use of natural compounds in 
biomaterials. Nevertheless, few examples are found about the incorporation of plant 
extracts in electrospun materials, such as the cellulose acetate electrospun mats containing 
curcumin from Curcuma longa L., (Suwantong et al. 2007a) widely known for its anti-
tumor, antioxidant, and anti-in#ammatory properties. The chemical integrity of curcumin 
was maintained after the electrospinning process and the materials revealed good potential 
as transdermal patches. Likewise, Sikareepaisan et al. (2008) and Suwantong et al. (2008) 
have studied, in vitro, the incorporation of Centella asiatica L. Urban extract in 
electrospun fibers of gelatin and cellulose acetate, respectively. The herbal extract has 
demonstrated a positive effect on the treatment of wounds and burns.  
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Incorporation of bioactive compounds in the electrospun materials could be particularly 
useful in skin healing or skin engineering applications, as the removal of the wound 
dressing material for topical administration of medicines, may damage the wound bed, 
delaying the wound healing process and causing pain. Taking this idea into consideration, 
Thakur et al. (2008) have fabricated PLA electrospun mats containing anesthesic and 
antibiotic compounds, lidocaine and mupirocin, respectively. A controlled release system 
with a burst release of the anesthesic, for an initial relief of pain, and a diffusion-mediated 
mechanism for a prolonged antibiotic release was developed. In vitro analysis confirmed 
that the antibiotic maintain its activity in the electrospun mats. More recently, Suganya et 
al. (2011) reported the development of PCL/PVP electrospun mats as release systems for 
Tecomella undulate extract, a medicinal plant widely known for its traditional application 
in the wound healing process.  
In this chapter we explore the incorporation of bioactive natural compounds into the 
PHBV/C scaffolds developed in chapter 2. For the present study, we have selected two 
bioactive extracts from natural origin and with potential effect on the skin healing process: 
the leaf storage parenchyma of Aloe barbadensis Miller, i.e. aloe vera gel, and the aqueous 
extract of Ilex paraguariensis leaf. The first one, aloe gel, has a well-known influence on 
the wound healing process while the aqueous extract of I. paraguariensis has recently 
demonstrated a positive effect on the blood vessel formation, which is also useful in the 
regeneration process. A brief review of the composition and properties of these two 
biological extracts is given below. 
3.1.2. Aloe barbadensis Miller 
Aloe barbadensis Miller is a member of the Liliaceae family. The leaf storage parenchyma 
of A. barbadensis, usually referred as aloe vera gel, contains 99% of water and the 
remaining dry matter contains mostly carbohydrates (72%), proteins (15%), and mineral 
elements (Femenia et al. 1999). Minor compounds also found in aloe gel include vitamins, 
enzymes, steroids, and salicylic acid, among many others (Choi and Chung 2003). Several 
pharmacological activities have been attributed to the rich matrix of aloe vera components, 
including, immunomodulatory, anti-inflammatory, anti-oxidant, anti-cancer, and anti-
allergenic properties, among many others. An excellent review on the relationship between 
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Aloe vera components and their biological effects was provided by Choi and Chung 
(2003). Among all the biological effects of aloe gel, the most traditional is probably the 
wound and burn healing effects. In fact, aloe vera gel has been used to treat wounds and 
burns at least since roman time and, nowadays, aloe gel and its components have been 
incorporated in numerous cosmetics and therapeutic products (Reynolds and Dweck 1999). 
The wound healing effect of aloe gel has been attributed to several different components 
such as the manose-6-phosphate (Davis et al. 1994), acemannan (Jettanacheawchankit et 
al. 2009), and also to a glycoproteic fraction (Choi et al. 2001). The remarkable features of 
aloe matrix, however, lie also in the synergetic action among their components.  
The mechanisms through which aloe gel acts in wound healing process are complexes. For 
instance, Chithra et al. (1998) have shown that aloe gel enhanced the synthesis of ECM 
components during the wound healing process. On the other hand, Jettanacheawchankit et 
al. (2009) have demonstrated that the acemannan component of aloe gel promoted the oral 
wound healing via the induction of fibroblast proliferation and stimulation of keratinocyte 
growth factor-1, VEGF, and type I collagen expressions. More recently, the oral 
administration of aloe gel in rats was shown to enhance the inflammatory cell infiltration, 
angiogenesis, ECM deposition, and epithelialization, as well as the levels of TGF-% and 
VEGF growth factors (Atiba et al. 2011). Also the antioxidant, bactericidal and fungicidal 
effects of aloe vera gel may also have a positive role in the wound healing process 
(Ranjani et al. 2010; Rosca-Casian et al. 2007). 
Due to all mentioned positive effects of the aloe vera gel, we have selected this 
phytochemical product to incorporate into the electrospun scaffolds for skin repair, aiming 
a positive effect in the wound healing process. 
3.1.3. Ilex paraguariensis 
Ilex paraguariensis St. Hill is an aboreous Aquifoliaceae plant native from South America 
countries. Its leaves and twigs are marketed as a fresh product, sold to yerba mate 
processing companies that dry, grind, and pack it. This processed product of I. 
paraguariensis has been used by local populations to prepare, by means of infusion, a 
beverage named mate (Spanish-speaking) or chimarrão (Portuguese-speaking populations) 
(Lunceford and Gugliucci 2005).  
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Interesting biological effects of I. paraguariensis aqueous extract have been reported, such 
as diuretic (Bastos et al. 2006), choleretic (Gorzalczany et al. 2001), antioxidant 
(Gugliucci 1996), neural stimulant, hypocholesterolemic, hepatoprotective, vasorelaxant, 
and atherosclerosis inhibition (Arbiser et al. 2005). More recently the effect of I. 
paraguariensis on the blood vessel formation by vasculogenesis and angiogenesis has been 
reported. Indeed, in an in vivo yolk-sac membrane assay, I. paraguariensis aqueous extract 
increased the number of blood vessels in more than 90% (Strassmann et al. 2008). 
It is well accepted that angiogenesis plays a critical role in the wound healing process. 
During the wound healing process, the damaged blood vessels are replaced from intact 
capillaries, and the newly formed blood vessels are one of the most important components 
of granulation tissue, being responsible for providing nutrition and oxygen to the 
regenerating tissue. Inadequate angiogenesis is many times in the origin of impaired 
wound healing. Indeed, it has been demonstrated that inhibition of angiogenesis with 
administration of TNP-470, a potent anti-angiogenic compound, signi"cantly decreased 
wound healing in a dose-dependent manner (Klein et al. 1999). Similarly, Kurosaka et al. 
(2009) have demonstrated that reduced angiogenesis causes a delayed wound healing and 
have also elucidated the role of the angiogenic factor, angiotensin II. In a complementary 
approach, Galiano et al. (2004) have demonstrated that topical VEGF accelerates diabetic 
wound healing through increased angiogenesis. In this context, we hypothesized that the I. 
paraguariensis aqueous extract may have a positive effect in the wound healing process 
due to its pro-angiogenic activity. For that reason, we have selected this plant extract for 
incorporation in the electrospun scaffolds for application in skin engineering.  
3.1.4. Electrospinning solvents and the incorporation of biocompounds 
Although the incorporation of bioactive molecules in the electrospun biomaterials through 
direct dissolution in the electrospinning solution is simple in theory, most of the polymeric 
systems require organic solvents that can degrade the bioactive molecules or impair their 
biological activity. Particularly, the PHBV/chitosan system described is chapter 2, uses a 
blend of a strong acid (TFA) and fluorinated alcohol (HFIP) for the nanofiber production 
and the processing time for the electrospinning of a 20 mL solution is approximately 42 
hours. These conditions make unfeasible the direct addition of the bioactive plant extracts 
!"#$%&'(+*&P2"$Q(3#%0&4"+,&",&*%7&,211'0+&4"+03/%,&"*6&>%B3/$%,&('0&#3'"/+3>%&/'41'2*6,&
& GL&
to the spun solution, as bioactivity would probably be lost due to degradation of 
compounds. To allow the addition of the bioactive molecules in the PHBV/C mats, we 
have developed a dual syringe electrospinning system in which an aqueous polymer 
solution is used as vehicle for the incorporation of plant extracts. 
3.1.5. Electrospinning in aqueous solution 
Although most of the electrospun nanofibers are produced from organic solutions, there are 
also some polymers that could be electrospun into fibers in aqueous conditions, e.g. PVA, 
PEO, and silk (Zhu et al. 2008; Liu et al. 2007; Koski et al. 2004). PVA is a semi-
crystalline polymer that shows an excellent electrospinnability in aqueous solution (Koski 
et al. 2004). Furthermore, PVA has been used as co-polymer to enhance electrospinnability 
and mechanical properties of biopolymers such as chitosan (Lin et al. 2006). The 
biocompatibility of PVA allows its application in biomaterials for tissue engineering of 
bone and skin (Gupta et al. 2009; Aramwit et al. 2010; You et al. 2004; Gao et al. 2012). 
Here, we used an aqueous solution of PVA and chitosan as vehicle for the incorporation of 
bioactive compounds of A. barbadensis and I. paraguariensis. PVA/chitosan fibers were 
combined with the PHBV/C ones, using a dual syringe electrospinning system, in order to 
create dual-polymer composite fibrous mats. The PHBV/C 4:1 (w/w) was selected for the 
dual-fiber system since it exhibited the best performance as scaffold for skin regeneration, 
as previously discussed in chapter 2. Morphological characterization, as well as bioactive 
compounds distribution in the mats, were performed and the potential of dual-fiber mats 
for skin engineering was analyzed in vitro and in vivo. 
3.2. Experimental 
3.2.1. Materials 
All chemicals were of analytical grade and obtained from Sigma-Aldrich (Sigma-Aldrich 
Chemical Company, St. Louis, MO). All biological supplies were purchased from 
Invitrogen (Invitrogen Grand Island, NY, USA) unless otherwise noted. Aloe vera leaves 
(Aloe barbadensis Miller) were kindly supplied by “Naturama Sucos Integrais do Brasil 
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Ltda”. Ilex paraguariensis leaves were gently donated by “Matevel-Erva Mate Verdinha, 
Ltda”. 
3.2.2. Preparation of aloe gel 
Fresh A. barbadensis leaves (~ 2 years age) from several plants were collected and washed 
with tap water. The basal (~1 cm) and apical (~10 cm) extremities, as well as the rind, 
were removed with a sharp blade. The clear pulp was homogenized with a multimixer 
(Walita, Billy RI 1340) and filtered under vacuum using a polyester mesh, in order to 
obtain the fresh aloe gel. 
3.2.3. Ilex paraguariensis 
3.2.3.1.  Preparation of aqueous extract 
I. paraguariensis leaves were collected from adult mate plants (about 5-year-old) in 
Catanduvas (South Catarina, Brazil). The leaves were dried at 45 °C, powdered, and stored 
at -20ºC. 
The aqueous extract of I. paraguariensis was prepared according to Strassmann et al. 
(2008) with some modifications. Briefly, 2 g of leaves (dry weight) were added to 50 mL 
of ultrapure water, followed by boiling (20 min.) under reflux in a Soxhlet apparatus. The 
aqueous extract was recovered by "ltration on a cellulose support, lyophilized, and stored 
at -20ºC.  
3.2.3.2.  Effect of aqueous extract on vasculogenesis and angiogenesis  
The experiment was approved by Animal Ethics Committee of UFSC (PP00069/2006). 
The effect of I. paraguariensis aqueous extract on the blood vessel formation by 
vasculogenesis and angiogenesis was evaluated by the yolk-sac membrane in vivo assay, 
following described.  
Chicken fertilized eggs (Gallus domesticus) supplied by “Tyson, S.A.” were incubated at 
37 °C and 30% relative humidity.  
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The treatments (n=8) were administered by implanting sterile disk-shaped PET pieces (2 
mm diameter and ~ 0.5 mm thickness; one disk per embryo) impregnated with aqueous 
extracts of I. paraguarensis (10 !L), at five concentrations: 0.015; 0.045; 0.15; 0.45 and 
1.5 mg of lyophilized extract/mL of water. PET disks (water ultra"ltered as vehicle; pH 
7.2) were used as negative control.  
For vasculogenesis study, after a preliminary period of 48 hours of incubation, a 10 mm 
diameter window was opened in the eggshell (adjacent to the embryo). For each treatment, 
the disk was implanted in the outer one-third surface of the yolk-sac membrane, near the 
embryo, where blood islands were present. The shell window was subsequently closed 
with black binding cellophane tape, and the egg returned to the incubator. Two days after 
implantation the zone around the disk was examined under a stereoscopic microscope 
(Olympus, Tokyo, Japan equipped with a digital camera Moticam 1000), as illustrated in 
Figure 3.1 . The effects in vessel formation were determined by the increase or decrease 
in vessel number intercepting the PET disk as compared to the control.  
For angiogenesis study, after a preliminary period of 48 hours of incubation, a 10 mm 
diameter window was opened in the eggshell in order to prevent embryo adhesion, and 
immediately closed with black binding cellophane tape. After another 48 hours of 
incubation, the tape was removed and the treatment disks were implanted on the blood 
vessels of the outer one-third surface of the yolk-sac membrane. The window was closed 
and the eggs were re-incubated for another 24 hours. Afterward, the vessels around the 
disk were observed using a stereoscopic, as described for the vasculogenesis procedure.  
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Figure 3.1. Illustrative representation of the blood vessel analysis in the yolk-sac membrane assay. 
 
3.2.4. Scaffolds fabrication by electrospinning 
A dual syringe electrospinning apparatus was used to fabricate the dual-fiber mats of 
PHBV/chitosan (PHBV/C) and PVA/chitosan (PVA/C) (Figure 3.2). One of the syringes 
was loaded with 10 wt.% of PHBV/C 4:1 (w/w) in TFA/HFIP 1:1 (v/v) (one of the spun 
solutions described in chapter 2). The second syringe was loaded with 10 wt.% of 
PVA/C1500 kDa 9:1 (w/w) in 0.2 mol/L acetic acid. The bioactive extracts, A. barbadensis 
and I. paraguariensis were directly added to the PVA/chitosan solution (final 
concentration of 1 wt.% and 0.01 wt.%, respectively). The solutions were maintained 
under stirring during the electrospinning process. The electrospinning process was 
conducted at 22 kV of applied voltage, with a flow rate of 8 µL/min and a needle tip-to-
collector distance of 14 cm. Fibers were collected as a nonwoven fibrous mat on the 
rotating drum (900 rpm), in air and at room conditions (20 ± 2 ºC, 45–50% RH). The 
scaffolds were dried at 35ºC for 24 hours. Table 3.1 . summarizes the chemical 
composition of the electrospinning solutions and final electrospun mats. 
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Table 3.1. Solution and electrospun mat composition.  
 Solution composition
a
 Dry mat composition
b
 
Dual-fiber Syringe 1: PHBV/C48kDa 4:1 (w/w) (10 wt.%) 
in TFA/HFIP 1:1 (v/v) 
45.0% PVA 
40.0% PHBV 
10.0% Chitosan 48 kDa 
5.0% Chitosan 1500 kDa 
 
Syringe 2: PVA/C1500 kDa 9:1 (w/w) (10 wt.%) 
in 0.2 mol/L acetic acid 
Aloe_dual-fiber Syringe 1: PHBV/C48kDa 4:1 (w/w) (10 wt.%) 
                 in TFA/HFIP 1:1 (v/v) 
42.9% PVA 
38.1% PHBV 
9.5% Chitosan 48 kDa 
4.8% Chitosan 1500 kDa 
4.8% A. barbadensis 
Syringe 2: PVA/C1500 kDa 9:1 (w/w) (10 wt.%) 
                  + A. barbadensis (1 wt.%) 
                  in 0.2 mol/L acetic acid 
Ilex_dual-fiber Syringe 1: PHBV/C48kDa 4:1 (w/w) (10 wt.%) 
                  in TFA/HFIP 1:1 (v/v) 
45.0% PVA 
40.0% PHBV 
10.0% Chitosan 48 kDa 
5.0% Chitosan 1500 kDa 
0.05% I. paraguariensis  
 
Syringe 2: PVA/C1500 kDa 9:1 (w/w) (10 wt.%) 
               + I. paraguariensis aqueous extract (0.01 wt.%) 
                 in 0.2 mol/L acetic acid 
Bioactive  
dual-fiber 
Syringe 1: PHBV/C48kDa 4:1 (w/w) (10 wt.%) 
                 in TFA/HFIP 1:1 (v/v) 
42.9% PVA 
38.1% PHBV 
9.5% Chitosan 48 kDa 
4.8% Chitosan 1500 kDa 
4.8% A. barbadensis 
0.05% I. paraguariensis  
 
Syringe 2: PVA/C1500 kDa 9:1 (w/w) (10 wt.%) 
                 + A. barbadensis gel (1 wt.%) 
               + I. paraguariensis aqueous extract (0.01 wt.%) 
               in 0.2 mol/L acetic acid 
a Initial composition of the spun solutions; 
b Final composition of the electrospun fibrous mats, assuming that all solvents have been removed during the 
electrospinning process. 
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Figure 3.2. Schematic representation of the dual syringe electrospinning system. 
3.2.5. Scaffolds characterization 
Electrospun mats were analyzed by SEM (Hitachi S4100) at an accelerating voltage of 25 
kV and by ATR-FTIR, using a Golden-gate single reflection ATR in a Bruker IFS-
spectrometer at a resolution of 8 cm-1 and 256 co-added scans. 
3.2.6. Biological studies  
In vitro cell culture studies were conducted using mouse fibroblast cells (L929). The 
detailed description of cell culture conditions, as well as the experimental procedures of 
the indirect cytotoxicity and MTS assays, SEM and CLSM analysis of cells cultured on the 
scaffolds are described in chapter 2 (§ 2.2.5.4).  
For the live/dead assay (Molecular probes, Invitrogen) cells were cultured on sterile 
scaffold pieces (24-well plates, 1 x 105 cells/well) for 2, 7, and 14 days, at 37 °C in a wet 
atmosphere containing 5% CO2. Cell culture medium was replaced every 3 days. 
Afterwards, the culture medium was removed and 100 µl of PBS solution containing of 4 
µM of ethidium homodimer-1 and 2 µM of calcein AM (live/dead kit components) were 
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added. Cells were re-incubated for 45 minutes, mounted and observed on a fluorescence 
microscope (Olympus BX41). 
The wound healing model used to evaluate the scaffolds in the skin healing process is 
described in chapter 2 (§ 2.2.6). 
3.2.7. Statistics 
Statistical analysis was carried out using Instat 3.0. Results were expressed as the mean ± 
standard deviation and compared through one-way ANOVA and Tukey-Kramer multiple 
comparisons test. P < 0.05 was considered statistically significant. 
3.3. Results and discussion 
In this chapter we describe the development of a dual-polymer composite fibrous mat 
prepared by a dual electrospinning system in which one syringe was loaded with PHBV/C 
in the organic solvents and the other with PVA/C in aqueous solution, in order to obtain 
dual-fiber electrospun mats. Plant extracts from A. barbadensis and I. paraguariensis with 
bioactivity in the wound healing process were added to the aqueous solution. We have 
selected A. barbadensis gel for its well-recognized effects on the wound healing process 
and the aqueous extract of I. paraguariensis for its positive effect on the blood vessel 
formation. A detailed description of the dual-fiber mats morphological characterization, as 
well as the fiber and plant extracts distribution in the mats, is given below.  
3.3.1. Morphological analysis of PVA/chitosan nanofibers 
SEM analysis revealed that the PVA/chitosan solution produced a typical nonwoven mesh 
of cylindrical nanofibers (Figure 3.3  a). The addition of A. barbadensis (Figure 3.3 b), I. 
paraguariensis (Figure 3.3 c), or both extracts (Figure 3.3 d) did not promote considerable 
modifications on the fibrous morphology, i.e. beads or clusters formation, suggesting that 
the plant extracts solubilized well in the electrospinning solutions and were successfully 
incorporated into the PVA/chitosan fibers.  
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Figure 3.3. Representative SEM images of fibers obtained from electrospinning solutions of (a) 
PVA/chitosan 9:1 (w/w) (10 wt.%) in acetic acid 0.2 M (spun S2), (b) S2 + 1 wt.% of A. 
barbadensis, (c) S2 + 0.01 wt.% of I. paraguariensis aqueous extract, and (d) S2 + 1wt.% of A. 
barbadensis + 0.01 wt.% of I. paraguariensis aqueous extract.  
3.3.2. Distribution of PHBV/chitosan and PVA/chitosan fibers in the dual-
fiber mat  
As previously mentioned, the dual-fiber mats were obtained by simultaneously 
electrospinning two different polymer solutions, one of PHBV and chitosan and the other 
of PVA and chitosan. In the electrospinning apparatus that has been used, the two syringes 
were displayed in parallel, in a top-bottom position, and pointing to the center of the 
rotating collector (Figure 3.2). The system was designed in order to homogeneously 
combine the two kinds of fibers during the trajectory of the jet to the collector. The 
distribution of the fibers in the mat was analyzed by SEM and FTIR. As illustrated in 
Figure 3.4, the dual-fiber mat evidenced morphological characteristics from both fibers 
(PHBV/C and PVA/C). Typical morphological details from the PHBV/C mat such as the 
smaller fiber diameter or the presence of ramifications and ruptures in the fibers (Figure 
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3.4 a), as well as from the PVA/chitosan mat such as the long cylindrical fiber shape, with 
higher diameters and no ramifications (Figure 3.4 b), were found all over the dual-fiber 
mat (Figure 3.4 c). 
&
Figure 3.4. SEM images of (a) PHBV/C mat, (b) PVA/C mat, and (c) dual-fiber mat. Blue arrows 
evidence details from the PHBV/C fibers and red arrows from the PVA/C ones. Bar = 1µm. 
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Figure 3.5  displays the FTIR spectra of PHBV/C and dual-fiber mat. The addition of the 
PVA/C component caused subtle modifications on the FTIR spectrum profile. In fact, the 
major differences in the FTIR bands are derived from the differences in the relative 
concentration of chitosan between the two mats (the relative amount of chitosan in 
PHBV/C 4:1 (w/w) is 20% while in dual-fiber mat is 15%). Therefore, the dual-fiber FTIR 
spectrum exhibited a decreased intensity of absorption of the chitosan bands, including the 
broad band observed from 3650 to 3050 cm-1 (O-H stretching), the peak at 1680 cm-1 
(C=O, amide I), and the N-H deformation of amide II at 1560 cm-1. Similar spectra profiles 
were found for different regions of the dual-fiber mat, confirming the homogeneous 
distribution of the PHBV/C and PVA/chitosan fibers within the final fibrous mats. 
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Figure 3.5. FTIR spectra obtained for electrospun fibers of PHBV/C 4:1 (w/w) and dual-fiber mat. 
3.3.3. Distribution of bioactive extracts in the dual-fiber mats  
Figure 3.6  displays representative SEM images of dual-fiber and bioactive dual-fiber 
mats. No important evidences of beads or clusters were found in the bioactive dual-fiber 
mat. This result also suggests a good incorporation and distribution of the bioactive 
extracts inside the fibers. An apparent effect of fiber diameter reduction was detected with 
the addition of the bioactive extracts. This reduction may be attributed to the presence of 
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salts and other components from the plant extracts that increase the solution conductivity 
and, consequently, the fiber stretching during electrospinning, resulting in the decrease of 
fiber diameter.  
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&
Figure 3.6. SEM pictures of (a and c) dual-fiber mat and (b and d) bioactive dual-fiber mat at 
6000x (a and b) and 10000x magnification (c and d).  
 
The distribution of the A. barbadensis gel and I. paraguariensis aqueous extract in 
aloe_dual-fiber and ilex_dual-fiber mats was also analyzed by FTIR (Figure 3.7  and 
Figure 3.8 , respectively). 
The addition of the A. barbadensis extract (final concentration of 4.8%, dry weight) 
promoted considerable changes in the FTIR spectrum of the dual-fiber mat. Among these 
changes are the enormous increase in the intensity of the band ranging from 3700-3035 
cm-1 (O-H stretching) and in the peak at 2950 cm-1 (C-H stretching), the occurrence of a 
new peak at 1680 cm-1 (C=O stretching of amide I), and the increase in the absorption 
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intensity of bands between 1150-980 cm-1 (C-O stretching) and 600-890 cm-1 (C-N-H and 
C=C-N-H deformation). These changes in the infrared absorption profile of the aloe_dual-
fiber mat are attributed to several different functional groups of compounds found in the 
complex matrix of aloe gel (FTIR spectrum in red, Figure 3.7), including proteins, sugars, 
alcohols, organic acids, and esters, among many others.  
Modifications on the FTIR spectrum of the dual-fiber mat due to the addition of I. 
paraguariensis extract include an increase in the broad band at 3700-3050 cm-1 (O-H 
stretching), in the 2940 cm-1 peak (C-H stretching), and in the 1540 cm-1 band (N-H 
deformation of amide II) (Figure 3.8). The occurrence of a new peak at 1680 cm-1 (C=O, 
amide I) and the increase in the intensity of bands at 600-890 cm-1 (C-N-H and C=C-N-H 
deformation region) found in the FTIR spectrum of ilex_dual-fiber mat also result from the 
inclusion of the compounds present in the I. paraguariensis extract. These changes are 
mainly attributed to the xanthines e.g. caffeine and theobromine, as well as polyphenols 
from the I. paraguariensis extract.  
FTIR analysis of the bioactive dual-fiber mat (Figure 3.9) showed the increase in the 
strength of peaks associated to both A. barbadensis gel and I. paraguariensis extract (many 
times coincident), including the increase in the intensity of the band ranging from 3700-
3035 cm-1 (O-H stretching), in the peaks at 2950 cm-1 (C-H stretching) and at 1540 cm-1 
(N-H deformation of amide II), the occurrence of a new peak at 1680 cm-1 (C=O stretching 
of amide I), and the increase in the absorption intensity of bands between 1150-980 cm-1 
(C-O stretching) and 600-890 cm-1 (C-N-H and C=C-N-H deformation). 
Additionally, FTIR analysis confirmed a good distribution of the bioactive extracts in the 
dual-fiber mats as no important changes were found in the spectra obtained from different 
regions of the electrospun mats. 
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Figure 3.7. FTIR spectra obtained for electrospun fibers of dual-fiber, aloe_dual-fiber, and 
lyophilized aloe vera gel. Whole spectra (top) and fingerprint region (bottom). 
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Figure 3.8. FTIR spectra obtained for electrospun fibers of dual-fiber, ilex_dual-fiber, and 
lyophilized I. paraguariensis aqueous extract. Whole spectra (top) and fingerprint region (bottom). 
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Figure 3.9. FTIR spectra obtained for electrospun fibers of dual-fiber and bioactive dual-fiber 
mats. Whole spectra (top) and fingerprint region (bottom). 
3.3.4. Biological studies 
Following a similar approach already described in chapter 2, the potential of the dual-fiber 
electrospun mats as scaffolds for skin engineering, with or without addiction of plant 
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bioactive extracts, was analyzed by combining in vitro cell culture studies with an in vivo 
wound healing assay. In this chapter, however, we focused on comparing the dual-fiber 
with the single-fiber PHBV/C mat (PHBV/C 4:1 (w/w)) and also on the effects of the 
bioactive extracts addition. These results will be discussed in the following subsections, 
but firstly, the results obtained for the effect of the I. paraguariensis aqueous extract on the 
blood vessel formation will be analyzed.  
3.3.4.1. Pro-vasculogenic and pro-angiogenic effects of the aqueous extract 
of I. paraguariensis 
In a recent study, Strassmann et al. (2008) have shown the positive effect of I. 
paraguariensis aqueous extract in blood vessel formation. Considering that angiogenesis is 
a key phenomenon in the tissue regeneration process, as the newly formed tissues depend 
on the reestablishment of the new vasculature for nutrition and oxygen, the addition of pro-
angiogenic agents may have a positive effect on the wound healing process. There are two 
main mechanisms of blood vessel formation: vasculogenesis and angiogenesis. The first 
one is limited to the early embryonic period, where the development of blood vessels 
occurs from in situ differentiation of mesodermal progenitor endothelial cells to 
endothelial cells. These precursor cells are recruited from mesoderm areas adjacent to the 
embryo and/or originated by local cell division, organizing blood islands and establishing a 
primordial vascular plexus (DeRuiter et al. 1993). Later, a subsequent remodeling of these 
preexisting vessels (angiogenesis) gives rise to a more re"ned microvasculature that 
accompanies the growth and shaping of the body (Folkman 1971). In the yolk-sac 
membrane assay, processes of vasculogenesis and angiogenesis coexist. Nevertheless, in 
the first 4 days the primordial vessels are essentially formed from the blood islands by 
vasculogenesis, and afterwards angiogenesis predominates. We used the yolk-sac 
membrane assay to confirm the positive effect of the aqueous extract of I. paraguariensis 
reported by Strassmann et al. (2008). However, the effects of the extract on both 
vaculogenesis and angiogenesis were tested. Figure 3.10 . displays the results obtained in 
the yolk-sac membrane assay. 
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Figure 3.10. Effects of I. paraguariensis aqueous extract on the formation of blood vessels by (a) 
vasculogenesis and (b) angiogenesis. Different letters indicate significant differences at P<0.05. 
 
Regarding to vasculogenesis, the aqueous extract of I. paraguariensis significantly 
increased the formation of new blood vessels for concentrations higher than 0.15 mg/mL 
(recall that 10 µL of the aqueous extract was added into a 2 x 0.5 mm PET disk). The 
highest effect was for the concentration of 0.45 mg/mL, where the percentage of blood 
vessels around the disk was 40 ± 10 % higher than the control. The extract also increased 
significantly the formation of blood vessels by angiogenesis for concentrations higher than 
0.045 mg/mL. The highest pro-angiogenic effect was also observed for 0.45 mg/mL, where 
an increase of 34 ± 7 % of control was observed. Illustrative examples of the effect of I. 
paraguariensis aqueous extract on the blood vessel formation are displayed in Figure 
3.11 . 
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Figure 3.11. Representative examples illustrating the effects of I. paraguariensis aqueous extract 
on vasculogenesis and angiogenesis.   
3.3.4.2.  Cell viability and growth 
As previously mentioned, the main purpose of this study is the development of a new dual-
fiber electrospinning system suitable for the incorporation of bioactive plant extracts into 
the polymeric electrospun fibers. Several details were analyzed, including the 
configuration of the electrospinning system, the characteristic of the vehicle fibers 
(PVA/chitosan fibers), the distribution of fibers and extracts within the mats, among 
others. Other important aspects could also have been explored, for example the 
concentration of the bioactive extracts in the electrospun mats, but we were compiled to 
limit the number of variables in this initial phase of investigation, giving its exploratory 
nature.  
With respect to the indirect cytotoxicity assay, no significant differences were found 
among PHBV/C, dual-fiber, and bioactive dual-fiber scaffolds (Figure 3.12). This result 
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indicates that, for the period analyzed, there was no evidence of cytotoxic compounds 
released from the scaffolds. 
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Figure 3.12. Absorbance 540 nm (% of control, i.e. TCP) of L929 cells cultivated on the PHBV/C 
4:1 (w/w), dual-fiber, and bioactive dual-fiber scaffolds extraction media. No significant 
differences were observed (P>0.05). 
 
L929 cells were cultivated on PHBV/C, dual-fiber, and bioactive dual-fiber scaffolds for 
different intervals. Viability, adhesion, and growth of cells were analyzed combining MTS 
colorimetric assay, with SEM, and different fluorescence cell staining procedures such as 
the live/dead, actin, and vinculin staining assays.  
Live /dead assay is a fluorescence cell viability assay, where live and dead cells are 
simultaneously stained with calcein AM and ethidium homodimer-1, respectively. Non-
fluorescent calcein AM is transported through the membranes of living cells and further 
enzymatically converted by intracellular estereases into calcein, producing a green 
fluorescence. On the other hand, the ethidium homodimer-1 only permeates membrane 
damaged cells, where it binds to cell nucleus, producing a red fluorescence. Therefore, this 
assay is used to evaluate cytotoxic and is particularly interesting for analysis of cells 
cultivated on biomaterials. As a fluorescence labeling technique, this assay gives a rapid 
illustration of how viable and dying cells are distributed on the scaffolds.  
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Results from MTS assay are plotted in Figure 3.13 . During the first 7 days of culture, an 
increase in the absorbance was observed for all scaffolds, which is indicative of the 
increase of cells metabolic activity. After 7 days of culture, all scaffolds already exhibited 
a confluent layer of cells, as evidenced in pictures from the live/dead assay (Figure 3.14) 
and thereby, the cell growth stabilized on the subsequent days of culture, as illustrated by 
the MTS assay (absorbance stabilizes). 
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Figure 3.13. MTS assay for cells cultured on the PHBV/C 4:1 (w/w), dual-fiber, and bioactive 
dual-fiber scaffolds for 2, 7, and 14 days.                                                                                            
No significant differences were observed among treatments (P>0.05). 
&
Although cells reached confluence on all scaffolds, live/dead assay indicated a slight 
increase in the number of dead cells for PHBV/C 4:1 (w/w), comparing to the dual-fiber 
scaffolds, at the 14th day of culture (Figure 3.14). 
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Figure 3.14. Live/dead assay of cells cultured on the PHBV/C 4:1 (w/w), dual-fiber, and bioactive 
dual-fiber scaffolds for 2, 7, and 14 days. Live cells appear in green and dead cells in red.    
Bar=100 µm. 
 
Figures 3.15 and Figure 3.16  display representative examples of SEM pictures 
obtained from L929 cells cultured on PHBV/C 4:1, dual-fiber, and bioactive dual-fiber, for 
different growing times. SEM pictures revealed that cells attached to multiple fibers of the 
scaffolds, showing a spherical morphology after 12 hours of culture that successively 
changed to a well-spread morphology, during the subsequent days of culture. At the 7th day 
after seeding, a confluent layer of cells and its extracellular secreted products, i.e. ECM, 
covered almost all the surface of scaffolds. SEM analysis of the bioactive dual-fiber 
scaffold also revealed that after hydrating, the mat surface became very irregular 
(shrinkage) and cells tended to form clusters, mainly during the first 2 days of culture. This 
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phenomenon is probably attributed to the high water absorption capacity of aloe gel 
present in this mat. 
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Figure 3.15. SEM analysis of cells cultured on PHBV/C 4:1 (w/w), dual-fiber, and bioactive dual-
fiber scaffolds for 12 hours, 2 days, and 7 days after seeding. Bar= 10µm. 
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Figure 3.16. SEM analysis (high magnification) of cells cultured on PHBV/C 4:1 (w/w), dual-
fiber, and bioactive dual-fiber scaffolds for 12 hours, 2 days and 7 days after seeding. Bar = 5 µm. 
 
CLSM of actin and nucleus showed similar cell behavior found by SEM analysis, i.e. 
initial lower level of spreading and cell cluster for cells cultured on bioactive dual-fiber 
scaffolds, in comparison to those cultured on PHBV/C and dual-fiber scaffolds (Figure 
3.17) . At the 7th day of culture a confluent layer of L929 cells covering the scaffold 
surfaces, with similar levels of cell spreading, was observed in the three scaffolds, as 
illustrated in Figure 3.18 .  
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Figure 3.17. CLSM images (a) low magnification and (b) high magnification of L929 fibroblasts 
cultured on bioactive dual-fiber scaffolds for 12 hours. F-actin (red) and nucleus (blue) stained with 
Alexafluor 546 conjugated to phalloidin and DAPI, respectively. Scale bar = 50 µm. 
 
 
Figure 3.18. CLSM images of L929 fibroblasts cultured on (a) PHBV/C 4:1 (w/w), (b) dual-fiber, 
and (c) bioactive dual-fiber scaffolds for 7 days. F-actin (red) and nucleus (blue) stained with 
Alexafluor 546 conjugated to phalloidin and DAPI, respectively. Scale bar = 10 µm. 
 
Representative examples of the vinculin immunolabeling of L929 cells cultivated on the 
PHBV/C and bioactive dual-fiber scaffolds for 2 days are displayed in Figure 3.19 . The 
focal adhesion analysis, i.e. vinculin immunolabeling, suggests a slight increase in the 
number of focal adhesion points in the bioactive dual-fiber scaffold, compared to the dual-
fiber scaffold, mainly at the 2nd day of culture. Proteins from aloe gel present in the 
bioactive dual-fiber scaffold may contain RGD sequences or enhance the adhesion of 
serum proteins (by changing the biomaterial surface properties), which may facilitate focal 
adhesion contacts. 
!"#$%&'(+*&P2"$Q(3#%0&4"+,&",&*%7&,211'0+&4"+03/%,&"*6&>%B3/$%,&('0&#3'"/+3>%&/'41'2*6,&
& IH&
&
Figure 3.19. CLSM images of L929 fibroblasts cultured on (a) PHBV/C 4:1 (w/w) and (b) 
bioactive dual-fiber scaffolds for 2 days. Vinculin (green) and nucleus (blue) stained with anti-
vinculin monoclonal antibody followed by Alexafluor 488 goat anti-mouse and DAPI, respectively. 
Scale bar =10 µm. 
3.3.5. Wound healing assay 
The potential of the dual-fiber and bioactive dual-fiber electrospun mats as scaffolds for 
skin regeneration was tested in the full-thickness wound healing model, previously used to 
evaluate the PHBV/C single fiber scaffolds. Figure 3.20  shows the wound area reduction 
for the different treatments.  
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Figure 3.20. Wound area (% of initial wound area) as a function of time for different treatments 
tested. Different letters indicate significant difference (P<0.05). 
 
The three electrospun scaffolds showed a significant reduction of wound area at the 7th day 
post injury compared to control (Tegaderm #), but no significant differences were found 
among them during the experimental time.  
The densities of PMN and MN cells are plotted Figure 3.21.  The electrospun scaffolds 
(PHBV/C, dual-fiber, and bioactive dual-fiber) showed shorter inflammatory phases in 
comparison to control, since the peak of PMN leucocytes occurred on the 3rd day after 
injury for those scaffolds and on the 7th day after injury for control. In respect to MN 
leukocyte densities, similar levels were found on day 3 and 7 after injury, however, on day 
14 and 21, an increased density of these cells was found for bioactive dual-fiber scaffold. 
In fact, addition of the bioactive extracts increased the MN cell density approximately 2 
times at day 14 and 3 times at day 21. This result may suggest a tendency for chronic 
inflammation caused by compounds from the bioactive dual-fiber scaffolds. 
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Figure 3.21. PMN and MN cell densities during the wound healing process. 
3.4. Conclusions and further studies 
In this chapter we report the development of new dual-fiber electrospun mats made of 
PHBV/chitosan and PVA/chitosan. The configuration of the electrospinning dual syringe 
system allowed an homogeneous distribution of the two kinds of fibers. PVA/chitosan 
fibers were used as vehicle for bioactive plant extracts. Combining SEM and FTIR 
analysis, we verified that the bioactive extracts were successfully incorporated and 
homogeneously distributed within the fibrous mats, without formation of beads or clusters. 
The dual-fiber mats, alone or enriched with the bioactive extracts, showed a good potential 
as scaffolds for L929 fibroblasts growth. Few differences were found as a result of the 
bioactive extracts addition in the dual-fiber scaffolds, which include the formation of L929 
cell clusters in the first 2 days of culture and the enhanced focal adhesion, i.e. vinculin 
expression. After 7 days of culture, however, similar level cell spreading and confluence 
(~100% of confluence) were observed on both dual-fiber scaffolds, with or without the 
bioactive compounds. Also, in vivo, those scaffolds showed a similar performance as 
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scaffolds for wound regeneration, although a slight increase of MN leucocyte density was 
observed for the bioactive dual-fiber treatment.  
In summary, this study constituted an initial investigation of the potential of dual-fiber 
PHBV/PVA/chitosan based mats as scaffolds for skin regeneration and vehicles for 
incorporation of bioactive compounds. Other important aspects remain to be explored, 
including: 
- Processing conditions that may have influence on the bioactivity of the compounds, 
such as the high voltage applied and the molecular interactions established between 
bioactive compounds and fibers components. Therefore, further studies are needed 
to elucidate if the bioactive compounds maintain their bioactivity in the electrospun 
mats; 
- Examination of the ideal concentration of the bioactive extracts incorporated into 
the mats and their release profile in vitro and in vivo. 
The dual-fiber system here presented may be used as a vehicle for incorporation not only 
of A. barbadensis and I. paraguariensis extracts, but also of other herbal or synthetic 
compounds.  
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4.1. Introduction 
In chapters 2 and 3 we reported the use of biodegradable electrospun mats as scaffolds for 
skin repair. Besides absorbable biomaterials, non-degradable materials are also used in 
wound care as removable wound dressing materials. Non-adherent films such as 
Tegaderm# and Bioclusive#, for example, are widely used products in the wound healing 
treatment, either as a primary or a secondary dressing. In fact, the British Pharmacopoeia 
have divided dressing materials in two subcategories, passive products, which protect and 
cover the wounds, and interactive products, which contain substances that actively 
participate in the wound healing process. Several examples of passive products are 
available commercially such as gauzes of cotton, viscose and polyesters, non-adherent 
films, and tulles. Bioactive wound dressings include films, foams, hydrocolloids, 
hydrogels, and scaffolds with variable compositions.  
In general, an ideal wound dressing should protect against external contaminants, maintain 
a moist environment, remove the excess of exudate, allow gas exchange, provide thermal 
insulation, cause no trauma on removing or toxicity to the wound tissues (Abdelrahman 
and Newton 2011). Notwithstanding, each wound has particular characteristics and, 
therefore, a specific treatment must be provided. Indeed, a broad spectrum of wound 
dressing products with distinct characteristics is available in the market. A meticulous 
analysis of the wound bed and a careful selection of the wound care product are 
determinant for the treatment success. For instance, polyurethane semi-occlusive films 
such as Tegaderm# and Bioclusive# are indicated for dry superficial wounds, surgical 
wounds or for use as a secondary dressing. Hydrogels such as Tegagel#, Nu-gel#, and 
Biodress#, foams (e.g. Hidrosorb and Softfoam) and hydrocolloids (e.g. Duoderm#) are 
used in low to moderately exuding wound or necrotic wounds. Sponges (e.g. Tielle#) and 
alginate based dressings such as Calcicare#, Sãf-gel# and Seasorb# are the materials of 
choice for moderate or heavy exuding and bleeding wounds, due to their high liquid uptake 
capacity. Non-adherent dressings, e.g. Telfa Ouchless#, Melolin#, and Mepore# cause no 
trauma on removal but have a minimal absorptive capacity and therefore are indicated for 
light exuding and superficial wounds (Abdelrahman and Newton 2011; Stashak et al. 
2004; Fonder et al. 2008). 
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Nonwoven materials possess several features that make them attractive as wound dressing 
materials such as the high area to volume ratio, the high absorbent capacity, the improved 
conformability and flexibility, and the great versatility of manufacturing technology and 
design. Indeed, nonwoven materials have been increasingly incorporated into wound care 
products and several nonwoven materials are found in the market including nonwoven 
calcium alginate fibers (Algisite M#), sodium carboximethylcellulose fibers (Aquacel#), 
and nonwoven polyethylene (Alicoat#), among many others (Mao and Russell 2004). An 
important emerging class of nonwoven materials regards the electrospun nonwoven mats. 
Because of their inherent properties several electrospun materials have been proposed as 
wound dressing materials, as already discussed in previous chapters. Nevertheless, the 
absolute majority of electrospun materials proposed for treating wounds concerns to 
biodegradable biomaterials that act as absorbable scaffolds during the tissue regeneration 
process. Notwithstanding, electrospun mats of non-degradable polymers such as PET 
could also be used as removable wound dressing materials. Nanofibrous mats of PET have 
already been produced by electrospinning and possess several characteristics that match 
the ideal criteria of a removable wound dressing material, in particular:  
 
(1) The microporosity of PET mats may function as a microbiological barrier. In fact, 
PET membranes are made of successive layers of small pores impermeable to 
several microorganisms and other contaminants, thus protecting against infection;  
(2) Due to their hydrophobic nature, PET mats may be non-adhesive to the wound, 
thus avoiding trauma on removing; 
(3) The mechanical proprieties of PET electrospun mats such as a high tensile strength 
(2.7 ± 0.2 MPa) and relatively high elongation (35 ± 8 %) are important for 
mechanical protection (Veleirinho et al. 2008); 
(4) Due to their high porosity and high hydrophobicity, PET electrospun materials are 
non permeable to liquid water but allow the excess fluid to be loss by vapor 
transmission, preventing dehydration and providing a moist semi-occlusive 
environment adequate for the wound healing process (Hong and Kang 2006);  
(5) The low density of the electrospun PET mats (~ 0.091 g/cm-3), as well as their 
softness, may be ideal for promoting comfort and alleviating pain (Veleirinho et al. 
2008).  
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In this chapter we explore the potential of an electrospun PET mat as a removable wound 
dressing material. For that, a full-thickness wound healing experiment was conducted with 
Wistar rats and the effects of PET wound dressing on the inflammatory and proliferative 
phases of the wound healing process were analyzed. 
4.2. Experimental 
4.2.1. Materials 
PET pellets were kindly supplied by Flexitex (Portugal). All chemicals were of analytical 
grade and obtained from Sigma-Aldrich Chemical Company.  
4.2.2. Fabrication of PET mat by electrospinning 
A 30% (w/v) PET solution was prepared in a blend of TFA and dichloromethane (DCM) 
(8:2) v/v by moderate stirring for 2 hours at room temperature. These PET concentration 
and solvent have been shown to allow for good polymer solubility and electrospinnability 
(Veleirinho et al. 2008). Electrospinning was performed using the experimental set up 
previously described in chapter 2 (§2.2.4). The process was conducted at 26 kV of applied 
voltage, with a flow rate of 0.080 mL/min and a needle tip-to-collector distance of 12 cm. 
A total solution volume of 20 mL was electrospun and fibers were collected as a nonwoven 
fibrous mat on the rotating drum (900 rpm), in air and at room conditions (20 ± 2 ºC, 45–
50% relative humidity). The mat was dried at 35 ºC for 24 hours. 
4.2.3. Morphological analysis  
Morphology of the fibrous mat was investigated by SEM. Small sections of the scaffolds 
were sputter-coated with gold and analyzed using a scanning electron microscope (Hitachi 
S4100) at an accelerating voltage of 25 kV. 
Image processing was performed using the ImageJ - 1.37c software. Five random images 
(1000X magnification) were obtained for each sample. Fiber diameters were calculated 
from at least 100 measurements of the sample fibers. SEM images were thresholded and 
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pore areas were automatically calculated using the “analyze particle” tool of ImageJ 
(n>200). 
4.2.4. Wound healing assay 
The full-thickness wound healing experiments were in compliance with all the criteria, 
technical standards and international animal research rights recommended by the Brazilian 
College on Animal Experimentation. The Ethical Committee on Research of the Santa 
Catarina South University (UNISUL) has approved this study. The animals were kept 
throughout the experiment in the Operative Technique and Experimental Surgery 
Laboratory at UNISUL in ambient temperature, continuous air flow, free of noise and 
stress and obeying natural day and night cycles. They remained in individual cages on 
shelves in the same distance from the light source with feed and water ad libitum.  
Male Wistar rats (Rattus norvegicus albinus), aged 3 months and weighing 300± 50 g were 
obtained from the UNISUL Central Biotery. Animals were divided in two groups 
(n=9/group), the control group corresponding to untreated/uncovered wounds and the PET 
treated group. 
Rats were anesthetized with a single intramuscular injection of ketamine (90 mg/kg) and 
xylazine (15 mg/kg). After manual depilation and antisepsis with polyvinylpyrrolidone, a 
full thickness wound with a surface area of 1.5 cm x 2.5 cm was made on the dorsum of 
the rat using a sterile surgical scalpel blade. The wound was covered with an equal size of 
PET mat (PET group) and left uncovered in the control group. The edges of PET mat were 
fixed to the wound with interrupted suture. After surgery, animals were housed 
individually and observed daily. 
Animals were sacrificed on the 3rd, 7th, and 14th postoperative days in a carbon dioxide 
chamber. Wound tissues were dissected and "xed in buffered formaldehyde solution (10%, 
pH 7.2) for 48h.  
4.2.4.1.  Histopathological analysis 
For histopathological analysis, tissues were dehydrated, embedded in paraffin according to 
standard procedures and cut into 5 µm sections. For each animal 25 sections were taken 
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(5x5 sections, separated by 25µm of distance). Sections were stained with HE and the 
slides were observed and photographed with an optical microscope (Leica DMRBE). The 
density of PMN and MN leukocytes, fibroblasts and fibrocytes were calculated for 5 areas 
(0.004 mm2) per section. A total of 125 areas were analyzed for each animal. 
4.2.5. Statistics 
Statistical analysis was conducted using Instat 3.0. Results were expressed as the mean ± 
standard deviation and compared through one-way ANOVA, Tukey-Kramer multiple 
comparisons test (for parametric data) and Mann–Whitney U test (for non-parametric data). 
P < 0.05 was considered statistically significant. 
4.3. Results and discussion  
4.3.1. Morphological analysis 
SEM analysis of PET mat revealed a typical nonwoven fibrous structure with high porosity 
and a random fibrous arrangement (Figure 4.1).  
 
(
Figure 4.1. SEM image of PET mat. 
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The average fiber diameter was 0.71 ± 0.28 µm and the average pore area was 9.4 µm2. In 
electrospun materials, pores are formed through the random layer-by-layer deposition of 
the nanofibers and, as expected, relative wide ranges of pore areas are obtained. The pore 
area distribution of PET mat is displayed in Figure 4.2 . The electrospun PET mat 
showed pores ranging from 1.0 to 64.2 µm2, however more than 50% of pores were 
smaller than 5 µm2. 
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Figure 4.2. Pore area distribution of PET mat. 
 
An ideal wound dressing material should maintain a moist clean environment that prevents 
mechanical trauma, reduces edema and stimulates repair. The electrospun non-degradable 
mat of PET possesses several characteristics attractive for this application, including the 
microporosity, the low density, the high hydrophobicity, and the adequate mechanical 
properties. Furthermore, PET is a biocompatible low-cost polymer and the versatility of 
the electrospinning technology allows the development of several distinct material designs. 
In this context, we hypothesize that when used as a wound dressing, PET mat may have a 
positive effect on the wound healing process of low exudate, non-infected wounds. To test 
this hypothesis, a full thickness wound was created on the back of Wistar rats and the 
electrospun PET mat was placed on the top of the wound as a wound dressing material. 
Details of macroscopic and histological results will be discussed in the following 
subsections. 
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4.3.2. Macroscopic observations of the wound healing process 
As previously referred, the PET membrane was developed to act as a non-adherent 
removable wound dressing material. On the contrary to PHBV mats, as previously 
discussed in chapter 2 and 3, PET mat did not adhere well to the wound bed and fixation 
had to be provided in order to keep the dressing on the wound site during the experimental 
period, due to the natural behavior of the testing animals. Adhesive tape, i.e. micropore 
surgical tape#, was not effective in fixing the dressing to the back of the animals. Hence, 
although this procedure does not simulate the real application of the wound dressing in the 
human being, fixation of the four edges of the mat with interrupted suture was the only 
feasible solution. An adequate design for use in human being must be further explored. 
During the postoperative period, although the PET wound dressing did not immediately 
adhere to the fresh wound, it was observed that the electrospun mat strongly adhered to the 
wound bed, after hemostasis has been initiated and the fibrin clot formed. Later, as re-
epithelialization occurred it was observed that the new epidermis and dermis were growing 
over the dressing material, incorporating the mat in the subcutaneous tissue. Because PET 
is a non-degradable material, this is an extremely disadvantageous outcome. Further details 
of this finding will be provided at subsection 4.3.3.3. Figure 4.3  shows illustrative 
pictures of the wounds in the control and PET treated groups on the 3rd, 7th, and 14th day 
after injury. 
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Figure 4.3. Macroscopic observation of the wound bed on control (a-c) and PET group (d-f) on the 
3rd (a and d), 7th (b and e), and 14th (c and f) postoperative day. 
 
4.3.3. Histopathological analysis 
Wound tissues were collected at different intervals, 3, 7, and 14 days, and subjected to 
histopathological analysis. Illustrative examples of histological sections obtained from 
control and PET groups during the experimental period are displayed in Figure 4.4 (low 
magnification) and in Figure 4.5 (high magnification). At the 3rd day after injury, 
inflammatory cells were found in both experimental groups, however in lower densities for 
PET group. At day 7, wounds were mostly composed by granulation tissue with high 
densities of fibroblast, whereas on day 14 a regenerated tissue with an increased density of 
fibrocytes and collagen fibers were observed. 
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Figure 4.4. HE staining of histological sections (magnification = 40x) representative of control   
(a-c) and PET (d-f) wounds on the 3rd (a and d), 7th (b and e), and 14th (c and f) postoperative day. 
(II) Inflammatory infiltrate, (GT) granulation tissue, (AT) adipose tissue, (RT) regenerated tissue. 
Bar = 500 µm. 
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Figure 4.5. HE staining of histological sections (magnification = 400x) of control (a, c, and e) and 
PET treated (b, d, and f) wounds on the 3rd (a and b), 7th (c and d), and 14th (e and f) postoperative 
day. Red arrow points to a fibroblast and black arrow points to a fibrocyte typical morphology.   
Bar = 50 µm. 
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4.3.3.1.  Effect of PET wound dressing on the inflammatory phase of 
the wound healing process 
When an injury destroys the protection conferred by the skin, allowing microorganisms 
and other contaminants to invade the inner tissues, an important inflammatory response is 
triggered out in order to prevent infection or major tissue damages. Since a rapid response 
is needed, PMN cells rapidly achieve the local of injury and start to act against 
contaminants. Although PMN inflammatory cells are rapid and efficient, these leucocytes 
are also very destructive and an inherent damage to the surrounding tissues is usually 
associated with their action. As a consequence, several symptoms are associated with the 
acute inflammatory phase, including swelling, redness, heat, pain and loss of function. To 
study the effect of PET wound dressing on the inflammatory phase of the wound healing, 
PMN and MN densities were calculated and plotted (Figure 4.6) . Significant lower PMN 
densities were found in animals treated with the electrospun PET mat, at the 3rd and 7th 
postoperative days, compared to control (P<0.05). This result indicates a less pronounced 
acute inflammatory phase, which is probably attributed to the physical protection conferred 
by the electrospun mat. In fact, PET electrospun mat possesses a dense microporous 
structure that acts as a filter, protecting the wound bed against microorganisms and other 
contaminants.  
MN leucocytes, which include monocytes, macrophages and lymphocytes arrive later at 
the wound site (approximately 48h after injury), although being more specific and less 
destructive to the surrounding tissues in comparison to PMN cells. Both PMN and MN 
levels tend to decrease as the inflammation progresses. It is generally accepted that 
persistent high levels of MN cells for several days are indicative of chronic inflammation. 
Here, decreasing densities of MN leucocytes with time were found for control and PET 
groups. In fact, animals treated with PET mat exhibited a significant lower density of MN 
cells at day 3, which is probably attributed again to the physical protection conferred by 
the mat. At the 7th and 14th postoperative days, although lower MN density levels were also 
found for PET group, the differences were not statistically significant. 
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Figure 4.6. (a) PMN and (a) MN leucocyte densities for control and PET treated groups at 3, 7, 
and 14 days after injury. (*) Indicates significant differences between control and PET groups 
(P<0.05). 
 
These results are very encouraging since the inflammatory phase is a determinant step of 
the wound healing process. In fact, several complications that result from an inadequate 
inflammatory phase including infection, necrosis, or chronic inflammation may result in 
impaired wound healing. Additionally, reduced inflammation results in fewer 
inflammatory symptoms and less pain.  
Following, the effects of the PET wound dressing on the proliferative phase of the wound 
healing will be discussed. 
4.3.3.2.  Proliferative phase 
Once inflammation is controlled the proliferative phase initiates in order to regenerate the 
damaged tissue. Fibroblasts are the key component of the proliferative phase as they are 
responsible for synthesis and secretion of collagen and other ECM components as well as 
cytokines and growth factors essential to the wound healing process. Fibroblast usually 
refers to an active stage of the cell while the term fibrocyte corresponds to a less active 
state of the same cell. Active fibroblasts are large cells with big nuclei and spread 
cytoplasms, whereas inactive fibroblast or fibrocytes are smaller with less prominent, 
heterochromatic nuclei (Junqueira and Carneiro 2005), as illustrated in Figure 4.5. 
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Fibroblasts have a peak of activity in the proliferative phase as they become activated to 
synthetize ECM components. In homeostasis, on the other hand, the less active fibrocyte 
stage is usually predominant. Both fibroblast and fibrocyte densities for PET and control 
groups were calculated and are plotted in Figure 4.7 . The peak activity of fibroblasts 
occurred on the 3rd day after injury for PET group and on the 7th postoperative day for 
control. This difference is evidenced in figure 4.5 (a and b) as fibroblasts are largely found 
on PET group, while the wound tissues for the control group were still predominantly 
characterized by high density of leucocytes. This result indicates that the proliferative 
phase initiated earlier in the PET group, which probably results from the less pronounced 
inflammatory phase found in this group. Nevertheless, as wound healing proceeded, no 
significant differences were found in respect to fibroblast or fibrocyte densities. Instead, 
the control group showed a higher degree of tissue maturation at day 14, with a fibrillar 
arrangement of collagen and the presence of skin appendages (figure 4.5 e and f).  
&
Figure 4.7. (a) Fibroblast and (b) fibrocyte densities for control and PET groups 3, 7, and 14 days 
after injury. (*) Indicates significant differences between control and PET groups (P<0.05). 
4.3.3.3.  Re-epithelialization 
Despites the positive effect of PET wound dressing in the inflammatory phase of the 
wound healing, a considerable delay on re-epithelialization was detected for the wounds 
treated with the PET mat. The average wound area of control and PET groups on the 3rd, 
7th, and 14th postoperative days is plotted in Figure 4.8.  In fact, the average wound area 
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observed for the animals treated with the PET mats at day 7 (5.5 ± 0.6 cm2) was 
approximately 2 times higher than control (2.3 ± 0.3 cm2). At the 14th postoperative day 
this difference was even bigger, as PET group exhibited an average wound area more than 
four times greater than control (4.0 ± 0.6 cm2 and 0.7 ± 0.1 cm2, respectively). 
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Figure 4.8. Average wound area of control and PET groups on the 3rd, 7th, and 14th day after injury. 
(*) Indicates significant differences between control and PET groups (P<0.05). 
 
The explanation for the delayed re-epithelialization observed on PET group lies on the fact 
that instead of acting as a removable dressing material, PET mat was incorporated on the 
subcutaneous region of animals as re-epithelialization occurred above the material. Figure 
4.9 shows the regenerated epidermis and dermis beyond the dressing material. As a 
microporous membrane, PET mat hampers the blood vessel access to the epithelial cells 
growing on the upper surface of the mat, thus delaying re-epithelialization.  
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Figure 4.9. HE staining of a histological section of PET group at the 7th day after injury illustrating 
the incorporation of PET mat in the subcutaneous region of the newly formed tissue. The arrow 
points to PET wound dressing lying beyond the dermal tissue. Bar=500 µm. 
4.4. Conclusions 
The main purpose of this chapter was to test the potential of a non-degradable electrospun 
PET mat as a removable wound dressing material. The in vivo wound healing model used 
revealed that although PET electrospun mat had a positive effect on the inflammatory and 
early proliferative phase, a delay in the re-epithelialization was detected for this 
experimental group. In fact, the regeneration of epidermis and dermis occurred above the 
PET mat, resulting in the incorporation of the dressing material in the subcutaneous tissue. 
Since PET is a non-degradable polymer this result constraints the application of PET mat 
as a wound dressing material. Notwithstanding, results from this study also opened other 
possibilities of application for PET electrospun mat, as positive aspects were also 
observed. For instance, an important evidence was that no signs of foreign body reaction 
was found in animals treated with the PET electrospun mat. Hence, in the following 
chapter the application of PET mat as a non-degradable scaffold for tissue engineering will 
be explored. 

  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5. PET/chitosan non-degradable 
scaffolds for tissue engineering 
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5.1. Introduction 
In the previous chapter we reported the use of an electrospun mat of PET as a removable 
dressing material. Results from the in vivo wound healing model showed that instead of 
acting as a removable dressing, the regenerated dermis and epidermis grow above the mat, 
incorporating the material in the subcutaneous region of the rats. Although undesirable for 
that specific purpose, the good mat integration into the tissues with no important 
inflammatory response associated opens a new range of possible applications for PET 
electrospun mats. Indeed, in the present chapter we explore the potential of PET 
electrospun mats as non-degradable scaffolds for tissue engineering applications. In despite 
of PET advantageous characteristics, the high hydrophobicity of this synthetic polymer 
restricts certain applications in the biomedical field. Combination with hydrophilic 
biopolymers can be an effective way to overcome this limitation.  
In fact, surface properties of the nanofibers have relevant importance for cell adhesion and 
biocompatibility. Hydrophilic surfaces have long been recognized to promote cellular 
growth and improved biocompatibility. Many attempts have been pursuit to achieve this 
goal. The preparation of hybrid electrospun nanofibrous scaffolds (Zhang et al. 2010; 
Casper et al. 2005), the use of post-electrospinning protein surface-coating approaches (Shi 
et al. 2010; Li et al. 2008), surface modification by covalent attachment of biomolecules 
onto the surface of hydrophobic polymeric nanofibers (Mattanavee et al. 2009), or specific 
bioactivation by covalent attachment of cell-adhesion-mediating peptides (Grafahrend et 
al. 2008) are among the strategies successfully explored to improve the cytocompatibility 
of these materials. 
As previously described in chapter one, architecture is also determinant for cell-scaffold 
interactions. Fiber size and orientation, porosity, distribution and pore size of biomaterials 
affect cell behavior, i.e. morphology, attachment, differentiation, and function, and are 
important factors to optimize the scaffold potential as substratum for cells. Hence, 
manipulation of the scaffold architecture constitutes an important tool to control scaffold-
cell interactions and, eventually, to obtain scaffolds with tunable properties and optimized 
designs for a certain application. 
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The possibility of tuning the physical/chemical properties, morphology and three-
dimensional (3D) structure of fibrous scaffolds, and thus scaffold-cell interactions, may 
allow the tailoring and control of cell adhesion, growth and proliferation and thus the 
materials’ final ability to act as a tissue engineering scaffold. 
Chitosan has shown ideal properties for biomedical applications such as biocompatibility, 
wound healing effect, anti-inflammatory and antimicrobial activity, as already mentioned. 
When used as a co-polymer in hybrid biomaterials, chitosan can not only improve 
hydrophilicity but also enhance architecture and biological properties, including several 
advantageous characteristics in electrospun nanofibrous scaffolds (Ignatova et al. 2009; 
Duan et al. 2007; Lopes-da-Silva et al. 2009). 
The preparation of PET and PET/chitosan mats by electrospinning was already 
demonstrated (Veleirinho et al. 2008; Lopes-da-Silva et al. 2009; Jung et al. 2007). PET 
mats showed a 3D fibrous structure with high porosity and good mechanical properties. 
Addition of chitosan promoted considerable changes in morphological and mechanical 
properties of the mats (Lopes-da-Silva et al. 2009), and also better cell adhesion (Jung et 
al. 2007). At the present chapter, our aim was to use this previous knowledge as a tool to 
manipulate the architecture and composition of non-degradable scaffolds and to study their 
effect on cell behavior. Scaffold architectures were controlled by varying PET/C ratio, 
chitosan MW and by post-electrospinning cross-linking with glutaraldehyde. The final 
effects on cell adhesion, morphology, and proliferation were studied in vitro using L929 
fibroblasts as model. 
5.2. Experimental 
5.2.1. Materials 
PET pellets were kindly supplied by Flexitex (Portugal). A commercial chitosan sample 
with medium MW (85% deacetylated) was purchased from Sigma-Aldrich Chemical 
Company. Chitosan samples with different MW were obtained by controlled oxidative 
fragmentation as previously described in chapter 2 (section 2.2.2). All chemicals were of 
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analytical grade and obtained from Sigma-Aldrich Chemical Company. All biological 
supplies were purchased from Invitrogen unless otherwise noted. 
5.2.2. Scaffolds fabrication by electrospinning 
A 30 wt.% PET solution was prepared in a blend TFA and DCM 8:2 (v/v) by moderate 
stirring for 2 hours at room temperature. PET/C blends were prepared by adding chitosan 
(2, 4 and 6 wt. %) to the 30% PET solution and stirring for 3 hours at room conditions. 
Chitosan samples with variable MW (15, 22, and 48 kDa) were tested. 
The electrospinning process was conducted at 26 kV of applied voltage, with a flow rate of 
80 !L/min (V=20 mL) and a needle tip-to-collector distance of 12 cm. Fibers were 
collected as a nonwoven fibrous mat on the rotating drum (900 rpm), in air and at room 
conditions (20 ± 2 ºC, 45–50% RH). The scaffolds were dried at 35 ºC for 24 hours. 
Selected scaffolds were cross-linked with glutaraldehyde vapor in a glass chamber (20 ± 2 
ºC) for 12 hours. After treatment, scaffolds were dried at 35 ºC for 24 hours to remove 
residual glutaraldehyde. 
5.2.3. Morphological analysis  
Morphology of the fibrous scaffolds was investigated by SEM and images were processing 
using ImageJ - 1.37c software, as described in chapter 4 (section 4.2.3). 
5.2.4. FTIR 
The nanofibrous mats were characterized by ATR-FTIR, using a Golden-gate single 
reflection ATR in a Bruker IFS-spectrometer at a resolution of 8 cm-1 and 256 co-added 
scans. 
5.2.5. Water contact angle (WCA) measurements 
The wettability of scaffolds was assessed by the sessile drop method using a contact angle 
system OCA-20 (DataPhysics Instruments). A drop of distilled water (1 !L) was 
.$%/+0',12*& ( 3#0'2, &4"+, & ('0 &,5 3* &"*6&"#6'43*"$ &7"$ $ & 0%1"30 &
&
&@@M&
calculated using the software SCA 20. At least 10 measurements were taken for each 
sample. 
5.2.6. Cell culture  
In vitro cell culture studies were conducted using mouse fibroblast cells (L929). The 
detailed description of the cell culture conditions, as well as the experimental procedures 
of the indirect cytotoxicity and MTS assays, SEM and CLSM analysis, and the annexin V 
and PI staining of cells cultured on the scaffolds are described in chapter 2 (subsection 
2.2.5.4).  
3D projections of L929 cells cultured on PET/C scaffolds were constructed to evaluate the 
internal cell colonization. For that, chitosan was stained with FITC, previously to 
electrospinning process, according to the method described by Ma et al. (2003).  
5.2.7. Statistics 
Statistical analysis was carried out using Instat 3.0. Results were expressed as the mean ± 
standard deviation, and compared through one-way ANOVA and Tukey-Kramer multiple 
comparisons test. P < 0.05 was considered statistically significant. 
5.3. Results and discussion 
Solutions of PET and PET/C were successfully electrospun into nano and microfibers, 
which were collected as nonwoven mats with a 3D architecture. Typical electrospun 
structures with random fiber orientation and high porosity were obtained for all polymer 
solutions tested. 
As already broadly described, manipulation of electrospinning parameters can be an 
effective way to control the morphology of electrospun mats (Theron et al. 2004; Tan et al. 
2005). Among these parameters, solution properties have the greatest impact on the final 
characteristics of these mats (Veleirinho et al. 2008). Substantial changes on the 
architecture and properties of the fibrous scaffolds, e.g. fiber diameter, pore sizes, surface 
roughness, and wettability, were achieved by varying the composition of electrospinning 
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solution, i.e. chitosan concentration (2, 4 or 6 wt.%) and MW (15, 22 or 48 kDa) and by 
post-electrospinning cross-linking.  
5.3.1. Effect of chitosan concentration and MW on fiber diameter  
Table 5.1  displays the average fiber diameter as a function of chitosan concentration and 
MW. Average fiber diameters of the electrospun scaffolds varied from 0.71 !m (PET) to 
3.01 !m (PC155:1), depending on the concentration and MW of chitosan. Fiber diameters 
increased with the increase of chitosan content for all MW tested. The increase of solution 
viscosity caused by the presence of chitosan resulted in higher resistance against the 
increase of surface area during the formation of the electrospinning jets and, consequently, 
fibers with higher diameters were obtained, in accordance with previous findings (McKee 
et al. 2004). Addition of chitosan also leaded to wider fiber diameter ranges, what may be 
related to the inherent high chemical variability of chitosan samples, e.g. MW distribution 
and acetylation degree (Figure 5.1).  
Additionally, it was also observed a tendency for the fiber diameter to increase as the 
chitosan MW decreases. This behavior may be attributed to the higher mobility of the 
smaller chitosan molecules that migrate to the outer layer of the nanofibers, increasing 
diameter (Lopes-da-Silva et al. 2009). Based on the fiber diameter differences, five mats 
(PET, PC4815:1, PC485:1, PC1515:1 and PC155:1) were selected to perform further studies. 
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Table 5.1. Fiber diameters (mean ± standard deviation) obtained for scaffolds prepared from PET 
and PET/C solutions, at different chitosan concentrations (2, 4, and 6 wt.%, corresponding to 
PET/C ratios of 15:1, 7.5:1, and 5:1, respectively) and MW, and for selected cross-linked fibers 
(CL). Abbreviated designations for each scaffold are also shown and will be used throughout the 
text. Different superscript letters within a column indicate significant differences (P < 0.05). 
PET/C ratio (w/w) Chitosan MW 
(kDa) 
Fiber diameters (µm) 
1:0 -- 0.71 ± 0.28 (PET) a 
0.64 ± 0.27 (PETCL) a 
15:1 15 0.88 ± 0.44 (PC1515:1)
 a 
0.65 ± 0.33 (PC1515:1CL)
 a 
 22 0.83 ± 0.33 (PC2215:1)
 a 
 48 0.89 ± 0.28 (PC4815:1)
 a 
0.84 ± 0.40 (PC4815:1CL)
 a 
7.5:1 15 1.85 ± 0.47 (PC157.5:1)
 b 
 22 1.74 ± 0.69 (PC227.5:1)
 b 
 48 1.61 ± 0.65 (PC487.5:1)
 b 
5:1 15 3.01 ± 0.72 (PC155:1)
 c 
2.24 ± 0.85 (PC155:1CL)
 d 
 22 2.32 ± 0.98 (PC225:1)
 d 
 48 2.30 ± 0.78 (PC485:1)
 d 
2.22 ± 0.75 (PC485:1CL)
 d 
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Figure 5.1. Fiber diameter histograms of PET and PET/C scaffolds, obtained by changing chitosan 
concentration (0, 2, 4, and 6 wt.%) and MW (15, 22, and 48 kDa). 
&
&
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5.3.2. Pore area characterization 
Pore area and pore area distribution define whether cells can populate the scaffold three-
dimensionally or not. Figure 5.2  represents the pore area distributions of PET and PET/C 
scaffolds. Electrospun mats were characterized by a wide pore size distribution given that 
pores are formed by a random fiber deposition during the electrospinning process. Larger 
pores and wider pore area ranges were observed as chitosan content increases and chitosan 
MW decreases. 
(
Figure 5.2. Pore area distributions of as-electrospun (AS) and CL scaffolds a) PET, b) PC4815:1, c) 
PC485:1, d) PC1515:1 and e) PC155:1. Inserts show the average values. x-Axis represents pore areas 
(µm2) and y-axis the relative frequency (%). 
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5.3.3. Post-electrospinning cross-linking 
Cross-linking was carried out by treating the scaffolds with glutaraldehyde vapor for 12 
hours. Figure 5.3  shows the SEM images of PET, PC485:1, and PC155:1 AS and CL 
scaffolds as examples. The morphology of the PET scaffold was not altered with cross-
linking. However, several modifications on the microscopic structure of PET/C scaffolds 
were observed, especially for scaffolds with higher chitosan content (PC485:1 and 
PC155:1). Among them, changes on fiber morphology, from a straight to a curly shape, the 
increase of fiber surface roughness, and the increased proximity among fibers were the 
most evident ones.  
Average fiber diameters of selected cross-linked PET and PET/C scaffolds are also shown 
in Table 5.1. The decrease of fiber diameter with cross-linking treatment was significant 
(P<0.05) for the scaffolds with the lowest MW chitosan (PC1515:1 and PC155:1). Among 
these scaffolds the highest decrease was observed for the scaffold with higher chitosan 
content where the average fiber diameter decreased from 3.01 ± 0.72 !m to 2.24 ± 0.85 
!m. 
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Figure 5.3. SEM micrographs of scaffolds a) PET, b) PETCL, c) PETCL high magnification, d) 
PC485:1, e) PC485:1CL, f) PC485:1CL high magnification, g) PC155:1, h) PC155:1CL and i) 
PC155:1CL high magnification. Bar = 10 µm (a, b, d, e, g, and h) or = 1 µm (c, f, and i). 
 
A decrease in pore areas with cross-linking (Figure 5.2 and 5.3) was observed for all 
scaffolds and this decrease was more pronounced as the chitosan content increased and 
MW decreased.  
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Cross-linking of chitosan with glutaraldehyde occurs through a Schiff’s base reaction 
between the aldehyde ends of the cross-linking agent and the amine groups of chitosan to 
form imine functions. ATR-FTIR spectra were obtained for the AS and CL mats (Figure 
5.4). FTIR analysis confirmed the cross-linking of chitosan molecules through the 
formation of imine functions. Indeed, an increase in the intensity of 1680 cm-1 peak (C=N 
imine bond) was observed with cross-linking of the fibrous mats while the intensity of the 
1540 cm-1 peak decreased due to the decrease of the free amine groups. The formation of 
bindings within a single fiber led to a decreased in fiber diameter and an increase of 
surface roughness. Similar morphological changes were previously observed as a result of 
chitosan cross-linking with glutaraldehyde (Monteiro and Airoldi 1999; Gupta and Jabrail 
2007). In addition, new bindings between adjacent fibers caused fiber approaching each 
other and, consequently, a reduction of pore areas. Therefore, the cross-linking process 
may be used as a strategy not only to decrease the solubility of the more hydrophilic 
polymer in aqueous media but also to manipulate the morphology of PET/C fibrous 
scaffolds. 
&
Figure 5.4. FTIR spectra (1700 – 1500 cm-1 region) of PC155:1 and PC155:1CL scaffolds. 
5.3.4. Surface properties 
WCAs and drop lives were measured in order to evaluate the wettability of AS and CL 
scaffolds (results are displayed in Table 5.2). As expected, the PET scaffold exhibited a 
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high hydrophobicity. The WCA measurements showed no significant differences among 
PET, PC4815:1, and PC1515:1. For these scaffolds, drops showed long life times (>600 s), 
with little decrease of WCA with time. However, a significant decrease of WCA was 
observed for scaffolds PC485:1 and PC155:1 (P<0.05), which clearly indicates an 
improvement on scaffolds hydrophilicity with the increase of chitosan content. In addition, 
water drops on these scaffolds were rapidly absorbed due to their high water uptake 
capacity and high pore sizes. 
Cross-linking treatment increased the hydrophobicity of PC485:1 and PC155:1 scaffolds 
(P<0.05), an expected effect since this treatment results in diminishing the number of 
chitosan's free amine groups. This increase of surface hydrophobicity also reflected in the 
drop life, which rose from 6 s to more than 600 s. 
 
Table 5.2. WCA (mean ± standard deviation) and drop life time 
for PET and PET/C scaffolds. Different superscript letters 
within a column indicate significant differences. (P < 0.05). 
 WCA (º) Drop life (s) 
PET 133.2 ± 2.9 a > 600 a 
PC4815:1 137.3 ± 1.7
 a > 600 a 
PC485:1 119.9 ± 7.3
 b 6 b 
PC1515:1 138.8 ± 1.8
 a > 600 a 
PC155:1 125.2 ± 4.6
 b 6 b 
PC4815:1CL 132.6 ± 3.9
 a > 600 a 
PC485:1CL 127.4 ± 6.5
 c > 600 a 
PC1515:1CL 132.3 ± 3.2
 a > 600 a 
PC155:1CL 135.0 ± 4.7
 a > 600 a 
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5.3.5. Cell studies 
Differences in architecture and composition of the scaffolds are expected to define the 
cellular environment and consequently to have a remarkable influence in cell activity. 
Therefore, after the initial screening of the scaffold characteristics, three samples (PET, 
PC155:1 and PC155:1CL) were picked to study L929 cell behavior in vitro since the major 
differences in architecture were found among them. 
Figure 5.5.  displays the results from the indirect cytotoxicity assay. No significant 
differences were found in respect to viability of cells cultured in the scaffolds extraction 
media (measured via MTT assay) in comparison to control, i.e. fresh medium. This result 
indicates that, for the time analyzed, no cytotoxic compounds were released from the 
scaffolds (P<0.05). 
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Figure 5.5. Indirect cytotoxicity evaluation of nanofibrous scaffolds based on the viability of 
fibroblasts (L929) cultured in the extraction media. The viability of cells cultured in fresh media 
was used as control. No significant differences were found. 
 
The viability of fibroblasts cultivated on PET and PET/C scaffolds for 2, 7, and 14 days 
was evaluated by MTS assay (Figure 5.6) . All samples showed a rapid cell growth 
during the first 7 days of culture, followed by a stationary phase. PET scaffold exhibited 
higher levels of cell viability when compared to PET/C scaffolds.  
The viability of anchorage dependent cells, such as fibroblasts, is greatly influenced by the 
cell adhesion processes. Cell-substrate contact area can determine whether or not a cell 
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proliferates, becomes quiescent or dies (McGrath 2007). Here, viability, adhesion, 
morphology, and proliferation of cells in the scaffolds were evaluated combining SEM, 
CLSM, and immunochemical techniques.  
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Figure 5.6. Viability of L929 cells cultured on PET, PC485:1, and PC485:1CL scaffolds for 2, 7, and 
14 days measured via MTS assay. No significant differences were found. 
 
Figure 5.7  displays SEM and CLSM micrographs illustrating the evolution of adhesion 
and spreading of L929 cells in PET scaffold, as an example. Twelve hours after seeded on 
PET and PET/C scaffolds, fibroblasts showed a circular morphology, typical of the early 
stages of adhesion. Following, cell proliferation and spreading took place and fibroblasts 
shape changed to a well-spread morphology with multiple cellular extensions adhering to 
the substratum. During the subsequent days of culture, cells exhibited intensive growth and 
abundant secretion of ECM that partially covered the scaffold surfaces.  
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Figure 5.7. SEM images (a- c) and CLSM images (d-f) of L929 fibroblasts cultured on PET 
scaffold for 12 hours (a and d), 48 hours (b and e), and 7 days (c and f). F-actin (red) and nucleus 
(blue) stained with Alexafluor 546 conjugated to phalloidin and DAPI, respectively. Bar = 10 µm. 
&
Cell adhesion and spreading was clearly influenced by the fiber size and porosity of the 
scaffold. High magnification SEM images of L929 fibroblasts adhered to PET, PC155:1 
and PC155:1 CL fibers are displayed in Figure 5.8 . On PET scaffold, cells tended to 
adhere to bundles of fibers spreading over them due to the small fiber diameter (0.71 ± 
0.28 !m). On the other hand, on PC155:1 and PC155:1 CL, fibroblasts generally adhered to 
single fibers, as a result of the higher fiber diameters (3.01 ± 0.72 !m and 2.24 ± 0,85 !m, 
respectively) and larger pore sizes.  
&
Figure 5.8. SEM micrographs of L929 fibroblasts cultured on a) PET, b) PC155:1, and c) PC155:1 
CL scaffolds after 48 hours incubation. Scale bar = 5 µm.  
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Labeling of actin filaments, vinculin, and nucleus was carried out in order to study 
adhesion of L929 fibroblasts cultured on the electrospun scaffolds. Figure 5.9  shows 
representative CLSM images for PET and PC155:1 scaffolds and Figure 5.10  displays the 
cytoskeleton area and density of cells cultured on the scaffolds for 12 hours, 48 hours, and 
7 days. An increase of cell density over the incubation time was observed for all the 
scaffolds, and higher density levels were obtained for PET scaffold. Cytoskeleton area of 
cells cultured on the scaffolds increased after 48 hours, and the highest mean cytoskeleton 
area was achieved for PET scaffold. 
&
Figure 5.9. CLSM images of L929 fibroblasts after 7 days of incubation on PET (a-c) and PC155:1 
(d-f) scaffolds. F-actin (red), vinculin (green) and nucleus (blue) stained with phalloidin Alexafluor 
546 conjugated, anti-vinculin monoclonal antibody followed by Alexafluor 488 goat anti-mouse, 
and DAPI, respectively. Scale bar = 100 µm (a and d) or =10 µm (b, c, e, and f). 
 
Fiber diameter and architecture influenced the cell spreading process. Higher levels of 
spreading, i.e. cytoskeleton area and vinculin expression, were achieved for cells cultured 
on PET scaffolds. The mean cytoskeleton area of cells cultured on PET scaffold was 565 ± 
149 !m at day 7, significantly greater than cells cultivated on PC155:1 (473± 119 !m) and 
PC155:1 CL (350± 74 !m). The lower pore areas of PET scaffold (9.4 !m
2) allow cells to 
spread across pores and establish several adhesion points on neighbor fibers. On the other 
hand, on PC155:1 and PC155:1 CL cells were not able to cover the pores due to their higher 
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areas (89.3 !m2 and 23.4 !m2, respectively) and the spreading process was limited to the 
diameter of the fiber.  
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Figure 5.10. Cell density (a) and cytoskeleton area (b) of L929 cells as a function of culture time, 
obtained for PET, PC155:1, and PC155:1CL scaffolds. Different letters indicate significant 
differences (p < 0.05). 
 
Since RGD motives are absent in PET or PET/C scaffolds, focal adhesion of L929 cells 
may initially occur via proteins adsorbed from serum containing medium. Cells would be 
able to secrete ECM components after attached to the scaffolds, improving cell spreading 
and adhesion. Immunolabeling of ECM fibronectin was performed after 2 and 7 days of 
culture. Results showed considerable amounts of extracellular fibronectin in the superficial 
and internal structure of the scaffolds, 2 days after seeding (Figure 5.11). The presence 
of ECM components in the scaffolds creates an environment even more similar to natural 
tissues, enhancing scaffolds’ ability to support cell growth. 
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Figure 5.11. Immunolabeling of extracellular fibronectin (green) deposited on the surface of PET 
scaffold after 7 days of incubation with L929 cells. Bar= 50 µm. 
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Several studies have demonstrated the antiapoptotic effect of focal adhesion on anchorage 
dependent cells (Sonoda et al. 2000). Chen et al. (1997) have shown that cells underwent 
programmed cell death when spreading was limited to islands of 20 !m of diameter. 
However, if the spaces among multiple islands were lower than 10 !m, cells were able to 
spread across the spaces and establish focal adhesion points on the neighbor adhesion 
islands, switching off apoptosis. Double staining of fibroblasts with annexin V and PI was 
carried out in order to test whether the limited area for cell adhesion of PET/C fibers was 
related to the lower densities of cells cultivated on these scaffolds via apoptosis induction. 
Cytograms of annexin V vs. PI uptake in the L929 cells cultured on the electrospun 
scaffolds are shown in Figure 5.12 . In accordance with the MTS results and 
microscopical analysis previously described, the percentage of viable cells was 
significantly higher in PET scaffold (92.4 ± 0.8%) compared to PC155:1 and PC155:1CL 
(81.7± 8.3% and 75.7± 2.8, respectively). Higher percentage of early apoptotic cells were 
found in cell populations cultured on PC155:1 and PC155:1CL (4.1±1.0 and 4.9±1.6) than in 
PET scaffold (1.6±1.0). Apoptosis induction may be related to the limited area available 
for the cell adhesion and spreading on PET/C scaffolds. Additionally, higher indices of 
necrosis were also found in the population of cells cultured on PC155:1 and PC155:1CL 
scaffolds (16.2±0.4 and 12.5±1.4) compared to PET scaffold (4.2±0.9). Since the indirect 
cytotoxicity assay showed no evidence of toxic compounds released to the medium, results 
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suggest that chitosan molecules exposed on the fiber surface may induce necrotic cell 
death. Indeed, the polycationic nature of chitosan may interact and damage the plasma 
membrane of cells, as already observed for PHBV/C blends (reported in chapter 2, 
subsection 2.3.7.1). 
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Figure 5.12. Annexin V-FITC/PI flow cytometry analysis of cell death after 48 hours of incubation 
in a) PET, b) PC155:1, and c) PC155:1 CL. Viable cells (Annexin V-FITC negative/PI negative) are 
in the lower left quadrants; Apoptotic cells  (Annexin V-FITC positive/PI negative) are in the lower 
right quadrants; late apoptotic cells (Annexin V-FITC positive/PI positive) are in the upper right 
quadrants; necrotic cells (Annexin V-FITC negative/PI positive) are in the upper left quadrants. 
The cytograms are representative of three independent experiments. 
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EdU proliferation assay was used to measure the ability of cells to proliferate when 
attached to the nanofibrous scaffolds. Figure 5.13  displays the percentage of 
proliferating cells cultured on the electrospun scaffolds (% of control). Higher level of 
proliferation was observed for cells cultivated on PET scaffolds compared to PET/C 
scaffolds. Again, the higher proliferative activity is probably correlated with the improved 
adhesion and spreading of fibroblasts on this scaffold. 
Cross-linking of the PET/C scaffold had a negative effect on the viability and adhesion of 
fibroblasts. A decrease in cell spreading and density was observed when comparing the AS 
and CL scaffolds. A possible explanation is related to the decrease of fiber diameter and, 
consequently, the available area for cell adhesion. Additionally, although cross-linking 
decreased the pore size, a single fiber attachment was also predominantly found on 
PC155:1CL scaffold, which demonstrates that this decrease was not enough for cell 
spreading through pores.  
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Figure 5.13. EdU incorporation assay of L929 cultured on PET, PC155:1, and PC155:1 CL. (a) 
Fluorescence micrographs of proliferative cells (green) stained with EdU Alexafuor 488 and nuclei 
(blue) counterstained with DAPI (100x magnification). (b) Quantitation of proliferative cells mean 
± S.D measured from 10 fields from 3 independent experiments. Results are expressed as % of 
control, i.e. TCP. Different letters indicate significant differences (P < 0.05). 
&
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Even though there are many studies showing that chitosan improves the biological 
performance of biomaterials, higher levels of viability, adhesion, and proliferation were 
obtained for cells cultivated on PET scaffold. The architecture of the scaffold seems to 
play a more important role on cell viability and growth than any chemical surface changes 
introduced by the presence of the hydrophilic biopolymer. In this context, the lower fiber 
diameters and lower pore sizes of PET scaffolds proved to be more suitable for fibroblasts 
growth. On the other hand, the higher pores of PET/C scaffolds allowed L929 cells to cross 
those pores and penetrate through the fibers (as illustrated in Figure 5.14).  
!
&
Figure 5.14. SEM image evidencing the relative size of L929 fibroblasts (12 hours after seeding) 
and PC155:1 scaffold pore size. Bar= 10 µm. 
 
3D CLSM (through z-axis) were performed to confirm that cells were able to cross pores 
and colonize the inside of these scaffolds. After 48h, cells were found within the section of 
the PET/C scaffolds, in a 3D culture while on PET scaffold a superficial cell growth was 
predominant (Figure 5.15). Depending on the application requirements, both 2D 
(monolayer) and 3D culture may be suitable. 
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Figure 5.15. CLSM 3D projection of L929 cells cultivated on PC155:1 scaffold for 48h. Fibers 
(green), F-actin (red) and nucleus (blue) stained with FITC, Alexafluor 546 conjugated to 
phalloidin and DAPI, respectively. Scale bar = 50 µm. 
5.4. Conclusions 
This chapter reports the preparation of PET and PET/C electrospun scaffolds followed by 
the analysis of their architecture and physicochemical properties. Secondly, the effects of 
the scaffolds were assayed on the cell growth. Properties of the scaffolds, e.g. morphology 
and wettability, were manipulated through the variation of the electrospinning solution 
composition and post-electrospinning cross-linking. In vitro experiments with L929 
fibroblasts revealed how these changes can modulate cell behavior and cell-scaffold 
interactions, including viability, adhesion, spreading, and proliferation. Although the fiber 
composition and scaffold architecture were not varied independently, the scaffold with 
smaller fiber diameters and pore areas has demonstrated to allow higher levels of 
fibroblasts adhesion, spreading, and proliferation, while a 3D cell colonization was 
achieved for scaffolds with higher fiber diameters. These results provide important 
information not only for this specific polymeric system (PET/C), but also for outlining 
strategies to enhance the design of other biomaterials towards a better biological 
performance.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6. PET and PET/chitosan 
electrospun hybrid mats as 
as abdominal meshes for 
hernia repair 
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6.1. Introduction 
6.1.1. Incisional hernias: occurrence and treatment 
Incisional hernia is a frequent complication of laparotomy due to the decrease of 
abdominal strength in the injured tissue. In fact, 10-15% of all patients eventually develop 
an incisional hernia after an abdominal surgery. Hysterectomy, cesarean section, and 
emergency laparotomies for generalized peritonitis are particularly likely to herniation. 
Medical conditions such as obesity, respiratory and circulatory diseases, and chronic 
constipation often contribute to hernia formation, recurrence and development of related 
complications (Anthony et al. 2000; Gecim et al. 1996). 
Traditionally, hernia repair have been performed by primary closure. This procedure, 
however, has been associated to unacceptable high reoccurrence rates (46 -54 %) 
(Luijendijk et al. 2000; Anthony et al. 2000; Gecim et al. 1996). Implementation of a 
tension-free repair, by using a prosthetic biomaterial, i.e. abdominal mesh, to substitute or 
reinforce abdominal strength at the damaged area has decreased the recurrence rates to 23-
29 % (Luijendijk et al. 2000; Anthony et al. 2000). All over the world, prosthetic mesh 
repair have been replacing the primary closure of abdominal defects, in particular for 
defects larger than 3 cm. In USA more than 90% of incisional hernias are already being 
repaired with prosthetic meshes (Kingsnorth and LeBlanc 2003). Numerous materials are 
commercially available, the most common are macroporous meshes made of PET (e.g. 
Mersilene# and Parietex#), polypropylene (Marlex#, Prolene#, and Surgipro#), and 
polytetrafluorethylene (Gore-Tex#).  
6.1.2. Complications of prosthetic mesh use 
Although the recurrence of hernias has decreased with the use of abdominal meshes, 
serious complications have been associated with this procedure, including infection, 
visceral adhesions to the mesh, seroma, mechanical failure of the mesh, and foreign body 
reaction (Carbajo et al. 1999; Robinson et al. 2005). For instance, Robinson et al. (2005) 
studied 252 cases of complications associated to the use of abdominal meshes and detected 
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that infection was the most frequent problem, representing 42% of the total cases. Another 
important conclusion of this study was that specific complications were related to specific 
materials, for example, polypropylene mesh (Sepra #) undergone higher mechanical 
failure, while biomaterial meshes (Surgisis Gold# and Alloderm #) had more host 
reactions, and PTFE meshes caused more intestinal adhesions. More recently, studying 32 
cases of infection associated to different meshes, Tolino et al. (2009) verified that 69% of 
the patients had to be operated again for mesh removal, which required 51 operations for 
more than 3 years. 
Besides infection, host reaction and intestinal adhesions to the abdominal mesh are 
complications of major concern after the prosthetic material implantation. Further details 
covering this subject will be reviewed in the subsequent subsections. 
6.1.2.1.  Intestinal adhesions  
Adhesion of organs to the implanted material is a serious complication related to the use of 
abdominal meshes. Bowel adhesion is particularly problematic as it causes severe 
complications including bowel obstruction, enterocutaneous fistula, and chronic pain. In a 
prospective analysis, Menzies and Ellis (1990) used laparoscopy to assess the formation of 
adhesions and verified that 93% of patients who had undergone laparotomy developed 
intra-abdominal adhesions. This study also showed that the adhesiolysis procedure 
represented 0.9% of total surgeries and 3.3% of all laparotomies carried out at the 
“Academic Surgical Unit of Westminster Hospital”. 
It is well established that the intra-abdominal adhesion is related to an inflammatory 
response to injuries, foreign bodies or infection. As a typical inflammatory process, 
adhesiogenesis initiates very early after the placement of the prosthetic mesh. In fact, in 
laboratory experiments, Baptista et al. (2000) have demonstrated that adhesions were 
already formed at the first postoperative day and did not progress after day 7. Indeed, the 
adhesion formation follows a very similar pathway to the wound healing process, which 
includes recruitment of inflammatory cells to the injured area, fibrin matrix formation, 
collagens deposition and maturation (Milligan and Raftery 1974). Several methods have 
been investigated to prevent adhesion including the use of fibrinolytic agents, antibiotics or 
anti-inflammatory drugs (Chu et al. 2011; Suckow et al. 2010; Bothin et al. 2003). Also, 
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the use of non-adhesive layers or coatings has been tried although with limited success 
(van't Riet et al. 2003; Bellon et al. 1996). Notwithstanding, the development of new 
materials that prevent adhesiogenesis is still an issue of enormous importance. 
6.1.2.2.  Foreign body reaction  
Once a biomaterial is implanted in the body, a normal wound healing response initiates as 
a result from injury. As described in chapter 1, the wound healing process begins with 
homeostasis and a subsequent acute inflammatory phase, characterized by a dense PMN 
infiltration. With implanted non-degradable biomaterials, however, inflammation usually 
progresses to a chronic state as a result of body inability to eliminate the foreign body. 
Hence, macrophages are recruited and adhere to the surface of the biomaterial in an 
attempt to phagocytize and degrade the foreign body. The size and the chemical 
composition of the non-degradable biomaterials, however, usually lead to a frustrated 
phagocytosis. As a consequence, macrophages fuse together in order to form 
multinucleated cells, i.e. foreign body giant cells (FBGC), as a strategy to isolate the 
foreign material. Apart from FBGC and macrophages, fibroblasts are also active elements 
of non-immunogenic foreign body granulomas, being responsible for synthesizing a dense 
layer of collagen that isolates the granuloma from the surrounding tissue (granuloma 
capsule). The extent and the duration of the foreign body reaction depend both on the 
properties of the biomaterial and on the characteristics of the tissue were the material is 
implanted. Many times, the foreign body reaction persists for the lifetime of the 
biomaterial without committing the normal function of the tissue. Excellent reviews are 
available for in depth information on foreign body reaction to biomedical devices 
(Babensee et al. 1998; Anderson et al. 2008). 
6.1.3. Electrospun materials as meshes for abdominal hernia repair 
Apart from preventing adhesion, it is generally accepted that the ideal abdominal mesh 
should be chemically inert and stable for long periods, cause no immune or inflammatory 
response, and fulfill the required mechanical needs for the application. In this context, 
electrospun mats of non-degradable polymers emerge as potential alternative meshes for 
abdominal defect repair.  
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As previously described in chapter 4, PET can be electrospun into nanofibrous nonwoven 
mats,  with an average fiber diameter of 0.71 ± 0.28 !m and with a microporous structure 
(94.9% of porosity and an average pore area of 9.4 !m2). These morphological 
characteristics, together with the high hydrophobicity of this material (WCA & 133 º) are 
thought to be ideal for prevention of visceral adhesion to the mesh. According to Matthews 
et al. (2003) biomaterials with pores lower than 75 !m reduce the occurrence of bowel 
adhesions. Besides, PET is a highly biocompatible, biostable, and non-degradable polymer 
and possesses the mechanical features required for this application. Even more, the low 
density of the electrospun PET mats (~ 0.091 g/cm-3) and the high malleability of these 
materials (Veleirinho et al. 2008) may promote an enhanced adaptation and comfort to the 
patient. 
On the one hand the mesh must prevent adhesions to the visceral tissues, but on the other 
hand the parietal side should also promote a good integration to the adjacent conjunctive 
tissue. Indeed, McGinty et al. (2005) have demonstrated that a better incorporation of the 
mesh in the parietal side reduces the number and the severity of adhesion formation on the 
visceral side. Composite meshes, with a visceral side that minimizes adhesions and a 
parietal side that maximizes tissue ingrowth have been designed. A well-known example is 
Dualmesh#, a PTFE mesh with a microporous layer that is turned to the visceral side and a 
macroporous layer designed to promote tissue ingrowth on the parietal side. Another 
example is Parietex#, a PET mesh with one of the sides (parietal side) covered with 
collagen to promote tissue integration.  
In this chapter we describe the application of three electrospun non-absorbable fibrous 
mats, composed by PET fibers, PET/chitosan (PET/C) hybrid fibers, and double-layer 
(DL) PET/chitosan mesh, respectively, in the repair of abdominal defects. An in vivo study 
with Wistar rats was performed to evaluate the clinical and histological aspects of the use 
of these electrospun mats as meshes for abdominal hernia repair. 
The PET mesh is expected to restrict the parietal tissue integration due to its small pores 
and hydrophobic characteristics. Hence, with the aim of enhancing the interaction of the 
mesh with the parietal conjunctive tissue, PET/C and double layer (DL) meshes were 
designed. Compared to PET, PET/C mats show higher fiber diameters, larger pores, lower 
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hydrophobicity and enhanced mechanical strength (Chapter 5) S9'1%,Q6"QT3$>"! "#! $%&&
AKKJU. 
Moreover several reports on the anti-inflammatory and wound healing effects of chitosan 
are found in literature, which may be useful to inhibit adhesiogenesis and to attenuate the 
typical symptoms of the post-surgery period (Zheng and Zhu 2003; Ueno et al. 2001; 
VandeVord et al. 2002; Ueno et al. 1999). 
The dual layer mesh (DL), containing one layer of PET and one layer of PET/C, was used 
with the PET side turned to the visceral side while the PET/C layer was in contact with the 
parietal side. 
6.2. Experimental 
6.2.1. Material 
Samples of PET and chitosan (15 kDa) were the same used in chapters 4 and 5. All 
chemicals were of analytical grade and obtained from Sigma-Aldrich (Sigma-Aldrich 
Chemical Company). Marlex® (Intracorp) was purchase from Cirurgica Passos Lda.  
6.2.2. Meshes fabrication 
Preparation and characterization of PET and PET/C (PC155:1) mats are described in 
chapter 5. DL meshes were fabricated by electrospinning of 10 mL PET solution 30 wt.% 
followed by 10 mL of PET/C solution (30 wt.% PET, 6 wt.% chitosan 15 kDa). Fibers 
were collected as a nonwoven fibrous mat on the rotating drum (900 rpm), in air and at 
room conditions (20 ± 2 ºC, 45–50% RH) and the mat was dried at 35 ºC for 24 hours.  
Morphology of DL meshes was also analyzed by SEM in a scanning electron microscope 
(Hitachi S4100) at an accelerating voltage of 25 kV. Pictures of transversal and 
longitudinal sections of both layers of the mat were obtained. 
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Previously to biological assays, all meshes were sterilized under UV light for 1 hour (both 
faces), immersed in ethanol 70% (v/v) for 10 minutes and washed with physiological 
solution.  
6.2.3. Animal model 
 Animal experiments were approved by Animal Ethics Committee of UFSC 
(PP0406/2009). Male Wistar rats 3 months age and weighting 250-300 g were obtained 
from the Central Biotery of UFSC. Animals were randomly distributed among the 7 
treatments, according to Table 6.1  (n=8).  
 
Table 6.1. Experimental groups of incisional hernia repair. 
Group 
Chemical 
composition 
Duration of 
experiment 
(days) 
Fiber 
diameter 
(µm) 
Pore area 
(µm
2
) 
Mesh 
thickness 
(mm) 
Marlex30 
Polypropylene 
30 
177 ± 24 31400 0.22 ± 0.07 
Marlex90 90 
PET30 
PET 
30 
0.71 ± 0.28 9.4 0.31 ± 0.02 
PET90 90 
PET/C PET/C 5:1 (w/w) 30 3.01 ± 0.72 89.3 0.49 ± 0.09 
DL 
PET + 
PET/C 5:1 (w/w) 
30 N.A. N.A. 0.52 ± 0.05 
WovenPE
T 
PET 30 342 ± 68* N.A. 0.46 ± 0.11 
* Average diameter of the multifilament yarn; 
N.A. not applicable. 
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A graphical illustration of the surgical procedure is provided in Figure 6.1 . After an 
intramuscular injection of a mixture of ketamine (90 mg/kg) and xylazine (15 mg/kg) and 
abdominal shaving, a 5 cm skin paramedian incision was made at the left size, using a 
sterile scalpel blade (Figure 6.1 (a) and (b)). Skin was dissected to expose the underlying 
abdominal fascia (Figure 6.1 (c)) and a 1.5 x 1.5 cm defect of anterior abdominal wall was 
created by the complete resection of abdominal layers (Figure 6.1 (d) and (e)). The edges 
of the meshes (2.0 x 2.0 cm) were sutured to the remaining muscle of the abdominal wall 
with interrupted suture (Figure 6.1 (f)) and also with simple running suture all over the 
borders (Figure 6.1 (g) and (h)), using 5-0 polypropylene. The skin was closed with 
intradermal suture with nylon 4-0 monofilament (Figure 6.1 (i)). Animals were allowed to 
recover from anesthesia, housed in individual cages, and observed daily for evidence of 
wound complications (such as inflammation, infection, seroma, abscess, hematoma or skin 
dehiscence). 
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Figure 6.1. Graphic illustration of the incisional hernia model. 
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On day 30 and 90 post-surgery, animals were sacrificed in a carbon dioxide chamber, and 
the presence of inflammation, seroma, abscess, hematoma, skin dehiscence or infection 
was analyzed. The abdominal wall was carefully excised well away from the mesh (as 
illustrated in Figure 6.2 (a)), to preserve any adherence to the bowel or omentum (after 
adhesion analysis, tissue was completely excised and collected for histopathological 
analysis). Tissues were fixed in buffered formaldehyde solution (10%, pH 7.2), divided in 
2 parts, embedded in paraffin, and sectioned at 4 µm thickness, according to Figure 6.2 
(b) . Giemsa and HE staining were performed and samples were analyzed under an optical 
microscope. The thickness of the foreign body granuloma was measured and the total 
number of FBGC surrounding the mesh was determined. 
 
a) b) 
Mesh 
Histological section 
Abdominal wall 
Paraffin block 
&
Figure 6.2. Illustrative representation of (a) excision of abdominal mesh and surrounding tissues 
and (b) preparation of histological sections. 
   
6.2.4. Statistics 
Statistical analysis was carried out using Instat 3.0. Results were expressed as the mean ± 
standard deviation and compared through one-way ANOVA, Tukey-Kramer multiple 
comparisons test (for parametric data) and Mann–Whitney U test (for non-parametric data). 
P < 0.05 was considered statistically significant. 
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6.3. Results and discussion 
Several biomaterials have been used as prosthetic meshes for abdominal wall repair, e.g 
incisional hernia repair. Among them, non-absorbable polymers with recognized 
biocompatibility such as polypropylene, PET or PTFE are the most common. Although a 
considerable improvement in the recurrence rate was already achieved with these 
materials, in comparison to the traditional suture technique, several problems are still 
associated with this procedure. Among them, the formation of adhesions between the mesh 
and the bowel is one of major concern since it results in several complications such as 
chronic pain, bowel obstruction or enterocutaneous fistula.  
As previously mentioned, during the electrospinning process a polymeric solution is 
transformed in a nonwoven nanofibrous mesh with unique properties. Some of these 
properties such as low density, microporosity and hydrophobicity are thought to be 
advantageous for application in hernia repair. Following, clinical and histopathological 
results of the application of non-degradable PET and PET/C mats in the repair of incisional 
hernia are discussed. 
6.3.1. Characterization of meshes 
The morphology and properties of PET and PET/C meshes are described in chapter 4 and 
5. DL mat is a composite mesh with one layer of PET and one layer of PET/C nanofibers. 
PET layer was thought to prevent formation of bowel adhesions while PET/C layer was 
designed to stimulate the integration of the mesh in the subcutaneous tissue, thus 
reinforcing the mechanical strength of the prosthetic wall. Figure 6.3  displays a SEM 
picture of the transversal section of the DL mesh, evidencing PET (bottom) and PET/C 
(top) layers. The PET layer presents a more compact fiber organization when compared to 
the PET/C layer, confirming the lower porosity already discussed in chapter 5. 
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Figure 6.3. SEM image of a transversal section of DL mesh. 
 
6.3.2. Surgical procedure and postoperative period 
A pilot study was conducted in order to assess the feasibility of the experimental 
methodology. Originally, the defect was placed at the alba linea and the skin was closed 
by interrupted suture. High levels of skin closure failure from animal over-grooming were 
found (more than 50%, independently of the group). These problems were solved by 
dislocating the defect to the paramedian plane and performing an intradermal suture. This 
strategy was subsequently implemented on the final methodology. 
Following the creation of the abdominal defect by resection of 1.5 x1.5 cm of the Wistar 
rats’ abdominal muscle, the prosthetic meshes were implanted and fixed through the 
borders to the remaining muscle. The suture of the electrospun meshes was easily 
performed with no breakage occurrences. In fact, electrospun meshes were more suitable 
and more resistant to suture than the Marlex mesh used as the control, where an extra 
margin of around 5 mm was used to avoid breaking of filaments. Additionally, the stiffness 
of Marlex mesh may constantly damage the surrounding tissues, causing discomfort and 
pain to the patient. In fact, Marlex mesh is even perceived through the skin by touching. 
Electrospun meshes on the other hand, were much more soft, malleable, and adaptable. In 
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spite of it, these meshes performed well their role of containing visceral components and 
no cases of mesh rupture were found during the experimental period.  
During the postoperative period some complications such as local inflammation, abscess, 
or skin dehiscence were registered. Table 6.2  displays macroscopic complications found 
through the postoperative period. Local inflammation, characterized by redness or 
swelling, was the most common complication found, with higher incidence rates observed 
for PET/C and DL groups, occurring in 50% and 75% of the animals, respectively. 
Inflammation tended to decrease and many times to disappear with time, while abscess and 
skin dehiscence persisted until the end of the experimental period.  
 
Table 6.2. Occurrence rate (%) of complications during postoperative period (PO)* and euthanize 
day (E). 
 
Marlex30 PET30 PET/C DL 
Woven PET 
PO E PO E PO E PO E PO E 
Inflammation 37.5 12.5 37.5 25 50 0 75 37.5 0 0 
Dehiscence 12.5 12.5 0 0 0 0 12.5 12.5 0 0 
Serome or abscess 12.5 12.5 12.5 12.5 0 0 12.5 12.5 0 0 
Adhesion N.A. omentum N.A. omentum N.A. omentum N.A. omentum N.A. omentum 
* Complications were observed for at least 1 day of the PO; 
N.A. Not available. 
 
Unexpectedly, no visceral adhesions were found on the experimental groups. Omentum 
adhesions, on the other hand, were present in all animals. In contrast to bowel adhesions 
that can lead to serious complications, omentum adhesions are clinically irrelevant 
(Karabulut et al. 2006). In fact, some authors have even suggested the interposition of 
omentum between the prosthetic mesh and the viscera, which was shown to be effective in 
restricting bowel adhesions, both in pre-clinical and clinical studies (Karabulut et al. 2006; 
Bingener et al. 2004).  
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Figure 6.4 displays illustrative examples of skin dehiscence found on an animal of the 
Marlex group and an omentum adhesion to a PET mesh. 
 
&
Figure 6.4. Examples of (a) skin dehiscence and (b) omentum adhesion to a PET mesh. 
&
If, on the one hand, these results suggest the good potential of the electrospun mats in 
preventing intestinal adhesions, on the other hand they also lead us to question the 
feasibility of the experimental model. In the literature significant rates of intestinal 
adhesion to Marlex meshes are often reported (van't Riet et al. 2003; Menzies and Ellis 
1990), either on animal or human, but in the present study no evidence of bowel adhesion 
was found. In fact, although rodent models are usually the first approach for testing 
abdominal meshes, several limitations are associated with this model, namely the huge 
difference on the size and abdominal tension between human and rats. Notwithstanding, 
rodent models are certainly an essential step of the pre-clinical trial of a biomaterial, 
providing significant information about the mechanisms underlying the success of hernia 
repair (DuBay et al. 2005; Ayubi et al. 2008; Macleod et al. 2005). The foreign body 
reaction to the prosthetic mesh, which will be discussed in the following subsection, is an 
important subject that can be extensively explored with this model. 
6.3.3. Histopathological analysis 
Tissues were collected and subjected to histological analysis to evaluate the inflammatory 
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response to the prosthetic biomaterials. All animals showed a typical non-immunogenic 
granuloma surrounding the mesh structure as illustrated in Figure 6.5 . The mean 
thickness of the granuloma and the average number of FBGC are plotted in Figure 6.6 . 
a) b) c) d) 
mesh 
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Figure 6.5. Histological sections evidencing the foreign body granuloma (Giemsa staining) of (a) 
Marlex30, (b) PET30, (c) PET/C, and (d) DL groups. (D) dermis, (SC) subcutaneous tissue, and 
(FBG) foreign body granuloma. Bar=220 µm. 
 
Surprisingly large granulomas were found in animals treated with the electrospun meshes, 
compared to control, i.e. Marlex. In fact, the average size of PET granuloma was 4.2 times 
greater than control. This is an unexpected result since the chemical composition of the 
mesh is 100% PET, a high biocompatible polymer, as already mentioned. Moreover, the in 
vitro cytotoxicity assay and the in vivo wound healing assay demonstrated the high 
biocompatibility of the electrospun PET mat (see chapters 4 and 5).  
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Figure 6.6. (a) Granuloma thickness and (b) number of FBGC surrounding the abdominal meshes. 
Different letters indicate significant differences (P<0.05). 
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Chitosan containing meshes, PET/C and DL, showed even larger granulomas (7.4 and 5.9 
times greater than control, respectively). Despites the numerous reports of the anti-
inflammatory and wound healing effects of chitosan, in this specific application chitosan 
had a negative impact and led to an increased inflammatory response. The foreign body 
granulomas were mostly composed of macrophages, FBGC, and fibroblasts. Huge amounts 
of FBGC were found in tissues surrounding the electrospun meshes, evidencing a typical 
foreign body reaction. For instance, PET and PET/C meshes showed, respectively, 11.5 
and 19.3 times more FBGC than the control. Several illustrative examples of those 
multinucleated cells in tissues treated with different meshes are displayed in Figure 6.7 . 
Interestingly, most of the times the FBGC were enclosing one or more nanofibers in an 
attempt to isolate the foreign material. Considering the high biocompatibility of PET in its 
bulk form, we hypothesize that, in some way, the nanodimension of the material elicited 
the huge foreign body reaction found in animals where the electrospun meshes had been 
implanted. 
!"#$%&'(.*&?.!&"*6&?.!O/B3+',"*&%$%/+0',12*&BR#036&4"+,&",&"#6'43*"$&4%,B%,&('0&B%0*3"&0%1"30&
& @F@&
&
Figure 6.7. Representative examples of the foreign body reaction (HE staining) of (a- c) Marlex30, 
(d-f) PET30, (g- i) PET/C, and (j- l) DL groups. Bar = 100 µm (a, d, g, and j) = 25 µm (b, e, h, and 
k), and  = 10 µm (c, f, i, and l). 
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Two main questions arose from this scenario: How does the foreign body reaction progress 
with time? Would the increase of filaments’ diameter of PET mesh decrease the magnitude 
of the foreign body reaction? To answer the first question, PET and Marlex group were 
selected to perform an experiment with 90 days of duration (PET90 and Marlex90 groups). 
Figure 6.8 displays illustrative examples of histological sections (HE staining) of 
Marlex90 and PET90 groups.  The average granuloma thickness of PET group decreased 
from 959 ± 473 µm to 513 ± 217 µm and the number of FBGC decreased from 106 ± 30 to 
89 ±12 (Figure 6.6). Although these differences were not statistically significant (p>0.05), 
the results obtained indicate some tendency for a decrease of the foreign body reaction 
with the time, probably due to a progress of the chronic inflammation, even thought there 
is still a large foreign body reaction persisting 90 days after the mesh implantation.  
a) b) 
 
Figure 6.8. Representative examples of the foreign body reaction (HE staining) of (a) Marlex90 
and (b) PET90. Bar = 50 µm. 
 
Although, most of times, the foreign body reaction has few clinical implications and is 
limited to the close periphery of the implanted material, it is always a disadvantageous 
condition. Indeed, chronic inflammation has been assumed to underlie most of chronic 
diseases, including cancer, cardiovascular diseases, and diabetes, for example (Bartsch and 
Nair 2006; Manabe 2011).  
In order to confirm the hypothesis that the large foreign body responses observed in the 
animals implanted with the electrospun meshes were related to the nanostructure of those 
materials, a new group implanted with a woven mesh of PET microfibers was included in 
the experiment (wovenPET group).  
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A minimum granulomatous reaction was observed in animals implanted with wovenPET 
mesh. In fact, this group exhibited an average granuloma thickness less than half of control 
and FBGC were rarely found (Figure 6.9). Furthermore, no complications were found 
during the postoperative period even though omentum adhesions were also observed Table 
6.2).  
 
a) b) c) 
mesh 
FBG 
D 
SC 
mesh 
FBG 
 
Figure 6.9. Representative examples at different magnification of the foreign body reaction 
observed on wovenPET group (HE staining). (D) dermis, (SC) subcutaneous tissue, and (FBG) 
foreign body granuloma. Bar = 200 µm (a), 100 µm (b), and 25 µm (c). 
 
These results are consistent with our hypothesis that the huge foreign body reaction found 
is probably related to the nanostructure of the electrospun meshes. Considering this 
evidence, we point out three main factors that may have contributed to the exacerbated 
foreign body reaction found in animals implanted with electrospun mats: 
(1) The high surface area to volume ratio of the electrospun materials; 
(2) The extension of the trauma and the location of the lesion;  
(3) The dimension of the nanofibers, which approximate the size of some 
microorganisms, e.g. bacteria. 
 
It is well established that the properties of biomaterials such as size, chemical composition, 
surface properties, and architecture, as well as the specific characteristics of the tissue 
where the biomaterial is implanted, influence the foreign body response (Kamath et al. 
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2008; Hu et al. 2001). Among surface properties, the material ability to adsorb proteins 
plays a key role, as those proteins and not the material composition by itself constitute the 
major contributors for the foreign body reaction (Hu et al. 2001). Several authors have 
demonstrated that the increase of the biomaterial surface area promotes higher levels of 
protein adsorption. For instance, Shalumon et al. (2011) have demonstrated the increase of 
protein adsorption with the increase of surface area per volume ratio of PCL electrospun 
mats. In fact, decreasing the fiber diameter from a micrometric (10 µm) to a nanometric 
range (250 nm) doubled the amount of protein adsorbed on the material surface. A 
correlation between the material’s surface area and the amount of protein adsorbed was 
also demonstrated for PLA nanofibrous scaffolds (Leong et al. 2009). 
In addition, higher foreign body reactions are often found for biomaterials with greater 
surface areas (Voskerician et al. 2006; Sanchez et al. 2011). Specifically related to 
abdominal defect repairs, Conze et al. (2004) have verified a large foreign body reaction 
for a multifilament small diameter mesh of polypropylene. In fact, the diameter of the 
foreign body granuloma 90 days after the mesh placement, decreased from 106.5 µm to 
70.9 µm by increasing the filament diameter from 0.6 mm to 2.5 mm.  
Controversially, there are also reports showing a decrease of inflammatory response with 
the decrease of fiber diameter. For example, Saino et al. (2011) showed that the decrease 
of fiber diameter of electrospun PLA fibrous mats reduced the in vitro macrophage 
activation and the secretion of pro-in#ammatory molecules. Likewise, a decrease of the 
granuloma thickness associated to subcutaneous PCL implants, from $ 38 µm for a PCL 
film to $ 8 µm or $ 4 µm, for aligned or nonwoven electrospun nanofibers, respectively, 
was also reported (Cao et al. 2010). 
The second aspect that may have influenced the large foreign body reaction found is 
related to the extension of the lesion caused and the specific characteristics of the tissues 
where the materials had been implanted. As described in chapter 4, the same PET 
electrospun mat was implanted on the skin of Wistar rats with a minimum foreign body 
reaction. The surgical procedure of the abdominal mesh implantation, however, involves 
the creation of a 1.5 x 1.5 cm defect by complete resection of the abdominal wall. This is a 
severe trauma if we consider the relative size of the animal and, consequently, a large 
inflammatory response may be induced. Furthermore, specific characteristics of the 
!"#$%&'(.*&?.!&"*6&?.!O/B3+',"*&%$%/+0',12*&BR#036&4"+,&",&"#6'43*"$&4%,B%,&('0&B%0*3"&0%1"30&
& @FF&
implantation local such as cell composition and function, vascularization, ECM 
composition, and contact with ascitic fluid, for example, have also an important effect on 
the foreign body reaction. 
The third point regards the mechanisms involved in the interaction between cells and 
nanostructures. Materials are becoming smaller than the basic body unity, i.e. the cell. 
How does that influence the cell-material interaction? Despite enormous progress of 
nanotechnology over the past decades, the risks involved in the use of nanostructure 
materials as biomaterials are still poorly understood (Soto et al. 2007; Stern and McNeil 
2008). Indeed, few studies are found in the literature that evaluate the inflammatory and 
the immune response to nanofibrous materials. For instance, 5301 matches are obtained on 
the search for topics of “electrospinning or electrospun” and “bio*” in the scientific 
research platform (Thomson Reuters Web of Knowledge). Adding the field “foreign body 
reaction” only 5 matches are obtained. This evidence illustrates that further studies 
regarding this issue are required. 
6.4. Concluding remarks and future work 
Despites PET and PET/C electrospun meshes have demonstrated a good performance 
during the implantation surgery, adequate mechanical attributes, and no evidences of 
intestinal adhesion, a large foreign body reaction was also found. This was an unexpected 
and undesirable result, however several conclusions arose from the present study, 
including: 
- The reduced dimension of nanofibers and the high surface area to volume ratio of 
electrospun nonwoven materials may induce a high foreign body reaction, 
depending on the extension and location of the lesion; 
- Chitosan had a negative effect on the inflammation process resultant from the 
abdominal mesh implantation, as postoperative complications and foreign body 
reaction were increased in animals treated with chitosan containing meshes; 
- There is a wide open field to investigate the mechanisms that govern the interaction 
between cells and nanomaterials and to comprehend the risks of nanostructured 
biomaterials implantation;
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Although not a primary objective of this study, an interesting result was the potential use 
of woven PET meshes for incisional hernia repair. PET woven, a cost-effective material, 
showed a better performance as abdominal mesh than control, i.e. Marlex, and emerges as 
a new possibility for the incisional hernia treatment. Further studies to evaluate the 
potential of this material are required. 
  
 
 
 
 
 
 
 
 
 
 
7. Concluding remarks and 
recommendations for future work  
work  
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This thesis focuses on the development of new electrospun materials with application in 
tissue engineering. Two distinct polymer systems were explored: a biodegradable one 
based on poly(3-hydroxybutyrate-co-3-hydroxyvalerate and chitosan blends with 
application in skin engineering and a non-degradable with poly(ethylene terephthalate) as 
the structural polymer. Two distinct applications were explored for PET non-degradable 
materials: removable wound dressing membranes and prosthetic meshes for abdominal 
defect repair. During the course of this exploratory investigation several interesting results 
were achieved, but also, as expected, some difficulties were found.  
The development of novel electrospun blends of PHBV and chitosan was the first 
important achievement. Several strategies to manipulate the morphology of these 
electrospun mats such as by varying the PHBV/C ratio, chitosan MW, or solvent 
composition were studied. These findings constitute an important tool to design a 
biomaterial with the required characteristics. In order to investigate cell-scaffold 
interactions, fibroblasts were selected as the cell model and viability, adhesion, spreading, 
proliferation, ECM secretion, and dead of these cells when cultured on the scaffolds were 
studied. The PHBV/C hybrid mats demonstrated ability to support fibroblast growth. In 
fact, fibroblasts adhered, spread over several nanofibers and secreted ECM components, 
forming a 2D confluent layer on the scaffolds. The PHBV/C ratio of 4:1 (w/w) showed a 
superior performance for fibroblasts growth, as higher levels of viability, adhesion, and 
spreading were found, in comparison to the ratio of 2:3 PHBV/C (w/w). In this scaffold 
with higher chitosan content, an increase in cell death by necrosis was found. In vivo, the 
PHBV/C 4:1 (w/w) hybrid scaffold has also demonstrated the best potential for promoting 
skin regeneration, decreasing the duration and extension of the inflammatory phase of the 
wound healing, with a consequent advance on the proliferative phase, and a higher level of 
tissue regeneration 21 days after injury. 
A novel dual-fiber mat was successfully developed with the purpose of incorporating 
bioactive compounds into the hybrid PHBV/C electrospun mats, using an additional 
aqueous polymer solution of PVA/chitosan. Although only a slight modification on the 
biological performance of the scaffolds resulted from the plant extracts addition, the 
developed electrospinning configuration allowed an homogeneous distribution of the two 
kind of fibers within the mat and the successful incorporation of plant extracts from Aloe 
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barbadensis and Ilex paraguariensis, what can open new routes to prepare bioactive and 
functional polymer nanofibers. Notwithstanding, further studies are required to verify if the 
biological activities are preserved in the fibrous mats and to control the release profile of 
the bioactive compounds. 
The second polymer system under studied was based on the synthetic non-degradable 
polyester, PET. Initial efforts have been carried out to develop a removable wound 
dressing material, based on known properties of electrospun PET mats (e.g. microporosity, 
hydrophobicity, and biocompatibility), potentially attractive for a wound dressing material. 
When tested in vivo, however, a strong affinity between the wound tissues and the PET 
mat was found, which seriously undermines the intended application. Although 
undesirable considering that specific application, results from this study opened new ways 
of application for PET electrospun mats, for example as a non-degradable scaffold for 
tissue engineering.   
The development of PET based non-degradable scaffolds was the subsequent target and 
chitosan was added to the system in order to enhance biological properties and also as a 
tool to control scaffolds’ morphology. Similarly to the PHBV/C hybrid system, we have 
studied the effect of PET/C ratio and chitosan MW on the final characteristics of the 
electrospun mats and also on their performance as scaffolds for tissue engineering. PET 
based scaffolds showed to be suitable for supporting cell growth and substantial 
differences were found as a result of scaffold morphological changes. Higher levels of 
adhesion, spreading, and superficial proliferation were achieved for PET scaffold due to its 
smaller fiber and pore sizes. Addition of chitosan allowed cell penetration and internal 
colonization (3D culture) through the increase of fiber diameter and pore area.  
The study and application of PET and PET/C non-degradable scaffolds as prosthetic 
meshes for abdominal repair was another goal of this work. These electrospun materials 
have demonstrated a good performance during surgery, an adequate mechanical strength, 
and no evidences of intestinal adhesion throughout the postoperative period. However, 
these materials also elicited a significant inflammatory response when used in this specific 
application. In fact, PET nanofibers caused an enormous foreign body reaction that was not 
found for PET microfibers, pointing out for the need of further studies in order to 
investigate and comprehend the risks of the use of nanostructured biomaterials. 
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Recommendations for future work: 
 
! Other biomedical applications for the PHBV/C scaffolds can be explored, for 
example: as support for grow and differentiation of stem cells, treatment of diabetic 
foot ulcers or other chronic wounds, scaffolds for the treatment of spinal cord 
lesions, among many others. 
! The study regarding the dual-fiber system developed must be deepen in order to 
comprehend several aspects that have not been elucidated such as bioavailability 
and the bioactivity of the entrapped compounds, as well as their release profile in 
vitro and in vivo. This dual-fiber system can be used as a vehicle for incorporation 
not only of A. barbadensis and I. paraguariensis extracts, but also of other herbal 
or synthetic compounds. 
! Despite the advantageous results obtained for the PET/C electrospun mats in cell 
culture experiments, in vivo studies to evaluate their biocompatibility are 
indispensable, especially considering the foreign body reaction observed for 
abdominal implantation. 
! Deeper studies are needed in order to elucidate the mechanisms involved in the 
huge foreign body reaction observed with the abdominal implantation of the 
electrospun PET and PET/C mats. In fact, these results demonstrate that there is a 
wide open field to investigate the interactions between cells and non-degradable 
nanostructured biomaterials and comprehend the risks of their implantation. 
 
 
 

  
 
 
 
 
 
 
 
 
 
 
 
References 
&

E%(%0%*/%, &
& @GF&
&
Abdelrahman, T., and H. Newton. 2011. Wound dressings: principles and practice.  29 
(10):491-495. 
Alipour, S. M., M. Nouri, J. Mokhtari, and S. H. Bahrami. 2009. Electrospinning of 
poly(vinyl alcohol)-water-soluble quaternized chitosan derivative blend. 
Carbohydrate Research 344 (18):2496-2501. 
Amiraliyan, N., M. Nouri, and M. H. Kish. 2009. Effects of Some Electrospinning 
Parameters on Morphology of Natural Silk-Based Nanofibers. Journal of Applied 
Polymer Science 113 (1):226-234. 
Anderson, J. M., A. Rodriguez, and D. T. Chang. 2008. Foreign body reaction to 
biomaterials. Seminars in Immunology 20 (2):86-100. 
Anthony, T., P. C. Bergen, L. T. Kim, M. Henderson, T. Fahey, R. V. Rege, and R. H. 
Turnage. 2000. Factors affecting recurrence following incisional herniorrhaphy. 
World Journal of Surgery 24 (1):95-101. 
Aramwit, P., T. Siritientong, S. Kanokpanont, and T. Srichana. 2010. Formulation and 
characterization of silk sericin-PVA scaffold crosslinked with genipin. 
International Journal of Biological Macromolecules 47 (5):668-675. 
Arbiser, J. L., X. C. Li, C. F. Hossain, D. G. Nagle, D. M. Smith, P. Miller, B. 
Govindarajan, J. DiCarlo, K. R. Landis-Piwowar, and Q. P. Dou. 2005. Naturally 
occurring proteasome inhibitors from mate tea (Ilex paraguayensis) serve as 
models for topical proteasome inhibitors. Journal of Investigative Dermatology 125 
(2):207-212. 
Atiba, A., H. Ueno, and Y. Uzuka. 2011. The effect of aloe vera oral administration on 
cutaneous wound healing in type 2 diabetic rats. Journal of Veterinary Medical 
Science 73 (5):583-589. 
Avella, M., E. Martuscelli, and M. Raimo. 2000. Review - Properties of blends and 
composites based on poly(3-hydroxy)butyrate (PHB) and poly(3-hydroxybutyrate-
hydroxyvalerate) (PHBV) copolymers. Journal of Materials Science 35 (3):523-
545. 
Ayubi, F. S., P. J. Armstrong, M. S. Mattia, and D. M. Parker. 2008. Abdominal wall 
hernia repair: a comparison of Permacol (R) and Surgisis (R) grafts in a rat hernia 
model. Hernia 12 (4):373-378. 
Babensee, J. E., J. M. Anderson, L. V. McIntire, and A. G. Mikos. 1998. Host response to 
tissue engineered devices. Advanced Drug Delivery Reviews 33 (1-2):111-139. 
 
.$%/+0',12*& ( 3#0'2, &4"+, & ('0 &,5 3* &"*6&"#6'43*"$ &7"$ $ & 0%1"30 &
&
&@GG&
Badami, A. S., M. R. Kreke, M. S. Thompson, J. S. Riffle, and A. S. Goldstein. 2006. 
Effect of fiber diameter on spreading, proliferation, and differentiation of 
osteoblastic cells on electrospun poly(lactic acid) substrates. Biomaterials 27 
(4):596-606. 
Baptista, M. L., M. E. Bonsack, I. Felemovicius, and J. P. Delaney. 2000. Abdominal 
adhesions to prosthetic mesh evaluated by laparoscopy and electron microscopy. 
Journal of the American College of Surgeons 190 (3):271-280. 
Barnes, C. P., S. A. Sell, E. D. Boland, D. G. Simpson, and G. L. Bowlin. 2007. Nanofiber 
technology: Designing the next generation of tissue engineering scaffolds. 
Advanced Drug Delivery Reviews 59 (14):1413-1433. 
Bartsch, H., and J. Nair. 2006. Chronic inflammation and oxidative stress in the genesis 
and perpetuation of cancer: role of lipid peroxidation, DNA damage, and repair. 
Langenbecks Archives of Surgery 391 (5):499-510. 
Bashur, C. A., L. A. Dahlgren, and A. S. Goldstein. 2006. Effect of fiber diameter and 
orientation on fibroblast morphology and proliferation on electrospun poly(d,l-
lactic-co-glycolic acid) meshes. Biomaterials 27 (33):5681-5688. 
Bastos, D. H. M., A. C. Fornari, Y. S. Queiroz, and E. A. F. S. Torres. 2006. Bioactive 
compounds content of chimarrão infusions related to the moisture of yerba maté 
(Ilex paraguariensis) leaves. Brazilian Archives of Biology and Technology 49 
(3):399-404. 
Bellon, J. M., L. A. Contreras, J. Bujan, and A. C. S. Martin. 1996. Experimental assay of 
a Dual Mesh(R) polytetrafluoroethylene prosthesis (non-porous on one side) in the 
repair of abdominal wall defects. Biomaterials 17 (24):2367-2372. 
Bingener, J., G. B. Kazantsev, S. Chopra, and W. H. Schwesinger. 2004. Adhesion 
formation after laparoscopic ventral incisional hernia repair with polypropylene 
mesh: a study using abdominal ultrasound. JSLS : Journal of the Society of 
Laparoendoscopic Surgeons / Society of Laparoendoscopic Surgeons 8 (2):127-
131. 
Blackwood, K. A., R. McKean, I. Canton, C. O. Freeman, K. L. Franklin, D. Cole, I. 
Brook, P. Farthing, S. Rimmer, J. W. Haycock, A. J. Ryan, and S. MacNeil. 2008. 
Development of biodegradable electrospun scaffolds for dermal replacement. 
Biomaterials 29 (21):3091-3104. 
Blanchemain, N., S. Haulon, B. Martel, M. Traisnel, M. Morcellet, and H. F. Hildebrand. 
2005. Vascular PET prostheses surface modification with cyclodextrin coating: 
development of a new drug delivery system. European Journal of Vascular and 
Endovascular Surgery 29 (6):628-632. 
Boretos, J. W., and M. Eden. 1984. Contemporary biomaterials: material and host 
response, clinical applications, new technology, and legal aspects: Noyes 
Publications. 
E%(%0%*/%, &
& @GH&
Bothin, C., T. Midtvedt, and L. Perbeck. 2003. Orally delivered antibiotics which lower 
bacterial numbers decrease experimental intra-abdominal adhesions. Langenbecks 
Archives of Surgery 388 (2):112-115. 
Boudreau, N., and M. J. Bissell. 1998. Extracellular matrix signaling: integration of form 
and function in normal and malignant cells. Current Opinion in Cell Biology 10 
(5):640-646. 
Bowers, S. L. K., I. Banerjee, and T. A. Baudino. 2010. The extracellular matrix: At the 
center of it all. Journal of Molecular and Cellular Cardiology 48 (3):474-482. 
Brown, N. H. 2000. Cell-cell adhesion via the ECM: integrin genetics in fly and worm. 
Matrix Biology 19 (3):191-201. 
Cai, Z. X., X.-M. Mo, K.-H. Zhang, L.-P. Fan, A.-L. Yin, C.-L. He, and H.-S. Wang. 2010. 
Fabrication of chitosan/silk fibroin composite nanofibers for wound-dressing 
applications. International Journal of Molecular Science 11: 3529-3539. 
Cao, H., K. McHugh, S. Y. Chew, and J. M. Anderson. 2010. The topographical effect of 
electrospun nanofibrous scaffolds on the in vivo and in vitro foreign body reaction. 
Journal of Biomedical Materials Research Part A 93A (3):1151-1159. 
Carbajo, M. A., J. C. M. del Olmo, J. I. Blanco, C. de la Cuesta, M. Toledano, F. Martin, 
C. Vaquero, and L. Inglada. 1999. Laparoscopic treatment vs open surgery in the 
solution of major incisional and abdominal wall hernias with mesh. Surgical 
Endoscopy-Ultrasound and Interventional Techniques 13 (3):250-252. 
Casper, C. L., J. S. Stephens, N. G. Tassi, D. B. Chase, and J. F. Rabolt. 2004. Controlling 
surface morphology of electrospun polystyrene fibers: Effect of humidity and 
molecular weight in the electrospinning process. Macromolecules 37 (2):573-578. 
Casper, C. L., N. Yamaguchi, K. L. Kiick, and J. F. Rabolt. 2005. Functionalizing 
electrospun fibers with biologically relevant macromolecules. Biomacromolecules 
6 (4):1998-2007. 
Chan, C. H., C. Kummerlowe, and H. W. Kammer. 2004. Crystallization and melting 
behavior of poly (3-hydroxybutyrate)-based blends. Macromolecular Chemistry 
and Physics 205 (5):664-675. 
Chen, C. S., M. Mrksich, S. Huang, G. M. Whitesides, and D. E. Ingber. 1997. Geometric 
control of cell life and death. Science 276 (5317):1425-1428. 
Chen, G. Q., and Q. Wu. 2005. The application of polyhydroxyalkanoates as tissue 
engineering materials. Biomaterials 26 (33):6565-6578. 
Chen, J.-P., G.-Y. Chang, and J.-K. Chen. 2008. Electrospun collagen/chitosan nanofibrous 
membrane as wound dressing. Colloids and Surfaces a-Physicochemical and 
Engineering Aspects 313:183-188. 
.$%/+0',12*& ( 3#0'2, &4"+, & ('0 &,5 3* &"*6&"#6'43*"$ &7"$ $ & 0%1"30 &
&
&@GI&
Chen, J. P., G. Y. Chang, and J. K. Chen. 2006. Electrospun collagen/chitosan nanofibrous 
membrane as wound dressing. Paper read at Asian Conference on Nanoscience and 
Nanotechnology (AsiaNANO 2006), Nov 01-04, at Busan, South Korea. 
Chen, P., Q.-S. Wu, Y.-P. Ding, M. Chu, Z.-M. Huang, and W. Hue. 2010. A controlled 
release system of titanocene dichloride by electrospun fiber and its antitumor 
activity in vitro. European Journal of Pharmaceutics and Biopharmaceutics 76 
(3):413-420. 
Chen, Y., G. Yang, and Q. Chen. 2002. Solid-state NMR study on the structure and 
mobility of the noncrystalline region of poly(3-hydroxybutyrate) and poly(3-
hydroxybutyrate-co-3-hydroxyvalerate). Polymer 43 (7):2095-2099. 
Chithra, P., G. B. Sajithlal, and G. Chandrakasan. 1998. Influence of Aloe vera on the 
glycosaminoglycans in the matrix of healing dermal wounds in rats. Journal of 
Ethnopharmacology 59 (3):179-186. 
Choi, J. S., K. W. Leong, and H. S. Yoo. 2008. In vivo wound healing of diabetic ulcers 
using electrospun nanofibers immobilized with human epidermal growth factor 
(EGF). Biomaterials 29 (5):587-596. 
Choi, S., and M. H. Chung. 2003. A review on the relationship between aloe vera 
components and their biologic effects. Seminars in Integrative Medicine 1 (1):53-
62. 
Choi, S. W., B. W. Son, Y. S. Son, Y. I. Park, S. K. Lee, and M. H. Chung. 2001. The 
wound-healing effect of a glycoprotein fraction isolated from aloe vera. British 
Journal of Dermatology 145 (4):535-545. 
Chong, E. J., T. T. Phan, I. J. Lim, Y. Z. Zhang, B. H. Bay, S. Ramakrishna, and C. T. 
Lim. 2007. Evaluation of electrospun PCL/gelatin nanofibrous scaffold for wound 
healing and layered dermal reconstitution. Acta Biomaterialia 3 (3):321-330. 
Chu, D. I., R. Lim, S. Heydrick, M. L. Gainsbury, R. Abdou, L. D'Addese, K. L. Reed, A. 
F. Stucchi, and J. M. Becker. 2011. N-acetyl-L-cysteine decreases intra-abdominal 
adhesion formation through the upregulation of peritoneal fibrinolytic activity and 
antioxidant defenses. Surgery 149 (6):801-812. 
Chuangchote, S., T. Sagawa, and S. Yoshikawa. 2009. Electrospinning of poly(vinyl 
pyrrolidone): Effects of solvents on electrospinnability for the fabrication of 
poly(p-phenylene vinylene) and TiO(2) nanofibers. Journal of Applied Polymer 
Science 114 (5):2777-2791. 
Conze, J., R. Rosch, U. Klinge, C. Weiss, M. Anurov, S. Titkowa, A. Oettinger, and V. 
Schumpelick. 2004. Polypropylene in the intra-abdominal position: influence of 
pore size and surface area. Hernia : the journal of hernias and abdominal wall 
surgery 8 (4):365-372. 
E%(%0%*/%, &
& @GJ&
Davis, R. H., J. J. Donato, G. M. Hartman, and R. C. Haas. 1994. Anti-inflammatory and 
wound healing activity of a growth substance in Aloe vera. Journal of the 
American Podiatric Medical Association 84 (2):77-81. 
DeRuiter, M. C., R. E. Poelmann, M. M. T. Mentink, L. Vaniperen, and A. C. 
Gittenberger-De Groot. 1993. Early formation of the vascular system in quail 
embryos. Anatomical Record 235 (2):261-274. 
Duan, B., C. H. Dong, X. Y. Yuan, and K. D. Yao. 2004. Electrospinning of chitosan 
solutions in acetic acid with poly(ethylene oxide). Journal of Biomaterials Science-
Polymer Edition 15 (6):797-811. 
Duan, B., L. Wu, X. Li, X. Yuan, X. Li, Y. Zhang, and K. Yao. 2007. Degradation of 
electrospun PLGA-chitosan/PVA membranes and their cytocompatibility in vitro. 
Journal of Biomaterials Science-Polymer Edition 18 (1):95-115. 
DuBay, D. A., X. Wang, B. Adamson, W. M. Kuzon, R. G. Dennis, and M. G. Franz. 
2005. Progressive fascial wound failure impairs subsequent abdominal wall repairs: 
A new animal model of incisional hernia formation. Surgery 137 (4):463-471. 
Femenia, A., E. S. Sanchez, S. Simal, and C. Rossello. 1999. Compositional features of 
polysaccharides from Aloe vera (Aloe barbadensis Miller) plant tissues. 
Carbohydrate Polymers 39 (2):109-117. 
Folkman, J. 1971. Tumor angiogenesis: therapeutic implications. New England Journal of 
Medicine 285 (21):1182-1186. 
Fonder, M. A., G. S. Lazarus, D. A. Cowan, B. Aronson-Cook, A. R. Kohli, and A. J. 
Mamelak. 2008. Treating the chronic wound: A practical approach to the care of 
nonhealing wounds and wound care dressings. Journal of the American Academy of 
Dermatology 58 (2):185-206. 
Formhals, A. 1934. Process and apparatus for preparing artificial threads, edited by U. S. 
P. a. T. Office. 
Galiano, R. D., O. M. Tepper, C. R. Pelo, K. A. Bhatt, M. Callaghan, N. Bastidas, S. 
Bunting, H. G. Steinmetz, and G. C. Gurtner. 2004. Topical vascular endothelial 
growth factor accelerates diabetic wound healing through increased angiogenesis 
and by mobilizing and recruiting bone marrow-derived cells. American Journal of 
Pathology 164 (6):1935-1947. 
Gao, C., Q. Gao, Y. Li, M. N. Rahaman, A. Teramoto, and K. Abe. 2012. Preparation and 
in vitro characterization of electrospun PVA scaffolds coated with bioactive glass 
for bone regeneration. Journal of biomedical materials research. Part A 100 
(5):1324-1334. 
Gecim, I. E., S. Kocak, S. Ersoz, C. Bumin, and D. Aribal. 1996. Recurrence after 
incisional hernia repair: Results and risk factors. Surgery Today-the Japanese 
Journal of Surgery 26 (8):607-609. 
.$%/+0',12*& ( 3#0'2, &4"+, & ('0 &,5 3* &"*6&"#6'43*"$ &7"$ $ & 0%1"30 &
&
&@HK&
Geng, X. Y., O. H. Kwon, and J. H. Jang. 2005. Electrospinning of chitosan dissolved in 
concentrated acetic acid solution. Biomaterials 26 (27):5427-5432. 
Gentsch, R., F. Pippig, S. Schmidt, P. Cernoch, J. Polleux, and H. G. Boerner. 2011. 
Single-step electrospinning to bioactive polymer nanofibers. Macromolecules 44 
(3):453-461. 
Gopal, R., S. Kaur, Z. W. Ma, C. Chan, S. Ramakrishna, and T. Matsuura. 2006. 
Electrospun nanofibrous filtration membrane. Journal of Membrane Science 281 
(1-2):581-586. 
Gorzalczany, S., R. Filip, M. D. R. Alonso, J. Miño, G. E. Ferraro, and C. Acevedo. 2001. 
Choleretic effect and intestinal propulsion of 'mate' (Ilex paraguariensis) and its 
substitutes or adulterants. Journal of Ethnopharmacology 75 (2-3):291-294. 
Grafahrend, D., J. L. Calvet, K. Klinkhammer, J. Salber, P. D. Dalton, M. Moeller, and D. 
Klee. 2008. Control of protein adsorption on functionalized electrospun fibers. 
Biotechnology and Bioengineering 101 (3):609-621. 
Gugliucci, A. 1996. Antioxidant effects of Ilex paraguariensis: Induction of decreased 
oxidability of human LDL in vivo. Biochemical and Biophysical Research 
Communications 224 (2):338-344. 
Gupta, A., R. Kumar, N. K. Upadhyay, P. Surekha, and P. K. Roy. 2009. Synthesis, 
Characterization and efficacy of chemically crosslinked PVA hydrogels for dermal 
wound healing in experimental animals. Journal of Applied Polymer Science 111 
(3):1400-1408. 
Gupta, K. C., and F. H. Jabrail. 2007. Glutaraldehyde cross-linked chitosan microspheres 
for controlled release of centchroman. Carbohydrate Research 342 (15):2244-
2252. 
Han, I., K. J. Shim, J. Y. Kim, S. U. Im, Y. K. Sung, M. Kim, I.-K. Kang, and J. C. Kim. 
2007. Effect of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) nanofiber matrices 
cocultured with hair follicular epithelial and dermal cells for biological wound 
dressing. Artificial Organs 31 (11):801-808. 
Han, S. O., W. K. Son, J. H. Youk, T. S. Lee, and W. H. Park. 2005. Ultrafine porous 
fibers electrospun from cellulose triacetate. Materials Letters 59 (24-25):2998-
3001. 
Hong, K. H. 2007. Preparation and properties of electrospun poly (vinyl alcohol)/silver 
fiber web as wound dressings. Polymer Engineering and Science 47 (1):43-49. 
Hong, K. H., and T. J. Kang. 2006. Hydraulic permeabilities of PET and nylon 6 
electrospun fiber webs. Journal of Applied Polymer Science 100 (1):167-177. 
Hsu, C. M., and S. Shivkumar. 2004. Nano-sized beads and porous fiber constructs of 
poly(epsilon-caprolactone) produced by electrospinning. Journal of Materials 
Science 39 (9):3003-3013. 
E%(%0%*/%, &
& @H@&
Hu, S. G., C. H. Jou, and M. C. Yang. 2003a. Antibacterial and biodegradable properties of 
polyhydroxyalkanoates grafted with chitosan and chitooligosaccharides via ozone 
treatment. Journal of Applied Polymer Science 88 (12):2797-2803. 
Hu, S. G., C. H. Jou, and M. C. Yang. 2003b. Protein adsorption, fibroblast activity and 
antibacterial properties of poly(3-hydroxybutyric acid-co-3-hydroxyvaleric acid) 
grafted with chitosan and chitooligosaccharide after immobilized with hyaluronic 
acid. Biomaterials 24 (16):2685-2693. 
Hu, W. J., J. W. Eaton, and L. P. Tang. 2001. Molecular basis of biomaterial-mediated 
foreign body reactions. Blood 98 (4):1231-1238. 
Hu, Y.-L., W. Qi, F. Han, J.-Z. Shao, and J.-Q. Gao. 2011. Toxicity evaluation of 
biodegradable chitosan nanoparticles using a zebrafish embryo model. 
International Journal of Nanomedicine 6:3351-3359. 
Huss, F. R. M., E. Nyman, J. S. C. Bolin, and G. Kratz. 2010. Use of macroporous gelatine 
spheres as a biodegradable scaffold for guided tissue regeneration of healthy dermis 
in humans: An in vivo study. Journal of Plastic, Reconstructive & Aesthetic 
Surgery 63 (5):848-857. 
Iannace, S., G. Sabatini, L. Ambrosio, and L. Nicolais. 1995. Mechanical behaviour of 
composite artificial tendons and ligaments. Biomaterials 16 (9):675-680. 
Ignatova, M., N. Manolova, N. Markova, and I. Rashkov. 2009. Electrospun non-woven 
nanofibrous hybrid mats based on chitosan and pla for wound-dressing 
applications. Macromolecular Bioscience 9 (1):102-111. 
Jansen, E. J. P., R. E. J. Sladek, H. Bahar, A. Yaffe, M. J. Gijbels, R. Kuijer, S. K. Bulstra, 
N. A. Guldemond, I. Binderman, and L. H. Koole. 2005. Hydrophobicity as a 
design criterion for polymer scaffolds in bone tissue engineering. Biomaterials 26 
(21):4423-4431. 
Jettanacheawchankit, S., S. Sasithanasate, P. Sangvanich, W. Banlunara, and P. 
Thunyakitpisal. 2009. Acemannan stimulates gingival fibroblast proliferation; 
expressions of keratinocyte growth factor-1, vascular endothelial growth factor, and 
type I collagen; and wound healing. Journal of Pharmacological Sciences 109 
(4):525-531. 
Jin, H. J., S. V. Fridrikh, G. C. Rutledge, and D. L. Kaplan. 2002. Electrospinning Bombyx 
mori silk with poly(ethylene oxide). Biomacromolecules 3 (6):1233-1239. 
Jung, K.-H., M.-W. Huh, W. Meng, J. Yuan, S. H. Hyun, J.-S. Bae, S. M. Hudson, and I.-
K. Kang. 2007. Preparation and antibacterial activity of PET/chitosan nanofibrous 
mats using an electrospinning technique. Journal of Applied Polymer Science 105 
(5):2816-2823. 
Junqueira, L. C., and J. Carneiro. 2005. Basic Histology: Text & Atlas: McGraw-Hill. 
.$%/+0',12*& ( 3#0'2, &4"+, & ('0 &,5 3* &"*6&"#6'43*"$ &7"$ $ & 0%1"30 &
&
&@HA&
Kamath, S., D. Bhattacharyya, C. Padukudru, R. B. Timmons, and L. Tang. 2008. Surface 
chemistry influences implant-mediated host tissue responses. Journal of 
Biomedical Materials Research Part A 86A (3):617-626. 
Karabulut, B., K. Sonmez, Z. Turkyilmaz, B. Demirogullari, R. Karabulut, C. Sezer, N. 
Sultan, A. C. Basaklar, and N. Kale. 2006. Omentum prevents intestinal adhesions 
to mesh graft in abdominal infections and serosal defects. Surgical Endoscopy and 
Other Interventional Techniques 20 (6):978-982. 
Karim, M. R., and M. S. Islam. 2011. Thermal behavior with mechanical property of 
fluorinated silane functionalized superhydrophobic pullulan/poly(vinyl alcohol) 
blends by electrospinning method. Journal of Nanomaterials. 
Kasaai, M. R., J. Arul, and C. Charlet. 2000. Intrinsic viscosity-molecular weight 
relationship for chitosan. Journal of Polymer Science Part B-Polymer Physics 38 
(19):2591-2598. 
Kasten, P., I. Beyen, P. Niemeyer, R. Luginb¸hl, M. Bohner, and W. Richter. 2008. 
Porosity and pore size of [beta]-tricalcium phosphate scaffold can influence protein 
production and osteogenic differentiation of human mesenchymal stem cells: An in 
vitro and in vivo study. Acta Biomaterialia 4 (6):1904-1915. 
Katti, D. S., K. W. Robinson, F. K. Ko, and C. T. Laurencin. 2004. Bioresorbable 
nanofiber-based systems for wound healing and drug delivery: Optimization of 
fabrication parameters. Journal of Biomedical Materials Research Part B-Applied 
Biomaterials 70B (2):286-296. 
Kenawy, E. R., G. L. Bowlin, K. Mansfield, J. Layman, D. G. Simpson, E. H. Sanders, and 
G. E. Wnek. 2002. Release of tetracycline hydrochloride from electrospun 
poly(ethylene-co-vinylacetate), poly(lactic acid), and a blend. Journal of 
Controlled Release 81 (1-2):57-64. 
Khil, M. S., S. R. Bhattarai, H. Y. Kim, S. Z. Kim, and K. H. Lee. 2005. Novel fabricated 
matrix via electrospinning for tissue engineering. Journal of Biomedical Materials 
Research Part B-Applied Biomaterials 72B (1):117-124. 
Khil, M. S., D. I. Cha, H. Y. Kim, I. S. Kim, and N. Bhattarai. 2003. Electrospun 
nanofibrous polyurethane membrane as wound dressing. Journal of Biomedical 
Materials Research Part B-Applied Biomaterials 67B (2):675-679. 
Kim, S.-S., M. Sun Park, O. Jeon, C. Yong Choi, and B.-S. Kim. 2006. Poly(lactide-co-
glycolide)/hydroxyapatite composite scaffolds for bone tissue engineering. 
Biomaterials 27 (8):1399-1409. 
Kim, T. G., and T. G. Park. 2006. Biomimicking extracellular matrix: Cell adhesive RGD 
peptide modified electrospun poly( D,L-lactic-Co-glycolic acid) nanofiber mesh. 
Tissue Engineering 12 (2):221-233. 
Kingsnorth, A., and K. LeBlanc. 2003. Hernias: inguinal and incisional. Lancet 362 
(9395):1561-1571. 
E%(%0%*/%, &
& @HL&
Klein, S. A., S. J. Bond, S. C. Gupta, O. A. Yacoub, and G. L. Anderson. 1999. 
Angiogenesis inhibitor TNP-470 inhibits murine cutaneous wound healing. Journal 
of Surgical Research 82 (2):268-274. 
Klosterhalfen, B., U. Klinge, and V. Schumpelick. 1998. Functional and morphological 
evaluation of different polypropylene-mesh modifications for abdominal wall 
repair. Biomaterials 19 (24):2235-2246. 
Koski, A., K. Yim, and S. Shivkumar. 2004. Effect of molecular weight on fibrous PVA 
produced by electrospinning. Materials Letters 58 (3-4):493-497. 
Kumbar, S. G., R. James, S. P. Nukavarapu, and C. T. Laurencin. 2008. Electrospun 
nanofiber scaffolds: engineering soft tissues. Biomedical Materials 3 (3). 
Kuppan, P., K. S. Vasanthan, D. Sundaramurthi, U. M. Krishnan, and S. Sethuraman. 
2011. Development of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) fibers for 
skin tissue engineering: effects of topography, mechanical, and chemical stimuli. 
Biomacromolecules 12 (9):3156-3165. 
Kurosaka, M., T. Suzuki, K. Hosono, Y. Kamata, A. Fukamizu, H. Kitasato, Y. Fujita, and 
M. Majima. 2009. Reduced angiogenesis and delay in wound healing in 
angiotensin II type 1a receptor-deficient mice. Biomedicine & Pharmacotherapy 63 
(9):627-634. 
Lee, I. S., O. H. Kwon, W. Meng, and I. K. Kang. 2004. Nanofabrication of microbial 
polyester by electrospinning promotes cell attachment. Macromolecular Research 
12 (4):374-378. 
Lee, J. J., S.-G. Lee, J. C. Park, Y. I. Yang, and J. K. Kim. 2007. Investigation on 
biodegradable PLGA scaffold with various pore size structure for skin tissue 
engineering. Current Applied Physics 7 (Supplement 1):e37-e40. 
Leong, M. F., K. S. Chian, P. S. Mhaisalkar, W. F. Ong, and B. D. Ratner. 2009. Effect of 
electrospun poly(D,L-lactide) fibrous scaffold with nanoporous surface on 
attachment of porcine esophageal epithelial cells and protein adsorption. Journal of 
Biomedical Materials Research Part A 89A (4):1040-1048. 
Li, D., Y. L. Wang, and Y. N. Xia. 2003. Electrospinning of polymeric and ceramic 
nanofibers as uniaxially aligned arrays. Nano Letters 3 (8):1167-1171. 
Li, D., and Y. N. Xia. 2004. Direct fabrication of composite and ceramic hollow nanofibers 
by electrospinning. Nano Letters 4 (5):933-938. 
Li, L., and Y. L. Hsieh. 2006. Chitosan bicomponent nanofibers and nanoporous fibers. 
Carbohydrate Research 341 (3):374-381. 
 
 
.$%/+0',12*& ( 3#0'2, &4"+, & ('0 &,5 3* &"*6&"#6'43*"$ &7"$ $ & 0%1"30 &
&
&@HM&
Li, X., K. L. Liu, M. Wang, S. Y. Wong, W. C. Tjiu, C. Bin He, S. H. Goh, and J. Li. 
2009. Improving hydrophilicity, mechanical properties and biocompatibility of 
poly (R)-3-hydroxybutyrate-co-(R)-3-hydroxyvalerate through blending with poly 
(R)-3-hydroxybutyrate -alt-poly(ethylene oxide). Acta Biomaterialia 5 (6):2002-
2012. 
Li, X., J. Xie, X. Yuan, and Y. Xia. 2008. Coating Electrospun Poly(epsilon-caprolactone) 
Fibers with Gelatin and Calcium Phosphate and Their Use as Biomimetic Scaffolds 
for Bone Tissue Engineering. Langmuir 24 (24):14145-14150. 
Lin, T., J. Fang, H. Wang, T. Cheng, and X. Wang. 2006a. Using chitosan as a thickener 
for electrospinning dilute PVA solutions to improve fibre uniformity. 
Nanotechnology 17 (15):3718-3723. 
Liu, X. F., Y. L. Guan, D. Z. Yang, Z. Li, and K. Yao. 2001. Antibacterial action of 
chitosan and carboxymethylated chitosan, Journal of Applied Polymer Science 
79:1324-1335. 
Liu, X., L. Ma, Z. Mao, and C. Gao. 2011. Chitosan-based biomaterials for tissue repair 
and regeneration. In Chitosan for Biomaterials Ii, edited by R. P. M. M. R. A. A. 
Jayakumar, 81-127. 
Liu, Y., J. Chen, V. Misoska, and G. G. Wallace. 2007. Preparation of novel ultrafine 
fibers based on DNA and poly(ethylene oxide) by electrospinning from aqueous 
solutions. Reactive and Functional Polymers 67 (5):461-467. 
Loh, J. W., G. Yeoh, M. Saunders, and L.-Y. Lim. 2010. Uptake and cytotoxicity of 
chitosan nanoparticles in human liver cells. Toxicology and Applied Pharmacology 
249 (2):148-157. 
Lopes-da-Silva, J. A., B. Veleirinho, and I. Delgadillo. 2009. Preparation and 
characterization of electrospun mats made of pet/chitosan hybrid nanofibers. 
Journal of Nanoscience and Nanotechnology 9 (6):3798-3804. 
Lowery, J. L., N. Datta, and G. C. Rutledge. 2010. Effect of fiber diameter, pore size and 
seeding method on growth of human dermal fibroblasts in electrospun 
poly(epsilon-caprolactone) fibrous mats. Biomaterials 31 (3):491-504. 
Lu, Q. J., A. Simionescu, and N. Vyavahare. 2005. Novel capillary channel fiber scaffolds 
for guided tissue engineering. Acta Biomaterialia 1 (6):607-614. 
Lubiatowski, P., J. Kruczynski, A. Gradys, T. Trzeciak, and J. Jaroszewski. 2006. Articular 
Cartilage Repair by Means of Biodegradable Scaffolds. Transplantation 
Proceedings 38 (1):320-322. 
Luijendijk, R. W., W. C. J. Hop, P. van den Tol, D. C. D. de Lange, M. M. J. Braaksma, J. 
N. M. Ijzermans, R. U. Boelhouwer, B. C. de Vries, M. K. M. Salu, J. C. J. 
Wereldsma, C. M. A. Bruijninckx, and J. Jeekel. 2000. A comparison of suture 
repair with mesh repair for incisional hernia. New England Journal of Medicine 
343 (6):392-398. 
E%(%0%*/%, &
& @HF&
Lukashev, M. E., and Z. Werb. 1998. ECM signalling: orchestrating cell behaviour and 
misbehaviour. Trends in Cell Biology 8 (11):437-441. 
Lunceford, N., and A. Gugliucci. 2005. Ilex paraguariensis extracts inhibit AGE formation 
more efficiently than green tea. Fitoterapia 76 (5):419-427. 
Ma, L., C. Y. Gao, Z. W. Mao, J. Zhou, J. C. Shen, X. Q. Hu, and C. M. Han. 2003. 
Collagen/chitosan porous scaffolds with improved biostability for skin tissue 
engineering. Biomaterials 24 (26):4833-4841. 
Ma, Z., M. Kotaki, T. Yong, W. He, and S. Ramakrishna. 2005a. Surface engineering of 
electrospun polyethylene terephthalate (PET) nanofibers towards development of a 
new material for blood vessel engineering. Biomaterials 26 (15):2527-2536. 
Macleod, T. M., G. Williams, R. Sanders, and C. J. Green. 2005. Histological evaluation of 
Permacol (TM) as a subcutaneous implant over a 20-week period in the rat model. 
British Journal of Plastic Surgery 58 (4):518-532. 
Manabe, I. 2011. Chronic Inflammation Links Cardiovascular, Metabolic and Renal 
Diseases. Circulation Journal 75 (12):2739-2748. 
Mao, N., and S. J. Russell. 2004. Nonwoven wound dressings. Textile Progress 36 (4):1-
57. 
Mattanavee, W., O. Suwantong, S. Puthong, T. Bunaprasert, V. P. Hoven, and P. 
Supaphol. 2009. Immobilization of Biomolecules on the Surface of Electrospun 
Polycaprolactone Fibrous Scaffolds for Tissue Engineering. Acs Applied Materials 
& Interfaces 1 (5):1076-1085. 
Matthews, B. D., B. L. Pratt, H. S. Pollinger, C. L. Backus, K. W. Kercher, R. F. Sing, and 
B. T. Heniford. 2003. Assessment of adhesion formation to intra-abdominal 
polypropylene mesh and polytetrafluoroethylene mesh. Journal of Surgical 
Research 114 (2):126-132. 
McGinty, J. J., N. J. Hogle, H. McCarthy, and D. L. Fowler. 2005. A comparative study of 
adhesion formation and abdominal wall ingrowth after laparoscopic ventral hernia 
repair in a porcine model using multiple types of mesh. Surgical Endoscopy and 
Other Interventional Techniques 19 (6):786-790. 
McGrath, J. L. 2007. Cell spreading: The power to simplify. Current Biology 17 
(10):R357-R358. 
McKee, M. G., G. L. Wilkes, R. H. Colby, and T. E. Long. 2004. Correlations of solution 
rheology with electrospun fiber formation of linear and branched polyesters. 
Macromolecules 37 (5):1760-1767. 
Meng, W., S. Y. Kim, J. Yuan, J. C. Kim, O. H. Kwon, N. Kawazoe, G. P. Chen, Y. Ito, 
and I. K. Kang. 2007. Electrospun PHBV/collagen composite nanofibrous scaffolds 
for tissue engineering. Journal of Biomaterials Science-Polymer Edition 18 (1):81-
94. 
.$%/+0',12*& ( 3#0'2, &4"+, & ('0 &,5 3* &"*6&"#6'43*"$ &7"$ $ & 0%1"30 &
&
&@HG&
Meng, W., Z. C. Xing, K. H. Jung, S. Y. Kim, J. Yuan, I. K. Kang, S. C. Yoon, and H. I. 
Shin. 2008. Synthesis of gelatin-containing PHBV nanofiber mats for biomedical 
application. Journal of Materials Science-Materials in Medicine 19 (8):2799-2807. 
Menzies, D., and H. Ellis. 1990. Intestinal-obstruction from adhesions - how big is the 
problem. Annals of the Royal College of Surgeons of England 72 (1):60-63. 
Milligan, D. W., and A. T. Raftery. 1974. Observations on pathogenesis of peritoneal 
adhesions - light and electron microscopical study. British Journal of Surgery 61 
(4):274-280. 
Min, B.-M., G. Lee, S. H. Kim, Y. S. Nam, T. S. Lee, and W. H. Park. 2004. 
Electrospinning of silk fibroin nanofibers and its effect on the adhesion and 
spreading of normal human keratinocytes and fibroblasts in vitro. Biomaterials 25 
(7-8):1289-1297. 
Monteiro, O. A. C., and C. Airoldi. 1999. Some studies of crosslinking chitosan-
glutaraldehyde interaction in a homogeneous system. International Journal of 
Biological Macromolecules 26 (2-3):119-128. 
Moreno, M. J., A. Ajji, D. Mohebbi-Kalhori, M. Rukhlova, A. Hadjizadeh, and M. N. 
Bureau. 2011. Development of a compliant and cytocompatible micro-fibrous 
polyethylene terephthalate vascular scaffold. Journal of Biomedical Materials 
Research Part B-Applied Biomaterials 97B (2):201-214. 
Moroni, L., R. Licht, J. de Boer, J. R. de Wijn, and C. A. van Blitterswijk. 2006. Fiber 
diameter and texture of electrospun PEOT/PBT scaffolds influence human 
mesenchymal stem cell proliferation and morphology, and the release of 
incorporated compounds. Biomaterials 27 (28):4911-4922. 
Moukwa, M. 1997. The development of polymer-based biomaterials since the 1920s. JOM 
Journal of the Minerals, Metals and Materials Society 49 (2):46-50. 
Neves, A. A., N. Medcalf, and K. M. Brindle. 2005. Influence of stirring-induced mixing 
on cell proliferation and extracellular matrix deposition in meniscal cartilage 
constructs based on polyethylene terephthalate scaffolds. Biomaterials 26 
(23):4828-4836. 
Ng, R., X. Zhang, N. Liu, and S.-T. Yang. 2009. Modifications of nonwoven polyethylene 
terephthalate fibrous matrices via NaOH hydrolysis: Effects on pore size, fiber 
diameter, cell seeding and proliferation. Process Biochemistry 44 (9):992-998. 
Ohkawa, K., D. I. Cha, H. Kim, A. Nishida, and H. Yamamoto. 2004. Electrospinning of 
chitosan. Macromolecular Rapid Communications 25 (18):1600-1605. 
Papenburg, B. J., S. Sch¸ller-Ravoo, L. A. M. Bolhuis-Versteeg, L. Hartsuiker, D. W. 
Grijpma, J. Feijen, M. Wessling, and D. Stamatialis. 2009. Designing porosity and 
topography of poly(1,3-trimethylene carbonate) scaffolds. Acta Biomaterialia 5 
(9):3281-3294. 
E%(%0%*/%, &
& @HH&
Peesan, M., R. Rujiravanit, and P. Supaphol. 2006. Electrospinning of hexanoyl 
chitosan/polylactide blends. Journal of Biomaterials Science-Polymer Edition 17 
(5):547-565. 
Pitzer, G. B., and K. G. Patel. 2011. Proper care of early wounds to optimize healing and 
prevent complications. Facial plastic surgery clinics of North America 19 (3):491-
504. 
Powell, H. M., and S. T. Boyce. 2008. Fiber density of electrospun gelatin scaffolds 
regulates morphogenesis of dermal-epidermal skin substitutes. Journal of 
Biomedical Materials Research Part A 84A (4):1078-1086. 
Qi, L., Z. Xu, and M. Chen. 2007. In vitro and in vivo suppression of hepatocellular 
carcinoma growth by chitosan nanoparticles. European Journal of Cancer 43 
(1):184-193. 
Ranjani, M., S. Rajan, and P. Brindha. 2010. Antioxidant and Antibacterial Potentials of 
Aloe vera Juice Extract against Wound Isolates. Journal of Pure and Applied 
Microbiology 4 (2):733-739. 
Reynolds, T., and A. C. Dweck. 1999. Aloe vera leaf gel: A review update. Journal of 
Ethnopharmacology 68 (1-3):3-37. 
Rho, K. S., L. Jeong, G. Lee, B. M. Seo, Y. J. Park, S. D. Hong, S. Roh, J. J. Cho, W. H. 
Park, and B. M. Min. 2006. Electrospinning of collagen nanofibers: Effects on the 
behavior of normal human keratinocytes and early-stage wound healing. 
Biomaterials 27 (8):1452-1461. 
Robinson, T. N., J. H. Clarke, J. Schoen, and M. D. Walsh. 2005. Major mesh-related 
complications following hernia repair - Events reported to the Food and Drug 
Administration. Surgical Endoscopy and Other Interventional Techniques 19 
(12):1556-1560. 
Rosca-Casian, O., M. Parvu, L. Vlase, and M. Tamas. 2007. Antifungal activity of Aloe 
vera leaves. Fitoterapia 78 (3):219-222. 
Saino, E., M. L. Focarete, C. Gualandi, E. Emanuele, A. I. Cornaglia, M. Imbriani, and L. 
Visai. 2011. Effect of electrospun fiber diameter and alignment on macrophage 
activation and secretion of proinflammatory cytokines and chemokines. 
Biomacromolecules 12 (5):1900-1911. 
Sanchez, V. C., P. Weston, A. Yan, R. H. Hurt, and A. B. Kane. 2011. A 3-dimensional in 
vitro model of epithelioid granulomas induced by high aspect ratio nanomaterials. 
Particle and Fibre Toxicology 8. 
Santos, C., P. Seabra, B. Veleirinho, I. Delgadillo, and J. A. L. da Silva. 2006. Acetylation 
and molecular mass effects on barrier and mechanical properties of shortfin squid 
chitosan membranes. European Polymer Journal 42 (12):3277-3285. 
.$%/+0',12*& ( 3#0'2, &4"+, & ('0 &,5 3* &"*6&"#6'43*"$ &7"$ $ & 0%1"30 &
&
&@HI&
Schreuder-Gibson, H., P. Gibson, K. Senecal, M. Sennett, J. Walker, W. Yeomans, D. 
Ziegler, and P. P. Tsai. 2002. Protective textile materials based on electrospun 
nanofibers. Journal of Advanced Materials 34 (3):44-55. 
Seitz, H., S. Marlovits, I. Schwendenwein, E. M¸ller, and V. VÈcsei. 1998. 
Biocompatibility of polyethylene terephthalate (TreviraÆ hochfest) augmentation 
device in repair of the anterior cruciate ligament. Biomaterials 19 (1-3):189-196. 
Shalumon, K. T., N. S. Binulal, M. Deepthy, R. Jayakumar, K. Manzoor, and S. V. Nair. 
2011. Preparation, characterization and cell attachment studies of electrospun 
multi-scale poly(caprolactone) fibrous scaffolds for tissue engineering. Journal of 
Macromolecular Science Part a-Pure and Applied Chemistry 48 (1):21-30. 
Shen, X., D. Yu, L. Zhu, C. Branford-White, K. White, and N. P. Chatterton. 2011. 
Electrospun diclofenac sodium loaded Eudragit (R) L 100-55 nanofibers for colon-
targeted drug delivery. International Journal of Pharmaceutics 408 (1-2):200-207. 
Shi, J., L. Wang, F. Zhang, H. Li, L. Lei, L. Liu, and Y. Chen. 2010. Incorporating Protein 
Gradient into Electrospun Nanofibers As Scaffolds for Tissue Engineering. Acs 
Applied Materials & Interfaces 2 (4):1025-1030. 
Shin, C., G. G. Chase, and D. H. Reneker. 2005. Recycled expanded polystyrene 
nanofibers applied in filter media. Colloids and Surfaces a-Physicochemical and 
Engineering Aspects 262 (1-3):211-215. 
Sikareepaisan, P., A. Suksamrarn, and P. Supaphol. 2008. Electrospun gelatin fiber mats 
containing a herbal-Centella asiatica-extract and release characteristic of 
asiaticoside. Nanotechnology 19 (1). 
Sombatmankhong, K., N. Sanchavanakit, P. Pavasant, and P. Supaphol. 2007. Bone 
scaffolds from electrospun fiber mats of poly (3-hydroxybutyrate), poly(3-
hydroxybutyrate-co-3-hydroxyvalerate) and their blend. Polymer 48 (5):1419-1427. 
Sonoda, Y., Y. Matsumoto, M. Funakoshi, D. Yamamoto, S. K. Hanks, and T. Kasahara. 
2000. Anti-apoptotic role of focal adhesion kinase (FAK) - Induction of inhibitor-
of-apoptosis proteins and apoptosis suppression by the overexpression of FAK in a 
human leukemic cell line, HL-60. Journal of Biological Chemistry 275 (21):16309-
16315. 
Soto, K., K. M. Garza, and L. E. Murr. 2007. Cytotoxic effects of aggregated 
nanomaterials. Acta Biomaterialia 3 (3):351-358. 
Spasova, M., N. Manolova, D. Paneva, and I. Rashkov. 2004. Preparation of chitosan-
containing nanofibres by electrospinning of chitosan/poly(ethylene oxide) blend 
solutions. E-Polymers. 
Stashak, T. S., E. Farstvedt, and A. Othic. 2004. Update on wound dressings: Indications 
and best use. Clinical Techniques in Equine Practice 3 (2 SPEC. ISS.):148-163. 
E%(%0%*/%, &
& @HJ&
Stern, S. T., and S. E. McNeil. 2008. Nanotechnology safety concerns revisited. 
Toxicological Sciences 101 (1):4-21. 
Strassmann, B. B., A. R. Vieira, E. L. Pedrotti, H. N. F. Morais, P. F. Dias, and M. 
Maraschin. 2008. Quantitation of methylxanthinic alkaloids and phenolic 
compounds in mate (Ilex paraguariensis) and their effects on blood vessel 
formation in chick embryos. Journal of Agricultural and Food Chemistry 56 
(18):8348-8353. 
Subramanian, A., D. Vu, G. F. Larsen, and H. Y. Lin. 2005. Preparation and evaluation of 
the electrospun chitosan/PEO fibers for potential applications in cartilage tissue 
engineering. Journal of Biomaterials Science-Polymer Edition 16 (7):861-873. 
Suckow, M. A., J. P. Hodde, W. R. Wolter, K. V. Wood, M. C. Hiles, and A. D. Janis. 
2010. Addition of nimesulide to small intestinal submucosa biomaterial inhibits 
postsurgical adhesiogenesis in rats. Journal of Biomedical Materials Research Part 
B-Applied Biomaterials 93B (1):18-23. 
Suganya, S., T. S. Ram, B. S. Lakshmi, and V. R. Giridev. 2011. Herbal drug incorporated 
antibacterial nanofibrous mat fabricated by electrospinning: an excellent matrix for 
wound dressings. Journal of Applied Polymer Science 121 (5):2893-2899. 
Sun, Z. C., E. Zussman, A. L. Yarin, J. H. Wendorff, and A. Greiner. 2003. Compound 
core-shell polymer nanofibers by co-electrospinning. Advanced Materials 15 
(22):1929. 
Suwantong, O., P. Opanasopit, U. Ruktanonchal, and P. Supaphol. 2007a. Electrospun 
cellulose acetate fiber mats containing curcumin and release characteristic of the 
herbal substance. Polymer 48 (26):7546-7557. 
Suwantong, O., U. Ruktanonchai, and P. Supaphol. 2008. Electrospun cellulose acetate 
fiber mats containing asiaticoside or Centella asiatica crude extract and the release 
characteristics of asiaticoside. Polymer 49 (19):4239-4247. 
Suwantong, O., S. Waleetorncheepsawat, N. Sanchavanakit, P. Pavasant, P. 
Cheepsunthorn, T. Bunaprasert, and P. Supaphol. 2007b. In vitro biocompatibility 
of electrospun poly (3-hydroxybutyrate) and poly (3-hydroxybutyrate-co-3-
hydroxyvalerate) fiber mats. International Journal of Biological Macromolecules 
40 (3):217-223. 
Taepaiboon, P., U. Rungsardthong, and P. Supaphol. 2007. Effect of cross-linking on 
properties and release characteristics of sodium salicylate-loaded electrospun 
poly(vinyl alcohol) fibre mats. Nanotechnology 18 (17). 
Tan, S. H., R. Inai, M. Kotaki, and S. Ramakrishna. 2005. Systematic parameter study for 
ultra-fine fiber fabrication via electrospinning process. Polymer 46 (16):6128-6134. 
 
.$%/+0',12*& ( 3#0'2, &4"+, & ('0 &,5 3* &"*6&"#6'43*"$ &7"$ $ & 0%1"30 &
&
&@IK&
Tchemtchoua, V. T., G. Atanasova, A. Aqil, P. Filee, N. Garbacki, O. Vanhooteghem, C. 
Deroanne, A. Noel, C. Jerome, B. Nusgens, Y. Poumay, and A. Colige. 2011. 
Development of a chitosan nanofibrillar scaffold for skin repair and regeneration. 
Biomacromolecules 12 (9):3194-3204. 
Thakur, R. A., C. A. Florek, J. Kohn, and B. B. Michniak. 2008. Electrospun nanofibrous 
polymeric scaffold with targeted drug release profiles for potential application as 
wound dressing. International Journal of Pharmaceutics 364 (1):87-93. 
Theron, S. A., E. Zussman, and A. L. Yarin. 2004. Experimental investigation of the 
governing parameters in the electrospinning of polymer solutions. Polymer 45 
(6):2017-2030. 
Tolino, M. J., D. E. Tripoloni, R. Ratto, and M. I. Garcia. 2009. Infections associated with 
prosthetic repairs of abdominal wall hernias: pathology, management and results. 
Hernia 13 (6):631-637. 
Tommeraas, K., Varum, K. M.,  Christensen, B. E., Smidsrod, O. 2001. Preparation and 
characterisation of oligosaccharides produced by nitrous acid depolymerisation of 
chitosan. Carbohydrate Research 333:137–144. 
Ueno, H., T. Mori, and T. Fujinaga. 2001. Topical formulations and wound healing 
applications of chitosan. Advanced Drug Delivery Reviews 52 (2):105-115. 
Ueno, H., H. Yamada, I. Tanaka, N. Kaba, M. Matsuura, M. Okumura, T. Kadosawa, and 
T. Fujinaga. 1999. Accelerating effects of chitosan for healing at early phase of 
experimental open wound in dogs. Biomaterials 20 (15):1407-1414. 
Uyar, T., and F. Besenbacher. 2008. Electrospinning of uniform polystyrene fibers: The 
effect of solvent conductivity. Polymer 49 (24):5336-5343. 
van't Riet, M., P. J. D. van Steenwijk, F. Bonthuis, R. L. Marquet, E. W. Steyerberg, J. 
Jeekel, and H. J. Bonjer. 2003. Prevention of adhesion to prosthetic mesh - 
Comparison of different barriers using an incisional hernia model. Annals of 
Surgery 237 (1):123-128. 
VandeVord, P. J., H. W. T. Matthew, S. P. DeSilva, L. Mayton, B. Wu, and P. H. Wooley. 
2002. Evaluation of the biocompatibility of a chitosan scaffold in mice. Journal of 
Biomedical Materials Research 59 (3):585-590. 
Veleirinho, B., M. F. Rei, and J. A. Lopes-da-Silva. 2008. Solvent and concentration 
effects on the properties of electrospun poly(ethylene terephthalate) nanofiber mats. 
Journal of Polymer Science Part B-Polymer Physics 46 (5):460-471. 
Vo, N. lcker, D. Klee, Ho, H. cker, and S. Langefeld. 2001. Functionalization of silicone 
rubber for the covalent immobilization of fibronectin. Journal of Materials 
Science: Materials in Medicine 12:111-119. 
E%(%0%*/%, &
& @I@&
Voskerician, G., P. H. Gingras, and J. M. Anderson. 2006. Macroporous condensed 
poly(tetrafluoroethylene). I. In vivo inflammatory response and healing 
characteristics. Journal of Biomedical Materials Research Part A 76A (2):234-242. 
Wang, X., D. E. Heath, and S. L. Cooper. 2012. Endothelial cell adhesion and proliferation 
to PEGylated polymers with covalently linked RGD peptides. Journal of 
Biomedical Materials Research Part A 100A (3):794-801. 
Wei, M., J. Lee, B. W. Kang, and J. Mead. 2005. Preparation of core-sheath nanofibers 
from conducting polymer blends. Macromolecular Rapid Communications 26 
(14):1127-1132. 
Xu, F., F.-Z. Cui, Y.-P. Jiao, Q.-Y. Meng, X.-P. Wang, and X.-Y. Cui. 2009. Improvement 
of cytocompatibility of electrospinning PLLA microfibers by blending PVP. 
Journal of Materials Science-Materials in Medicine 20 (6):1331-1338. 
Yang, F., R. Murugan, S. Wang, and S. Ramakrishna. 2005. Electrospinning of nano/micro 
scale poly(L-lactic acid) aligned fibers and their potential in neural tissue 
engineering. Biomaterials 26 (15):2603-2610. 
Yang, Y., T. Xia, F. Chen, W. Wei, C. Liu, S. He, and X. Li. 2012. Electrospun Fibers 
with Plasmid bFGF Polyplex Loadings Promote Skin Wound Healing in Diabetic 
Rats. Molecular Pharmaceutics 9 (1):48-58. 
Yoshimoto, H., Y. M. Shin, H. Terai, and J. P. Vacanti. 2003. A biodegradable nanofiber 
scaffold by electrospinning and its potential for bone tissue engineering. 
Biomaterials 24 (12):2077-2082. 
You, Y., W. H. Park, B. M. Ko, and B. M. Min. 2004. Effects of PVA sponge containing 
chitooligosaccharide in the early stage of wound healing. Journal of Materials 
Science-Materials in Medicine 15 (3):297-301. 
Yuan, J., Z.-C. Xing, S.-W. Park, J. Geng, I.-K. Kang, J. Yuan, J. Shen, W. Meng, K.-J. 
Shim, I.-S. Han, and J.-C. Kim. 2009. Fabrication of PHBV/Keratin Composite 
Nanofibrous Mats for Biomedical Applications. Macromolecular Research 17 
(11):850-855. 
Zhang, K., H. Wang, C. Huang, Y. Su, X. Mo, and Y. Ikada. 2010. Fabrication of silk 
fibroin blended P(LLA-CL) nanofibrous scaffolds for tissue engineering. Journal 
of Biomedical Materials Research Part A 93A (3):984-993. 
Zhang, K., X. F. Wang, D. Z. Jing, Y. Yang, and M. F. Zhu. 2009. Bionic electrospun 
ultrafine fibrous poly(L-lactic acid) scaffolds with a multi-scale structure. 
Biomedical Materials 4 (3). 
Zheng, L.-Y., and J.-F. Zhu. 2003. Study on antimicrobial activity of chitosan with 
different molecular weights. Carbohydrate Polymers 54 (4):527-530. 
.$%/+0',12*& ( 3#0'2, &4"+, & ('0 &,5 3* &"*6&"#6'43*"$ &7"$ $ & 0%1"30 &
&
&@IA&
Zhou, Y., D. Yang, X. Chen, Q. Xu, F. Lu, and J. Nie. 2008. Electrospun water-soluble 
carboxyethyl chitosan/poly(vinyl alcohol) nanofibrous membrane as potential 
wound dressing for skin regeneration. Biomacromolecules 9 (1):349-354. 
Zhu, J., Y. Zhang, H. Shao, and X. Hu. 2008. Electrospinning and rheology of regenerated 
Bombyx mori silk fibroin aqueous solutions: The effects of pH and concentration. 
Polymer 49 (12):2880-2885. 
Zuo, W. W., M. F. Zhu, W. Yang, H. Yu, Y. M. Chen, and Y. Zhang. 2005. Experimental 
study on relationship between jet instability and formation of beaded fibers during 
electrospinning. Polymer Engineering and Science 45 (5):704-709. 
 
 
 
